" 

    Biocatalysts Ltd",Ms.,Naroa,Garcia,New Product Development Scientist,,Cellulosomes,Cellulosomes,1536,,,,,,
" 

    Biocatalysts Ltd",Mr.,Stephen,Timms,Business Development Manager at Biocatalysts Ltd,,Cellulosomes,Cellulosomes,1536,,,,,,
 IngredienTech,Mr.,James J,Jasko,Leads the company,james@ingredientech.com,Betalain,Betalain ,1782,,DO NOT SEND,,,,
 Lallemand SAS,Dr. ,Anne,Julien-Ortiz, Director R&D Yeasts & Nutrients,ajulien@lallemand.com,Betalain and L-DOPA,Betalain and L-DOPA,1782,On vacation till Aug 12th 2016,08/04/2016,,,,
3M,Ms.,Laura,Nereng,Sustainability and Business Development Leader at 3M, lrnereng@mmm.com,,Filter for Nanoparticles and water,1564,2017-08-01 She is on vacation till the 7th.,08/02/2017,,,08/15/2017,
A4F – AlgaFuel ,,Nuno,Coelho,Template,nuno.coelho@a4f.pt,Algal Oil,Algal Oil,1796,,,,,,
A4F – AlgaFuel ,Ms.,Melissa,Fernandes,Business Development and Special Projects na A4F-Algae for Future,melissa.fernandes@a4f.pt,Algal Oil,Algal Oil,1796,,email failed,,,,
A4F – AlgaFuel ,Ms.,Margarida,Duarte,"Marine Biologist, A4F-Algafuel, SA",margarida.duarte@a4f.pt,Algal Oil,Algal Oil,1796,,,,,,
,,,,,,,,,,,,,,
Abbott,Ms.,Kathryn,Short,"Director, R&D at Abbott Laboratories",kathryn.short@abbott.com,,,,,,,,,
Abbott,Ms.,Klara,Abravaya,"Senior Director, R&D at Abbott Molecular",Klara.Abravaya@abbott.com,,,,,,,,,
Abbott Laboratories,Dr.,Gary,Gordon,VP Oncology Development,gary.gordon@abbott.com,Bcl2 inhibitor predictive software,Cover letter,1881,,bounced,,,,
Achaogen Inc (?),,,,,,,,,,,,,,
Achilles Technology Solutions (MER Corporation),Ms.,Lori,Bracamonte,"Chief Technology Officer at ATS-MER, LLC",LORIB@MERCORP.COM,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,03/21/2018,,,,
Achilles Technology Solutions (MER Corporation),Dr.,William David,Thweatt,Senior Scientist at MER Corporation,wdthweatt@mercorp.com,,,,,bounced,,,,
Achilles Technology Solutions (MER Corporation),Mr.,James C,Withers,CEO,jcwithers@mercorp.com,,,,,,,,,
Acorda,Mr. ,Ravneesh,Sachdev,Corporate and business development professional,rsachdev@acorda.com,L-DOPA,Using L-DOPA Exclusive Exec Summary,1782,Wait with this one,,,,,
Acorda,MD,Steven,Komjathy,Medical Director Clinical Development,DKOMJATHY@AOL.COM,L-DOPA,Using L-DOPA Exclusive Exec Summary,1782,,07/11/2016,,,08/04/2016,
Adama Agricultural Solutions Ltd,,,,,yossi.kuttin@adama.com,,,,,,,,,
Adama Agricultural Solutions Ltd,Mr.,Gliad Reznik,Cohen,Global Product Strategy Manager at ADAMA (Makhteshim Agan Industries),gilad.cohen@adama.com or gilad.reznik.cohen@adama.com,Alkaloids,Alkaloids,1587,Lycored is part of this company,,,,,
Adama Agricultural Solutions Ltd,Dr. ,Renato,Castagna,Head of Global Product Development at ADAMA Agricultural Solutions Ltd,renato.castagna@adama.com,Alkaloids,Alkaloids,1587,Lycored is part of this company - He is not the right person he redirected me to Ronen Golan,08/22/2016,08/22/2016,,,
Adama Agricultural Solutions Ltd,Mr.,Ronen,Golan,Head of Novel Technologies at ADAMA,ronen.golan@adama.com,Alkaloids,Alkaloids,1587,He forwarded me to Sami Shabtai,08/22/2016,10/09/2016,,09/26/2016,
Adama Agricultural Solutions Ltd,Mr.,Sami,Shabtai,Tech Scouting,Sami.Shabtai@adama.com,Alkaloids,Alkaloids,1587,,10/26/2016,,,,
Adicet Bio,Dr. ,Stewart,Abbot,Chief Scientific Officer,Stewart Abbot <sabbot@adicetbio.com>,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,"Moved from Fate Therapeutics, email was forwarded and expressed interest in learnin about only the Universal CAR-T tech",07/09/2018,07/10/2018,Expressing interest and would like to learn more,,
Aequor Inc (?),Dr.,Marilyn,Bruno,"CEO, AEQUOR, Inc.",mbruno@aequorinc.com; bruno.marilyn@gmail.com,,,,,,,,,
Aequor Inc (?),Dr.,Cynthia,Burzell,"President at AEQUOR, Inc.","cburzell@gmail.com, cburzell@aequorinc.com",,,,,,,,,
Agios Pharmaceutical,Dr.,David,Schenkein,CEO,david.schenkein@agios.com,,,,,,,,,
Agios Pharmaceutical,Dr.,Kevin,Marks,VP of Biology,kevin.marks@agios.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,,07/18/2018,
Agios Pharmaceutical,Dr.,Kate,Yen,"Director, Clinical Science",kate.yen@agios.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,Bounced,,
Agrivida,Dr.,Jeremy,Johnson,Co-founder and Vice President, jeremy.johnson@agrivida.com  or johnsonj@agrivida.com,Genetic Logic Gates,NOR based Device,1764,,06/15/2017,,,,
AGTC ,,,,,,,,,,,,,,
AgTech Accelerator Corp.,Mr.,John W.,Dombrosky,Chief Executive Officer ,jdombrosky@agtechaccelerator.com,Carbon Fixing,Carbon Fixing,1736,Was forwarded to us by Michael Lee at Syngenta,,01/13/2017,"Reviewing the Technology, looks like he wants to setup a phone call. 2017-01-27 Final answer is no.",,
AiCuris Anti-infective Cures GmbH,Mr.,Simon,Rybach,Senior Manager Business Development & Licensing bei AiCuris Anti-infective Cures GmbH,business@aicuris.com ; simon.rybach@aicuris.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,05/12/2017,Negative,,
AiCuris Anti-infective Cures GmbH,Mr.,Holger,Schmoll,CFO,holger.schmoll@aicuris.com ,,,,,,,,,
Air Canada,Ms.,Bambina,Marcello,Director Business Development - Air Canada / Connecting Canada and the world through people and technology,bambina.marcello@aircanada.ca,,,,,,,,,
Air Canada,Ms.,Renee , Smith-Valade,"Vice President, Inflight Service at Air Canada",renee.smith-valade@aircanada.ca,,,,,,,,,
Air France KLM,Mr.,Thierry ,Spagnou,Partnerships Development Manager at Air France KLM,thspagnou@airfrance.fr,,,,,,,,,
Air France KLM,Mr.,Eric,Caron,General Manager at Air France KLM,ercaron@airfrance.fr,,,,,,,,,
Air France KLM,Mr.,Fabien,Pelous,Senior Vice President at Air France-KLM,fapelous@airfrance.fr,,,,,,,,,
Air New Zealand,Mr.,Lucas,McWilliams,Strategy Manager at Air New Zealand,lucas.mcwilliams@airnz.co.nz,,,,,,,,,
Air New Zealand,Ms.,Goergina,Borowczyk,Strategy Consultant at Air New Zealand,goergina.borowczyk@airnz.co.nz,,,,,,,,,
Ajinomoto co,Mr.,Takashi,Miyaki,"Manager, North American Research & Innovation Center at Ajinomoto North America, Inc.",miyakit@ajiusa.com,L-DOPA,Using L-DOPA Exclusive Exec Summary,1782,"Email bounced back, but only after second time, telling me he blocking me. ",08/04/2016,,,08/11/2016,
Ajinomoto co,Dr. ,Takashi,Yamamoto,"Manager, Licensing Group, Business Development Drpt.",takashia_yamamoto@ajinomoto.com,L-DOPA,Using L-DOPA Exclusive Exec Summary,1782,,07/11/2016,,,07/24/2016,
ALAR Engineering Corp,Mr.,Visalakshi ,Baskaran,Chemist at Alar Engineering,Visalakshib@alarcorp.com,,,,,bounced,,,,
ALAR Engineering Corp,Mr.,Christian ,Castañeda,Project Engineer at Alar Engineering Corp.,,,,,,,,,,
ALAR Engineering Corp,Mr.,Robert ,Schiffer ,Tech support,roberts@alarcorp.com,,,,,,,,,
"Alexion Pharmaceuticals, Inc.",,,,,,,,,,,,,,
Algae Natural food,Ms.,Lea,Gini,Ingénieur biotechnologie chez Algae Natural Food,lea.g.gini@gmail.com,Algal Oil,Algal Oil,1796,,01/10/2017,,,01/17/2017,
AlgaEnergy,Mr.,Carlos Alexander Rodriguez-Villa,Förster,"Managing Director at ALGAENERGY, S.A.",crv@algaenergy.es,Algal Oil,Algal Oil,1796,,01/10/2017,,2017-01-17 Reviewing the technology,01/17/2017,2017-03-06 Sent email
AlgaEnergy,Dr.,Federico G Witt,Sousa,Production Director,fws@algaenergy.es,Algal Oil,Algal Oil,1796,,,,,,
algaia,Dr. ,Benoit,Queguineur,"Partnership Manager, R+D at ALGAIA",benoit.queguineur@algaia.com,Algal Oil,Algal Oil,1796,,01/16/2017,,,,
algaia,Mr.,Franck,Hennequart,Director Research & Innovation at ALGAIA,franck.hennequart@algaia.com,Algal Oil,Algal Oil,1796,,,,,,
Algalif,Dr.,Amid,Derayat,Cultivation Specialist at Algalif Iceland ehf,aderayat@hotmail.com,Algal Oil,Algal Oil,1796,,,,,,
Algalif,Dr.,Tryggvi,Stefansson,Science Manager at Algalíf,tryggvi@algalif.com,Algal Oil,Algal Oil,1796,,01/10/2017,,,01/17/2017,
Algalo Industries  ,Dr.,Oran,Ayalon,VP Development at Algalo Industries ltd.,info@algalo.com ,Algal Oil,Algal Oil,1796,,01/10/2017,,,01/17/2017,
AlgaTechnologies,Dr.,Tair,Lapidot,Science Director at Algatechnologies,info@algatech.com,Algal Oil,Algal Oil,1796,,hold off,,,,
Algenol,Mr.,Jacques,Beaudry-Losique,Chairman at Algae Biomass Organization,tonya.dubois@algenol.com jacques.beaudry-losique@algenol.com,Algal Oil,Algal Oil,1796,,01/17/2017,01/17/2017,Negative - but want to hear from us in the future,,
Algenol,Dr.,Ming-De,Deng,Director of Molecular Biology at Algenol Biotech LLC,ming-de.deng@algenol.com,Algal Oil,Algal Oil,1796,,email failed,,,,
Algenuity,Dr.,Michiel,Matthijs,Chief Scientific Officer at Algenuity,michiel.matthijs@gmail.com,Carbon Fixing + Algal Oil,Carbon Fixing + Algal Oil,1736 + 1796,,01/10/2017,01/12/2017,"No, but wants to hear more from us in the future.",,
Algenuity,Dr.,Andrew,Spicer,CEO,aps@algenuity.com,Carbon Fixing + Algal Oil,Carbon Fixing + Algal Oil,1736 + 1796,,,,,,
Algosource,Ms,Fanny,Olivier,Executive Assistant,fanny.olivier@algosource.com,Algal Oil,Algal Oil,1796,,,,,,
Algosource,Dr.,Jean-Michel,Pommet,"Director, Innovation & Business Development",jean-michel.pommet@algosource.com,Algal Oil,Algal Oil,1796,,01/10/2017,01/17/2017,2017-01-17 Reviewing the technology,01/17/2017,2017-03-06 Sent email
All Nippon Airways,Mr. ,Takashi,Yamamoto,"All Nippon Airways ? Business Development, Innovation &amp; IT Strategy",takashi.yamamoto@ana.co.jp,,,,,,,,,
All Nippon Airways,Mr.,Tom,Mano,Vice President Business Development & Partnership at ANA X Incorporated,tom.mano@ana.co.jp,,,,,,,,,
Allogene Therapeutics,Ms.,Sarah,Honig,Chief Of Staff ,sarah.honig@allogene.com,,,,,,,,,
Allogene Therapeutics,Dr.,Alison ,Moore,Chief Technical Officer,alison.moore@allogene.com,,,,,,,,,
Allogene Therapeutics,Dr.,David,Chang,CEO and Co-founder,David.chang@allogene.com,,,,,,,,,
Allogene Therapeutics,Dr.,Barbra,Sasu,CSO,Barbra.sasu@allogene.com,Universal CAR-T,ES,1884,,06/21/2018,07/17/2018,Neutral - Sent for Review,07/08/2018,
Alnylam Pharmaceuticals,Ms.,Caroline Stark,Beer,"Senior Director, Head of Business Development",cbeer or cstark-beer,,,,,,,,,
Alnylam Pharmaceuticals,Dr. ,Akshay,Vaishnaw,Executive VP of R&D,avaishnaw@alnylam.com,,,,,,,,,
Alnylam Pharmaceuticals,Dr.,Kevin,FitzGerald,"Senior Vice President Research, Head of Research",kfitzgerald@alnylam.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
Alnylam Pharmaceuticals,Ms.,Caroline Stark,Beer,"Senior Director, Head of Business Development",cbeer or cstark-beer,,,,,,,,,
Alnylam Pharmaceuticals,Dr. ,Akshay,Vaishnaw,Executive VP of R&D,avaishnaw@alnylam.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Alnylam Pharmaceuticals,Dr.,Kevin,FitzGerald,"Senior Vice President Research, Head of Research",kfitzgerald@alnylam.com,,,,,,,,,
ALS Biopharma,Dr.,Jay,Wrobel,"VP, Business Development",jwrobel@alsbiopharma.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
ALS Biopharma,Dr.,Allen,Reitz,CEO,"areitz@alsbiopharma.com
",,,,,,,,,
AltuCell,Mr,Gary,Harlem,CEO at Altucell biotech,garyh1955@earthlink.net | info@altucell.com,Beta Cell isolation method,ES,1643,,04/15/2018,,,,
AMD (Radeon),Mr.,Joseph ,John,Director Product Engineering & Operations,,,,,,,,,,
AMD (Radeon),Mr.,Nick,Pandher,"Director, Market Development - Radeon Professional Graphics Business Unit",,,,,,,,,,
AMD (Radeon),Mr.,Roy,Taylor,Corporate Vice President of Alliances.,roy.taylor@amd.com,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,,,07/19/2017,
AMD (Radeon),,Kathy,Whyte,Template, kathy.whyte@amd.com ,,,,,,,,,
Ameda,Ms.,Jill,Dancewicz,"Global Marketing Manager, Consumer and Innovation at Ameda, Inc.",Jill.Dancewicz@ameda.com,Breastfeeding monitoring device,onepager,1431,,08/15/2017,,,08/22/2017,
Ameda,Mr.,Terry,Chung,Director of Engineering,Terry.Chung@ameda.com,,,,,,,,,
American Airlines,Mr.,Shawn,McGhee,Director - Partner Strategy & Business Development at American Airlines,shawn.mcghee@aa.com,,,,,,,,,
American Airlines,Mr.,Fernand,Fernandez,Vice President - American Airlines,fernand.fernandez@aa.com,,,,,,,,,
American Airlines,Mr.,Paul,Swartz,Strategic Partnerships Manager at American Airlines,paul.swartz@aa.com,,,,,,,,,
American Elements,Mr.,Justin,Large,Sales and Business Development Manager at American Elements,justin.large@americanelements.com,,Filter for Nanoparticles,1564,Forwarded to Gabriel Lies,08/02/2017,,,,
American Elements,Mr.,Gabriel,Leis,Product Engineer,Gabriel Leis <gabriel.leis@americanelements.com>,,Filter for Nanoparticles,1564,He is checking with his Engineers if they want to trial the technology.,,08/03/2017,Some interest,,
American Elements,,,,Template,gabriel.leis@americanelements.com,,,,,,,,,
American Water,Mr.,Timothy,Leahy,"Director of Business Development at American Water, Midwest Division ",,,,,,,,,,
American Water,Mr.,Mark,Strauss,Senior VP Corporate Strategy and Business Development at American Water,mark.strauss@amwater.com,,Filter for water,1564,,08/02/2017,,,08/08/2017,
American Water,,Denise,Free,,denise.free@amwater.com ,,,,,,,,,
Amgen,,,,,,,,,,,,,,
Amgen,Dr.,Karim ,Iskander,"Executive Medical Director, Amgen Global Medical Affairs",kiskander@amgen.com or kiskander@onyx.com,,,,,,,,,
Amgen,Dr.,Jude,Canon,Principal Scientist - Oncology Research Therapeutic Area,jcanon@amgen.com,Bcl2 inhibitor predictive software,Cover letter,1881,,03/21/2018,,,04/09/2018,
Amgen,Ms.,Michelle,Fortin,Progam lead of academic collaborations,mfortune@amgen.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,"Automated Reponse, will be out till July 16",07/18/2018,
Amylyx,Mr.,Joshua,Cohen,CEO and Founder at Amylyx Pharmaceuticals,,,,,,,,,,
Amylyx,Mr.,Kent,Leslie,Chief Scientific Officer at Amylyx Pharmaceuticals,,,,,,,,,,
Amyris,Dr. ,Joel,Cherry,"President, R&D at Amyris Inc",cherry@amyris.com ,Cellulosomes,Cellulosomes,1536,Has Ed as LinkedIn connection,09/18/2016,,,09/26/2016,
Amyris,Ms.,Cynthia,Bryant,SVP Corporate Development and Collaborations at Amyris,Bryant@amyris.com,Cellulosomes + Betalains,Cellulosomes,1536 + 1782,,10/26/2016,,,11/01/2016,
Amyris,Dr.,Greg,Manuel,Senior Vice President for Corporate Development and Strategy at Amyris Biotechnologies,Manuel@amyris.com,,,,,,,,,
Amyris,Dr.,A Ray,Chaudhuri,Senior Director Business Development at Amyris,Chaudhuri@amyris.com,Genetic Logic Gates,NOR based Device,1764,,06/15/2017,,,06/21/2017,
Amyris,Dr. ,Joel,Cherry,"President, R&D at Amyris Inc",cherry@amyris.com ,,,,,,,,,
Amyris,Ms.,Cynthia,Bryant,SVP Corporate Development and Collaborations at Amyris,Bryant@amyris.com,,,,,,,,,
Amyris,Dr. ,Joel,Cherry,"President, R&D at Amyris Inc",cherry@amyris.com ,PFL metabolic pathway for Formate + Acetate conversion to Pyruvate,ES,1657,,01/30/2018,,,02/06/2018,
ANDRITZ Separation - a division of the Andritz Group,Mr.,Steve,Huff,President at Andritz Separation Inc.,s.huff@andritz.com,,Filter for water,1564,,bounced,,,,
Anheuser-Busch InBev,Mr. ,Nathaniel,Davis,"Global Vice President, Innovation & Development ",Nathaniel.Davis@anheuser-busch.com,Betalain,Betalain,1782,,07/27/2016,,,08/03/2016,
Annapurna Labs,,Dan,Trock,Template,danit@annapurnalabs.com,,,,,,,,,
Annapurna Labs,Mr.,Yaniv,Shapira,Director of chip architecture and validation at Annapurna Labs,yanivs@annapurnalabs.com ?,,,,,,,,,
Annapurna Labs,Mr.,Zorik,Machulsky,Technical Director at Annapurna Labs,zorik@annapurnalabs.com,,,,,,,,,
AntibioTx ApS,Dr.,Daniel,Simon,Lead Scientist at AntibioTx ApS,info@antibiotx.com ,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,No Response,,05/22/2017,
AntibioTx ApS,Dr.,Morten,Sommer,CSO and Co-Founder,Morten Sommer <morten.sommer@antibiotx.com>,MRSA crystal structure,MRSA crystal scture (shortened),1760,Responded in place of Dr. Simon. Asked for more information sent it to him 2017-05-23.,,05/23/2017,Neutral,,
Apple,Mr.,John,Dorsey,Senior Scientist,jdorsey@apple.com,,,,,,,,,
Apple,Mr.,Fletcher ,Rothkopf,"Director of Product Design, Technology Investigation at Apple",frothkopf@apple.com,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,,,07/19/2017,
Apple,Mr.,Geoff,Stahl,"Director of Software, Technology Development Group @ Apple",,,,,,,,,,
Apple,Mr.,David,Schmuck,"Engineering Program Manager, Technology Investigation at Apple",,,,,,,,,,
Applied Nanotech,Dr.,Richard,Fink,"President, Applied Nanotech Inc.",dfink@appliednanotech.net,,Filter for Nanoparticles,1564,,08/02/2017,08/02/2017,No,,
"Aqua America, Inc",Dr.,Dan,Schuller,"EVP, Strategy & Corporate Development at Aqua America",,,,,,bounced,,,,
"Aqua America, Inc",Mr.,Michael,Senft,Chief Chemist-Inorganic Chemistry at Aqua America,MBSENFT@AQUAAMERICA.COM,,Filter for water,1564,,08/02/2017,,,08/08/2017,
"Aqua America, Inc",Mr.,Alan,Roth,Managing Director at Aqua America,,,,,,,,,,
"Aqua America, Inc",Mr.,Colton,Janes,,cjanes@aquaamerica.com ,,,,,,,,,
"Aqua America, Inc",Mr.,Robert,Ervin,,reervin@aquaamerica.com ,,,,,,,,,
Aquagro Fund LP,Dr. ,Hadar,Sutovsky,General Partner at Aquagro Fund LP,hadar@earthboundllc.com,Betalain and L-DOPA +Alkaloids,Betalain and L-DOPA +Alkaloids,1587 + 1782,2016-10-02 She is really interested in our stuff,07/27/2016,08/03/2016,She wants a meeting,08/03/2016,
Aquanos,Mr.,Udi,Leshem,CEO and Co-Founder at Aquanos,udi@aquanos.net,Algal Oil,Algal Oil,1796,,hold off,,,,
Aquatech,Mr.,Alan,Daza,Vice President Sales & Business Development - Americas & Europe Regions at Aquatech International Corporation,Dazaa@aquatech.com,,Filter for water,1564,Autoreply 2017-08-22,08/22/2017,,,08/29/2017,
Aquatech,Mr.,Simone,Callioni,Global Lead Project Development - Light Industrial at Aquatech Inernational LCC,Callionis@aquatech.com,,,,,,,,,
Aquatech,,Amy,Bloom,,BLOOMA@AQUATECH.COM,,,,,,,,,
Aquinnah Pharmaceutical,Dr.,Benjamin,Wolozin,"Co-Founder and Chief Scientific Officer at Aquinnah Pharmaceuticals, Inc.",bwolozin@aquinnahpharma.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Aquinnah Pharmaceutical,Dr.,Jean-Francois,Jean-Francois Blain,Director of Biology at Aquinnah Pharmaceuticals,,,,,,,,,,
Aquinnah Pharmaceutical,Dr.,Glenn,Larsen,President & CEO Aquinnah Pharmaceuticals,Glarsen@aquinnahpharma.com,,,,,,,,,
Arbutus Biopharma (changed name from Tekmira Pharmaceuticals) ,Mr.,Gregg,Ashby,Senior Director of Finance at Arbutus Biopharma,gashby@arbutusbio.com,,,,,,,,,
Arbutus Biopharma (changed name from Tekmira Pharmaceuticals) ,Ms.,Amy,Lee,"Senior Director, In Vivo Pharmacology and Macro-Molecular Discovery at Arbutus Biopharma Corporation",alee@arbutusbio.com,,,,,,,,,
Arbutus Biopharma (changed name from Tekmira Pharmaceuticals) ,Dr. ,James,Heyes,"VP, Technology Development",jheyes@arbutusbio.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
Arbutus Biopharma (changed name from Tekmira Pharmaceuticals) ,Mr.,Gregg,Ashby,Senior Director of Finance at Arbutus Biopharma,gashby@arbutusbio.com,,,,,,,,,
Arbutus Biopharma (changed name from Tekmira Pharmaceuticals) ,Ms.,Amy,Lee,"Senior Director, In Vivo Pharmacology and Macro-Molecular Discovery at Arbutus Biopharma Corporation",alee@arbutusbio.com,,,,,,,,,
Arbutus Biopharma (changed name from Tekmira Pharmaceuticals) ,Dr. ,James,Heyes,"VP, Technology Development",jheyes@arbutusbio.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Archer Daniels Midland Compan,,,,,,,,,,,,,,
Archer Daniels Midland Company ,,Mark W.,Collison,Template,Mark.Collison@adm.com,,,,,,,,,
Archer Daniels Midland Company ,Dr.,Will,Schroeder,Director of Biotechnology at Archer Daniels Midland,Will.Schroeder@adm.com or William.Schroeder@adm.com,Betalain+ Algal Oil + Cellulosomes ,Betalain+ Algal Oil + Cellulosomes ,1782 + 1796 +1536,,01/10/2017,01/17/2017,Reviewing the Technology,01/17/2017,2017-03-01 prepared response
Archer Daniels Midland Company ,Ms.,Kimberly J.,Hurm,Director - Food Ingredient Research & Innovation at Archer Daniels Midland Company,kimberly.hurm@adm.com,Betalain+ Algal Oil + Cellulosomes ,Betalain+ Algal Oil + Cellulosomes ,1782 + 1796 +1536,,,,,,
Archer Daniels Midland Company ,Dr.,Ware,Flora,"Vice President, R&D at Archer Daniels Midland Company",ware.flora@adm.com,Betalain+ Algal Oil + Cellulosomes ,Betalain+ Algal Oil + Cellulosomes ,1782 + 1796 +1536,,,,,,
Archer Daniels Midland Company ,Mr.,Robert,Pierceall,Biodiesel Research Manager at Archer Daniels Midland Company,robert.pierceall@adm.com,Betalain+ Algal Oil + Cellulosomes ,Betalain+ Algal Oil + Cellulosomes ,1782 + 1796 +1536,,,,,,
Archer Daniels Midland Company ,Dr.,Will,Schroeder,Director of Biotechnology at Archer Daniels Midland,William.Schroeder@adm.com,Colitis Treatment,,1831,"Bounced back, he no longer works there!! He works at Ginkgobioworks",06/01/2017,,,,
Archer Daniels Midland Company ,Ms.,Kimberly J.,Hurm,Director - Food Ingredient Research & Innovation at Archer Daniels Midland Company,kimberly.hurm@adm.com,Colitis Treatment,,1831,Bounced back,06/01/2017,,,,
Archer Daniels Midland Company ,Mr.,Mark,Stephens,"Director, Strategic Initiatives",mark.stephens@adm.com,Colitis Treatment,,1831,,06/13/2017,,,,
Archimede Ricerche Srl,Mr.,Silvio,Mangini,Responsabile Tecnico presso Archimede Ricerche srl,mangini@archimedericerche.com,Algal Oil,Algal Oil,1796,,01/10/2017,01/10/2017,"Wants more info, in regard to safety and units. prepared another email in response Replied 2017-01-16, no response and was more about getting information.",,
Arcturus Therapeutics ,Mr.,Mark ,Herbert,Director of Business Development at Arcturus Therapeutics,bd@arcturusrx.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
Arcturus Therapeutics ,Dr.,Padmanabh,Chivukula,COO & CSO at Arcturus Therapeutics,pad@arcturusrx.com,,,,,,,,,
Arcturus Therapeutics ,Mr.,Mark ,Herbert,Director of Business Development at Arcturus Therapeutics,bd@arcturusrx.com,,,,,,,,,
Arcturus Therapeutics ,Dr.,Padmanabh,Chivukula,COO & CSO at Arcturus Therapeutics,pad@arcturusrx.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Arena Pharmaceuticals,,BR,Teegarden,, bteegarden@arenapharm.com,,,,,,,,,
Arena Pharmaceuticals,Dr.,Ron,Christopher,"Vice President, Preclinical Development at Arena Pharmaceuticals",rchristopher@arenapharm.com,,,,,,,,,
Arena Pharmaceuticals,Dr. ,Anna ,Crivici,"Vice President, Program Management at Arena Pharmaceuticals",,,,,,,,,,
Arix Biosciences,Mr.,Owen,Smith,No longer at ARIX bioscience.,owen@arixbioscience.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,07/09/2018,No longer working there - Automated reply,,
Arix Biosciences,Dr.,Jonathan ,Tobin, Investment Director at Arix Bioscience , jonathan@arixbioscience.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,2018-07-09 Wanted to know whether this was for a Newco or to be licensed to a company. I emailed and explained that is focused on licensing as the tech is more a support tech. ,07/09/2018,07/09/2018,Initial interest; reviewing the tech.,,
Arkema,Dr.,Mickael ,Havel,Business Development Manager at Arkema Inc.,mickael.havel@arkema.com,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,03/21/2018,,,,
Arkema,Mr.,Pierre ,BRAUD,Business Development Manager at ARKEMA,,,,,,,,,,
Arrakis,,,,,,,,,,,,,,
Arrowhead Research,Dr.,David,Lewis,Chief Scientific Officer - Arrowhead Research Corporation,dlewis@arrowheadpharma.com,,,,,,,,,
Arrowhead Research,Dr.,Steven,Kanner,"VP, Biology",skanner@arrowheadpharma.com,,,,,,,,,
Arrowhead Research,Mr.,Peter,Leone,"Vice President, Strategic Business Initiatives at Arrowhead Pharmaceuticals, Inc.",pleone@arrowheadpharma.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,06/13/2017,"Unclear email, but no they are focused on their internal pipeline.",06/13/2017,
Arrowhead Research,Dr.,David,Lewis,Chief Scientific Officer - Arrowhead Research Corporation,dlewis@arrowheadpharma.com,,,,,,,,,
Arrowhead Research,Dr.,Steven,Kanner,"VP, Biology",skanner@arrowheadpharma.com,,,,,,,,,
Arrowhead Research,Mr.,Peter,Leone,"Vice President, Strategic Business Initiatives at Arrowhead Pharmaceuticals, Inc.",pleone@arrowheadpharma.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Ascletis ,,,,General Business Development Email,bd@ascletis.com,,,,,,,,,
Ascletis ,Mr.,Weilun (Spike),Lo,Associate Director Business Development at Ascletis BioScience,spike.wll@gmail.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
Ascletis ,,,,General Business Development Email,bd@ascletis.com,,,,,,,,,
Ascletis ,Mr.,Weilun (Spike),Lo,Associate Director Business Development at Ascletis BioScience,spike.wll@gmail.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Astareal,Dr.,Arun,Nair,President & CEO at AstaReal Inc,,,,,,hold off,,,,
Astareal,Dr.,Gary,Allison,"Executive Vice President, CMO AstaReal Inc.",,,,,,,,,,
Astellas,Mr.,Bill ,Calliss,"Director, Alliance Management and Licensing",bill.calliss@astellas.com,,,,,,,,,
Astellas Pharmaceuticals,,,,,,,,,,,,,,
AstraZeneca,Mr.,Steve,Twait,Vice President - Alliance and Integration Management (AIM) at AstraZeneca,Steven.Twait@astrazeneca.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,2017-06-09 Passed along to CVMD team to Kay Brickmann. Cursory interest but not wanting to proceed further.,06/07/2017,06/07/2017,Neutral - Under review,,
AstraZeneca,Dr.,Kay,Brickmann,Business Development Director at AstraZeneca (cardiovascular related),Kay.Brickmann@astrazeneca.com,,,,She is picking up from Steven Twait,,06/09/2017,"Negative - not interested at the moment, but wants to hear more in regard to 1610 in the future (specifically diabetes)",,
AstraZeneca,Dr.,Kurt G. ,Pike,Associate Director - Strategy and Licensing,Kurt.Pike@astrazeneca.com,TNBC shRNA,TNBC shRNA,1619,Very thorough response. ,,08/02/2017,"No, primarily because it is shRNA and they want small molecules. ",,
AstraZeneca,Ms.,Bavani,Shankar,"Senior Director, Scientific Partnering & Alliances, AstraZeneca",Bavani.Shankar@astrazeneca.com,,,,,,,,,
AstraZeneca,Mr.,Steve,Twait,Vice President - Alliance and Integration Management (AIM) at AstraZeneca,Steven.Twait@astrazeneca.com,,,,,,,,,
AstraZeneca,Dr.,Kay,Brickmann,Business Development Director at AstraZeneca (cardiovascular related),Kay.Brickmann@astrazeneca.com,,,,,,,,,
AstraZeneca,Mr.,Steve,Twait,Vice President - Alliance and Integration Management (AIM) at AstraZeneca,Steven.Twait@astrazeneca.com,Mouse monitoring systems,ES,1571 and 1593,,07/17/2018,07/17/2018,Negative - AstraZeneca is no longer in the area of Neuroscience,,
AstraZeneca - MedImmune,Mr.,Eric,Victory,"Vice President & Head for Cardiovascular & Metabolic Disease, Partnering & Strategy at MedImmune",VictoryE@medimmune.com,,,,,,,,,
AstraZeneca Plc ,Dr.,Astrid,McKeown,Senior Principal Clinical Scientist - Director Medical Development Oncology at AstraZeneca,astrid.mckeown@astrazeneca.com,Bcl2 inhibitor predictive software,Cover letter,1881,Out of office from april 6th…,03/21/2018,,,04/09/2018,
AstraZeneca plc (?) Divested from antibiotics in 2016,,,,,,,,,,,,,,
Atara Biotherapeutics,Mr.," Dan 
",Maziasz,Head of Business Development and Alliance Management,dmaziasz@atarabio.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,"2018-07-05 Slow response on my end, however not interested due to the challenge of reformulating the drug. Also general non-interest in the Synthetic niches.",06/21/2018,06/21/2018,Neutral - reviewing tech but with positive connotation. 2018-07-Negative.,,
Atara Biotherapeutics,Mr.,David,Carmel," Vice President, Strategic Alliances at Atara Biotherapeutics ",dcarmel@atarabio.com,,,,,,,,,
AuraSense Therapeutics (most likely Exicure as well),,,,,,,,,,,,,,
Auspherix Limited,Dr.,Nikki,D'Arcy,Associate Director,"firefly2280@yahoo.co.uk, nikki.darcy@auspherix.com",MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,No Response,Negative,05/22/2017,
Auspherix Limited,Mr.,Grant ,Hawthorne,COO,,,,,,,,,,
Auspherix Limited,Dr.,Neil,Miller,CEO,neil.miller@auspherix.com,,,,,,,,,
Auspherix Limited,Dr.,Richard,Rutter,CSO,richard.rutter@auspherix.com,,,,,,,,,
AutoDesk,Dr.,Cornelia,Scheitz,Principal Research Scientist,cornelia.scheitz@autodesk.com,Genetic Logic Gates,NOR based Device,1764,,06/15/2017,06/15/2017,Negative - They simply aren't in this area. Only software.,,
Autolus,Mr.,Jim,Faulkner, SVP and Head of Product Delivery at Autolus Ltd. ,j.faulkner@autolus.com,,,,,,,,,
Autolus,Dr.,Alireza ,Alavi,"Director, US Site Translational Medicine Lead",a.alavi@autolus.com,,,,,,,,,
Autolus,Dr.,James,Francis,"Director, Translational Research",j.francis@autolus.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,Made contact via Arix Bio,,
Autolus,Dr.,Saga,Johansson,Project Director,s.johansson@autolus.com,,,,,,,,,
Autolus,Dr.,Chris,Williams,"Director, Business Development ",c.williams@autolus.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,"2018-07-11 Forwaded by Jonathan Tobin of Arix to Autolus. Email with relevant patents, publications, and general data sent.",,07/11/2018,Neutral - but would like to learn more.,,
Avanir Pharmaceuticals Inc,Mr.,Tom,Witt,Sr. Director of Corporate Development,twitt@avanir.com,miR-218,ES,1498,,08/16/2017,09/10/2017,Negative - but still welcomes new compounds from YEDA if they have animal data,08/23/2017,
Avista Technologies,Mr.,Dave,Walker,"President & CEO at Avista Technologies, Inc.",dwalker@avistatech.com,,Filter for water,1564,Setup a connection with Doug Eisberg,08/22/2017,08/24/2017,Positive setting up a TC with Ronen,,
Avista Technologies,Mr.,Doug,Eisberg,Director of Business Development ,deisberg@avistatech.com,,Filter for water,1564,,,08/24/2017,Setting up a meeting with Ronen,,
Avista Technologies,Mr.,Lee,Durham,"Director of Technical Services, Avista Technologies.",,,,,,,,,,
Avista Technologies,,MELISSA,kaysen,,mkaysen@avistatech.com,,,,,,,,,
AXEON Water Technologies,Mr.,Henry,Avina,VP of Sales & Business Development at AXEON Water Technologies,HAVINA@AXEONWATER.COM,,Filter for water,1564,,08/22/2017,,,08/29/2017,
BASF,,,,,first.last@basf.com,,,,,,,,,
BASF,Dr. ,Lahoucine,Achnine,"Technology Acquisition Manager, Americas",lahoucine.achnine@basf.com,Betalain and L-DOPA +Alkaloids,Betalain and L-DOPA +Alkaloids,1782 + 1587,,08/04/2016,08/22/2016,Positive - will send it for review seems to know Asaph Personally,08/11/2016,prepared
BASF,Dr. ,Richard,Trethewey,"Vice President, Innovation & Scouting, Bioscience Research at BASF",richard.trethewey@basf.com,Betalain and L-DOPA +Alkaloids,Betalain and L-DOPA +Alkaloids + Cellulosomes,1782 + 1587 +1536,,,,,,
BASF,Dr. ,Lahoucine,Achnine,"Technology Acquisition Manager, Americas",lahoucine.achnine@basf.com,Cellulosomes (biofuels),Cellulosomes,1536,,09/18/2016,09/20/2016,Sending it off for review,,
BASF,Dr. ,Lahoucine,Achnine,"Technology Acquisition Manager, Americas",lahoucine.achnine@basf.com,Carbon Fixing,Carbon Fixing,1736,,,,,,
BASF,Dr. ,Stefan,Tresch,Teamleader MoA/HTC Glaobal Research Herbicides,stefan.tresch@basf.com,Carbon Fixing,Carbon Fixing,1736,,,,,,
Bayer,Dr.,Gregor,Fachinger,"Senior Director, BD&L-Early Licensing at Bayer HealthCare Pharmaceuticals",Gregor.Fachinger@bayer.com,Diabetes treatment augmentation,1-pager,1804,,02/11/2018,,,02/15/2018,
Bayer,Dr. ,EunJu ,Lee,"APAC Regional Alliance Manager, Bayer Global External Innovation and Alliances",,,,,,,,,,
Bayer,Dr. ,Feng Aaron,Chen,"Senior Director, Global Business Development & Licensing at Bayer HealthCare",,,,,,,,,,
Bayer,Dr. ,Mark,Wolters,LEAPs by Bayer: Breaking through the impossible,mark.wolters@bayer.com,,,,,,,,,
Bayer,,Johan,Groenewald,Field development manager at Bayer Pharmaceuticals,johan.groenewald@bayer.com,,,,,,,,,
Bayer Crop Science,Mr.,Diego ,Angelo,,,,,1587,,,,,,
Bayer Crop Science,Mr.,Frank,Claessens,Managing Director Operations at Bayer CropScience Vegetable Seeds,frank.claessens@bayer.com,,Alkaloids,1587,,06/27/2016,06/27/2016,Negative - Not interested,,
Bayer Crop Science,Mr.,Joachim,Schneider,Head of Bayer CropScience Vegetable Seeds,joachim.schneider@bayer.com,,Alkaloids,1587,,06/27/2016,06/28/2016,Positive - Passed along to Samir Bennabi (samir.bennabi@bayer.com) and then to Alan Kriz ,,
Bayer Crop Science,Dr.,Adrian ,Percy,Research & Development at Bayer CropScience,adrian.percy@bayer.com,,Alkaloids,1587,Got redirected to Alan Kriz,06/27/2016,,,,
Bayer Crop Science,Mr.,Frank,Terhorst,Global Head of Seeds bei Bayer CropScience,frank.terhorst@bayer.com,,Alkaloids,1587,,06/27/2016,06/27/2016,Positive- Redirected Alan Kriz (alan.kriz@bayer.com) - but overall not interested at the moment,,
Bayer Crop Science,Ms.,Stacy ,Woodruff,Processing - Bayer Vegetable Seeds,stacy.woodruff@bayer.com,,Alkaloids,1587,,06/27/2016,,,,
Bayer Crop Science,Dr. ,Johan ,Botterman,R&D & New Ventures Manager EMEA,johan.botterman@bayer.com,Carbon Fixing,Carbon Fixing,1736,,,,,,
Bayer Crop Sciences,Dr. ,Alan,Kriz,Strategic Alliance Manager at Bayer CropScience,alan.kriz@bayer.com,L-DOPA and Betalians,Using Betalian and L-DOPA Exec Summary,1782,Finally responded and wants a phone meeting,07/11/2016,"07/12/2016, 2016/08/01","Out of office - till May 13th? (I am guessing to till July 13th), 2nd response not officially interested, but will have a phone chat with Orly to discuss future possible technologies they are interested in. ",07/24/2016,
Bayer Crop Sciences,Dr. ,Alan,Kriz,Strategic Alliance Manager at Bayer CropScience,alan.kriz@bayer.com,Carbon Fixing,Carbon Fixing,1736,,01/10/2017,01/23/2017,At a conference till January 20th 2017 - 2017-01-23 reviewing. 2017-02-14 Wants meeting related to technology. 2017-02-21 Meeting agreed upon for the technology on 2017-03-21.,01/17/2017,
BCL2 Inhibitor project for Ravid Staussman,,,,,,,,,,,,,,
BDI – BioLife Science GmbH,Dr.,Katharina,Dokulil,Biotechnologin bei BDI BioLife Science,katharina.dokulil@bdi-bioenergy.com,Algal Oil,Algal Oil,1796,,email failed,,,,
Beckman Coulter,,,,,,,,,,,,,,
Beiersdorf,,Andrea M.,Schoelermann,TEMPLATE,andrea.schoelermann@beiersdorf.com,,,,,,,,,
Beiersdorf,Dr.,Sascha,Baumann,Actives Scouting at Beiersdorf,sascha.baumann@beiersdorf.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,01/10/2017,,,,
Beiersdorf,Dr.,Inken,Groth,Research Scientist Active Ingredients at Beiersdorf,inken.groth@beiersdorf.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,,,,,
Beiersdorf,Dr.,Andreas,Clausen,Corporate Director R&D Category Unit Body bei Beiersdorf,andreas.clausen@beiersdorf.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,,,,,
Bellicum Pharmaceuticals,Dr.,Tsvetelina Pencheva ,Hoang,Director of Translational Research at Bellicum Pharmaceuticals,Thoang@bellicum.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,,07/18/2018,
Bellicum Pharmaceuticals,Mr.,Devin,Blass,Director Manufacturing ,dblass@bellicum.com,,,,,,,,,
Bellicum Pharmaceuticals,Mr.,Rick,Fair,President & CEO ,rfair@bellicum.com,,,,,,,,,
Bellicum Pharmaceuticals,Dr.," Matthew
", Hewitt,Principal Scientist/Director Tumor Immunology/Microenvironment,mhewitt@bellicum.com,,,,,,,,,
Benitec Biopharma [Tacere Therapeutics ],Mr.,Carl,Stubbings,Chief Business Officer,cstubbings@benitec.com,,,,,,,,,
Benitec Biopharma [Tacere Therapeutics ],Dr.,Michael,Graham,Scientific Consultant at Benitec,mgraham@benitec.com.au,,,,,,,,,
Benitec Biopharma [Tacere Therapeutics ],Dr. ,Cliff,Holloway,Chief Business and Operating Officer at Benitec Biopharma Ltd (ASX:BLT; NASDAQ; BNTC),cholloway@benetic.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,,
Benitec Biopharma [Tacere Therapeutics ],Dr.,Badriprasad,Ananthanarayanan,Research Scientist at Benitec Biopharma Ltd,,,,,,,,,,
Benitec Biopharma [Tacere Therapeutics ],Mr.,Kermit,Zhang,Molecular Biology Research Associate at Benitec Biopharma Ltd,,,,,,,,,,
Benitec Biopharma [Tacere Therapeutics ],Dr.,Tin,Mao,Senior Scientist at Benitec Biopharma Ltd,,,,,,,,,,
Benitec Biopharma [Tacere Therapeutics ],Dr.,David,Suhy,CSO,,,,,,,,,,
Benitec Biopharma [Tacere Therapeutics ],Dr.,Petrus W,Roelvink,Senior Director Research at Benitec Biopharma,,,,,,,,,,
Beta Renewables,Mr.,Paolo,Carollo,"Executive Vice President, North America, Beta Renewables USA, Inc.",paolo.carollo@betarenewables.com and carollo.paolo@gmail.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,09/26/2016,Forwarded my email to Dr.Alessandra Frattini,09/26/2016,
Beta Renewables,Dr.,Alessandra,Frattini,CTO of Beta Renewables,alessandra.frattini@gruppomg.com,Cellulosomes,Cellulosomes,1536,,10/26/2016,,,,
Betalin Therapeutics,Ms.,Laura,Sexer,Business Development Analyst at Betalin Therapeutics Ltd.,,,,,,,,,,
Betalin Therapeutics,Dr.,Manuela ,Vecsler,Senior Scientist at Betalin Therapeutics Ltd.,,,,,,,,,,
Betalin Therapeutics,Mr.,Shay,Hershcovich,Co-Founder at Betalin Therapeutics,shay@betalintherapeutics.com,Beta Cell isolation method,ES,1643,,04/15/2018,,,04/23/2018,
Betalogics (acquired by ViaCyte),,,,,,,,,,,,,,
Bio-Rad,,,,,,,,,,,,,,
Bioamber,Ms.,Louise,Batchelor,VP Strategy at BioAmber Inc.,louise.batchelor@bio-amber.com,Cellulosomes (Biofuels),Cellulosomes,1536,,01/23/2017,,,prepared,
Bioamber,Mr.,Patrick,Piot,"Vice President, Business Development at BioAmber Inc.",patrick.piot@bio-amber.com,Cellulosomes (Biofuels),Cellulosomes,1536,,01/10/2017,,,01/17/2017,
Bioamber,Ms.,Louise,Batchelor,VP Strategy at BioAmber Inc.,louise.batchelor@bio-amber.com,,,,,,,,,
Bioamber,Mr.,Patrick,Piot,"Vice President, Business Development at BioAmber Inc.",patrick.piot@bio-amber.com,Genetic Logic Gates,NOR based Device,1764,,06/15/2017,,,06/21/2017,
Biocatalysts,,,,General Email,enquiries@biocats.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,09/28/2016,"Not interested but now have the emails of Mark Blight [MarkB@biocats.com],  Aelig Robin ?[AeligR@biocats.com]??; Danielle Lloyd ?[DanielleL@biocats.com]? ",09/26/2016,
BioGen,Dr.,Philipp ,von Rosenstiel,Senior Medical Director Neurology Discovery & Development,vonrosenstiel@gmail.com or philipp.vonrosenstiel@biogen.com,Mouse monitoring systems,ES,1571 and 1593,,07/17/2018,,,,
BioGen,Dr.,Jacob,Elkins,"Vice President, Head Acute Neurology Research Unit",,,,,,,,,,
BioGen,Dr.,Michael,Ehlers,Executive Vice President,,,,,,,,,,
Biogen Idec Inc,Ms.,Gillian,Mullins,Alliance Development at Biogen Idec,gillian.mullins@biogenidec.com or @biogen.com,miR-218,ES,1498,,bounced,,,,
BioMedica (Oxford BioMedica) ,,,,,,,,,,,,,,
Biomics Biotechnology ,,,,,,,,,,,,,,
Bioneer ,,,,,,,,,,,,,,
Bluebird Biosciences,Dr.,Kevin,Friedman,Senior Director,kfriedman@bluebirdbio.com,,,,,,,,,
Bluebird Biosciences,Dr.,Derek,Adams,Chief Technology and Manufacturing Officer,dadams@bluebirdbio.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,,07/18/2018,
Bluebird Biosciences,Mr.,Nick,Leschly,CEO,nleschly@bluebirdbio.com,,,,,,,,,
Boehringer Ingelheim,Dr.,Johannes ,Zanzinger,"Global Head, Business Development & Licensing CardioMetabolic Diseases at Boehringer Ingelheim","
johannes.zanzinger@boehringer-ingelheim.com",,,,,,,,,
Boehringer Ingelheim,Dr.,Monica ,Cheng,Deputy Head - Business Development & Licensing - Cardiometabolic Diseases at Boehringer Ingelheim,monica.cheng@boehringer-ingelheim.com,Diabetes treatment augmentation,1-pager,1804,,02/11/2018,04/09/2018,Negative - Does not align -  repositioned to focus on T2D remission instead of glucose control,02/15/2018,
Boehringer Ingelheim,Dr. ,Christine,Grygon,"Executive Director, Business Development and Licensing at Boehringer Ingelheim",,,,,,,,,,
Boehringer Ingelheim,Ms.,Alexia ,Priest,"Associate Director, Business Development & Licensing/ Strategic Transactions Boehringer Ingelheim Pharmaceuticals, Inc.",,,,,,,,,,
Boehringer Ingelheim,Ms.,Susan,Davidson,Business & Development Licensing Coordinator at Boehringer Ingelheim,,,,,,,,,,
Boehringer Ingelheim GmbH,Dr.,Thomas,Seck,Vice President Clinical Development and Medical Affairs - Primary Care at Boehringer Ingelheim,thomas.seck@boehringer-ingelheim.com,Bcl2 inhibitor predictive software,Cover letter,1881,,03/21/2018,,,04/09/2018,
Boston Biomedical (Dainippon Sumitomo Pharma) ,,,,,,,,,,,,,,
BP,,,,,adam.smith3@bp.com,,,,,,,,,
BP,Mr.,Steve,Taggart,Head of Development - LC Bioethanol Scaleup at BP Biofuels,steve.taggart@bp.com,Cellulosomes,Cellulosomes,1536,Biofuels,09/18/2016,,,09/26/2016,
BP,Dr.,Ian,Dobson,,,,,,,,,,,
Bristol-Myers Squibb,,,,,junshu.zhao@bms.com,,,,,,,,,
Bristol-Myers Squibb,Ms.,Michele,DeBlasio,"Director, Alliance Management",,,,,,,,,,
Bristol-Myers Squibb,Mr.,Michael,Iafolla ,"VP, Alliance Management at Bristol-Myers Squibb",,,,,,,,,,
Bristol-Myers Squibb,Ms.,Tracy,Ruggiero,"Director, Alliance Management at Bristol-Myers Squibb",,,,,,,,,,
Bristol-Myers Squibb Co,Dr.,Saul,Fink,"Head, Translational Medicines, Discovery and Pharmaceutical Development Strategy & Operations at Bristol-Myers Squibb",,,,,,,,,,
Bristol-Myers Squibb Co,Dr.,Martin,Crook,"Global Lead - Cardiovascular Search & Evaluation, Business Development at Bristol-Myers Squibb",martin.crook@bms.com,Diabetes treatment augmentation,1-pager,1804,,02/11/2018,02/12/2018,Negative,,
Bristol-Myers Squibb Co,Mr.,Graham ,Brazier,Business Development Executive,graham.brazier@bms.com,,,,,,,,,
Bristol-Myers Squibb Co,Dr. ,Myra ,Beaudoin Bertrand,"Cardiovascular, Fibrosis and Immunoscience Opportunities",BD-CFISnE@bms.com,,,,,,,,,
Bristol-Myers Squibb Co,,Michael,Cucolo,Discovery Technology Opportunities,BD-TechTrans@bms.com,,,,,,,,,
Bristol-Myers Squibb Co,Dr.,Michael M.,Miller,Director at Bristol-Myers Squibb,michael.miller@bms.com,,,,,,,,,
British Airways,Mr.,Ron David,Sachs,"Commercial Leader Specialised in Sales, Strategy and Change Management. MBA",,,,,,,,,,
British Airways,Mr.,Roger,Blackburn,Head of Strategy and Business Planning at British Airways,roger.blackburn@ba.com,,,,,,,,,
Broadcom,,pat,thaler,template," 
pthaler@broadcom.com",,,,,,,,,
Broadcom,Mr.,Sudhakar,Sabada,Senior Vice President / General Manager at Broadcom,Sudhakar.Sabada@broadcom.com,Multi-state polymers for memory and logic gates,Web page,1568,Email bounced,,,,,
Broadcom,Dr.,Andrew,Blanksby,Distinguished Engineer at Broadcom,andrew.blanksby@broadcom.com,,,,,,,,,
Broadcom,Dr.,Mehmet,Tazebay,Director at Broadcom,,,,,,,,,,
BTS research,,,,,,,,,,,,,,
Calysta,Dr.,Alan,Shaw,CEO,ashaw@calysta.com,,,,,,,,,
Calysta,Mr.,Dennis,Leong," Vice President, Business Development",dleong@calysta.com,Genetic Logic Gates,NOR based Device,1764,,06/15/2017,06/22/2017,Negative - Does not suit them,06/21/2017,
Calysta,Dr.,Josh,Silverman, Chief Product and Innovation Officer,,,,,,,,,,
Calysta,Mr.,Dennis,Leong," Vice President, Business Development",dleong@calysta.com,PFL metabolic pathway for Formate + Acetate conversion to Pyruvate,ES,1657,,01/30/2018,,,02/06/2018,
Cantab Anti-infectives Ltd.,Ms.,Pamela,Brown,"Director, Medicinal Chemistry at Cantab Anti-infectives",pamela.brown@cantabanti.com,,,,,,,,,
Cantab Anti-infectives Ltd.,Dr.,Steven,Boakes,Head of Microbiology/Deputy Program Manager at Cantab Anti-infectives Ltd. Co-founder of Icklelingo.,steven.boakes@cantabanti.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,No Response,Doesn't work,05/22/2017,
Cardax,Dr.,Gilbert M,Rishton,CSO at Cardax ,grishton@cardaxpharma.com,Astaxanthin producing ecoli,ES,1650,,04/08/2018,04/08/2018,Neutral - simply acknowledged receiving the tech.,,
Cardinal Health,Ms.,Debra,Schotz,Senior Vice President/General Manager of Surgical and Medical Products at Cardinal Health,debra.schotz@cardinalhealth.com,Breastfeeding monitoring device,onepager,1431,,08/15/2017,,,,
Cardinal Health,Ms.,Michelle (Rethman),Zaluzney,Vice President Business Development at Cardinal Health,,,,,,,,,,
Cardinal Health,Mr.,Jimmy ,Steinberg,"Vice President, Corporate Development (M&A) at Cardinal Health",,,,,,,,,,
Cargill,Dr.,Geert,Maesmans,"Director Research and Development at Cargill Food Ingredients and BioIndustrials, Starches and Sweeteners Group",Geert_Maesmans@cargill.com,Carbon Fixing + Algal Oil + Cellulosomes (sweeteners),Carbon Fixing + Algal Oil + Cellulosomes (sweeteners),1736 + 1796 +1536,"Knows Orly, more friendly",01/10/2017,01/17/2017,Reviewing the technology,01/17/2017,2017-03-06 Sent email
Cargill,Dr.,Kerr,Dow,"Vice President, Global Research and Development at Cargill",Kerr_Dow@cargill.com,Carbon Fixing + Algal Oil,Carbon Fixing + Algal Oil,1736 + 1796,,,,,,
Cargill,,Jack,Staloch,VP Global Director of Biotechnology R&D at Cargill,Jack_Staloch@cargill.com,Carbon Fixing + Algal Oil,Carbon Fixing + Algal Oil,1736 + 1796,,,,,,
Cargill,Dr.,Aristos,Aristidou,"Technology Director, Cargill Biotechnology Development Center",Aristos_Aristidou@cargill.com,Carbon Fixing + Algal Oil + Cellulosomes (sweeteners),Carbon Fixing + Algal Oil + Cellulosomes (sweeteners),1736 + 1796 +1536,,,,,,
Cargill,Dr.,Bill,Aimutis,Global Director – External Innovation,Bill_Aimutis@cargill.com,Colitis Treatment,,1831,,,08/15/2017,"Negative - "".  After reviewing the document you forwarded and speaking with the appropriate business, we have decided this technology is not a good fit for our strategy at the present time.""",,
Cargill,Mr.,Peter C.,Hawthorne,"Vice President, Corporate Strategy & Development at Cargill",peter.hawthorne@cargill.com,,,,,,,,,
Cargill,Dr.,Geert,Maesmans,"Director Research and Development at Cargill Food Ingredients and BioIndustrials, Starches and Sweeteners Group",Geert_Maesmans@cargill.com,Colitis Treatment,,1831,,06/01/2017,06/08/2017,Neutral - Under review,06/08/2017,
Cargill,Dr.,Kerr,Dow,"Vice President, Global Research and Development at Cargill",Kerr_Dow@cargill.com,,,,,,,,,
Cargill,,Jack,Staloch,VP Global Director of Biotechnology R&D at Cargill,Jack_Staloch@cargill.com,,,,,,,,,
Cargill,Dr.,Aristos,Aristidou,"Technology Director, Cargill Biotechnology Development Center",Aristos_Aristidou@cargill.com,,,,,,,,,
Cargill (Email Template and company info),,Tyler,Howells,http://www.cargill.com/company/research-development/capabilities/index.jsp,"Tyler_howells@cargill.com, Louis_de_Schorlemer@cargill.com",,,,,,,,,
Caribou Biosciences,Ms.,Vonnie,Estes,"Group Leader, Agricultural and Industrial Biotechnology at Caribou Biosciences",vonnie.estes@cariboubio.com,Carbon Fixing + Betalain/L-DOPA,Carbon Fixing + Betalain/L-DOPA,1736+1782,,email failed,,,,
Caribou Biosciences,Dr.,Andy ,May,Chief Scientific Officer at Caribou Biosciences,andy.may@cariboubio.com,Carbon Fixing + Betalain/L-DOPA,Carbon Fixing + Betalain/L-DOPA,1736+1782,,01/10/2017,01/17/2017,Negative- But can pass on future technologies,01/17/2017,
Caribou Biosciences,Dr.,Andy ,May,Chief Scientific Officer at Caribou Biosciences,andy.may@cariboubio.com,Doesn't work there anymore,,,,,,,,
Caribou Biosciences,Dr. ,Rachel,Haurwitz,"CEO, Caribou Biosciences, Inc.",rachel.haurwitz@cariboubio.com,Genetic Logic Gates,NOR based Device,1764,bounced back,06/15/2017,,,,
CARsgen Therapeutics,Dr. , JIE ,J,Vice President Of Strategic Alliances,,,,,,,,,,
CARsgen Therapeutics,Dr.,Zonghai,Li,"Foudner, CEO & CSO", Zonghaili@shsmu.edu.cn and zonghaili@carsgen.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,07/09/2018,"2018-07-09 Strong intial interest, now waiting for him to review. 2018-07-10 Thanked him and awaiting his reply.",,
Cascades Inc,Ms.,Nathalie,Comeau,Innovation Director at Cascades Tissue Group,nathalie_comeau@cascades.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,,"She is out till the 26th of Sept, so email later",10/26/2016,
Cathay Pacific,Mr.,Alex,McGowan,"General Manager, Strategic Transformation at Cathay Pacific Airways",alex_mcgowan@cathaypacific.com*,,,,,,,,,
Cathay Pacific,Mr.,Paul,Loo,Chief Customer & Commercial Officer at Cathay Pacific Airways,,,,,,,,,,
Cathay Pacific,Ms.,Wendy,Kwok,Head of Planning at Cathay Pacific Airways,,,,,,,,,,
Celanese Corporation,Dr.,Thomas,Verghese ,Vice President and Chief Technology & Innovation Officer at Celanese,thomas.verghese@celanese.com,,,,,,,,,
Celanese Corporation,Mr.,Kekin,Ghelani,"Sr. Director, Corporate Strategy & Business Development at Celanese",kekin.ghelani@celanese.com,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,03/21/2018,,,,
Celanese Corporation,Mr.,Travis,Hemphill,Director of Strategy and Business Development ,travis.hemphill@celanese.com,,,,,,,,,
CelGene,Dr.,Bitao ,Liang,"Sr. Director, CAR T CMC Development",bliang@celgene.com,,,,,,,,,
CelGene,Dr. ,Tonia ,Nesheiwat,"Senior Director, Global Medical Affairs, CAR T",tnesheiwat@celgene.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,,07/18/2018,
CelGene,Mr.,Scott,Bateman,"Director, Research Alliance Development",sbateman@celgene.com,,,,,,,,,
CelGene,Dr.,Susana,Parathath,"Associate Director, Global Alliances",sparathath@celgene.com,,,,,,,,,
CelGene,Mr.,Scott,Bateman,"Director, Research Alliance Development",sbateman@celgene.com,Mouse monitoring systems,ES,1571 and 1593,,07/17/2018,,,,
CelGene,Dr.,Susana,Parathath,"Associate Director, Global Alliances",sparathath@celgene.com,,,,,,,,,
Cell Design labs,Dr.,Timothy S.,Heuer,Senior Director Translational Science at Cell Design Labs,"tim@celldesignlabs.com
",Genetic Logic Gates,NOR based Device,1764,,06/15/2017,,,06/21/2017,
Cell Design labs,Dr.,Peter,Emtage,CSO,peter@celldesignlabs.com,,,,,,,,,
Cell Design labs,Mr.,Daniel,Lev,Project Manager,Daniel@celldesignlabs.com,,,,,,,,,
Cell Design labs,Dr.,Brian,Atwood,CEO,Brian@celldesignlabs.com,,,,,,,,,
Cellana,Dr.,Johanna,Anton,"VP and Director, Kona Demonstration Facility at Cellana Inc.",johanna.anton@cellana.com,Algal Oil,Algal Oil,1796,,01/10/2017,,,01/17/2017,
Cellana,Mr.,Martin,Sabarsky,CEO,martin.sabarsky@cellana.com,Algal Oil,Algal Oil,1796,,,,,,
Cellana,Dr.,Jeff,Obbard,"Vice President, Science & Technology",jeff.obbard@cellana.com,Algal Oil,Algal Oil,1796,,email failed,,,,
Cellectis ,,Simon,harnest,,simon.harnest@cellectis.com,,,,,,,,,
Cellectis ,Dr.,Julia,Berretta,Business Development Manager at Cellectis,julia.berretta@cellectis.com,Genetic Logic Gates,NOR based Device,1764,2017-07-04 sending another reminder email.,06/15/2017,06/21/2017,"Neutal - sent it for review. 2017-09-07 Was interested, but the tech is no longer available. But still wants to hear more from YEDA in the future",06/21/2017,
Cellectis ,Dr. ,Frederic,Cedrone,"Alliance Manager / Director of Business Development, Cellectis",frederic.cedrone@cellectis.com,,,,,,,,,
Cellectis ,Dr.,Julia,Berretta,Business Development Manager at Cellectis,julia.berretta@cellectis.com,Universal CAR-T,ES,1884,,06/21/2018,Automatic - On maternity leave,,,
Cellectis ,,Frederic,Cedrone ,Alliance Management,frederic.cedrone@cellectis.com',Universal CAR-T,ES,1884,,06/21/2018,Forwarded my messages to team,,07/09/2018,
Cellectis ,Dr.,Laurent,Poirot,Head of Early Discovery,laurent.poirot@cellectis.com,Universal CAR-T,ES,1884,Email was forwared by Frederic to Laurent.,,07/17/2018,,,
Celularity,Dr.,Xiaokui ,Zhang,Chief Scientific Officer,xiaokui.zhang@celularity.com,,,,,,,,,
Celularity,Dr.,Qian ,Ye,"Director, Innovative and Integrated Research",qian.ye@celularity.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,,07/18/2018,
Celyad ,Dr.,David ,Gilham, Vice President Research and Development at Celyad ,dgilham@celyad.com,Universal CAR-T,ES,1884,"2018-07-02 Reminder/thanks sent, will wait another few days to see what comes of this…",06/21/2018,06/21/2018,Neutral - Sent for Initial Review,07/18/2018,
Celyad ,Dr.,Bikash ,Verma,"Head, Clinical Development & Medical Affairs",dverma@celyad.com,,,,,,,,,
Celyad SA (formerly known as Cardio3 ,,,,,,,,,,,,,,
Cempra Inc.,Dr.,Sara,Wu,Executive Director of Drug Product Development,swu@cempra.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,No Response,,05/22/2017,
Cempra Inc.,Dr.,David,Oldach,Chief Medical Officer at Cempra Pharmaceuticals, doldach@cempra.com,,,,,,,,,
Cempra Inc.,Mr. ,Carl,Foster,"Executive Vice President, Business Development",cfoster@cempra.com,,,,,,,,,
"CEVA, Inc.",Mr.,Ran,Snir,"VP R&D at CEVA, Inc.",ran.snir@ceva-dsp.com,,,,,,,,,
"CEVA, Inc.",Mr.,Erez,Bar-Niv,CTO,erez.bar-niv@ceva-dsp.com,,,,,,,,,
Chanel,,Hava,Cekovic,TEMPLATE,Hava.Cekovic@chanelusa.com,,,,,,,,,
Chanel,Ms.,Amy,Wyatt,"Vice President, Research & Development and Regulatory Affairs at CHANEL",Amy.Wyatt@chanelusa.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,hold off,,,,
Chanel,Mr.,Randall,Johnson,Director at Chanel Inc.,,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,,,,,
Charles River,Dr.,Robert ,Hodgson ,Director,robert.hodgson@crl.com,Mouse monitoring systems,ES,1571 and 1593,,07/04/2018,,,07/17/2018,
Charles River,Dr.,Holden Brown,Janssens,Associate Director,,,,,,,,,,
ChenMing Paper,Mr.,Danny,Zang,BU General Manager - ChenMing Paper,13701698807@163.com,Cellulosomes,Cellulosomes,1536,,prepared,,,,
Chr. Hansen,,,,, elke.brockmann@dk.chr-hansen.com,,,,"""Officially"" email bounced back, but took a couple of days making me suspicious ",,,,,
Chr. Hansen,Mr.,Mikkel,Jurgensen,Consulting Scientists,"They have blocked their email system, I cannot access",,,,,,,,,
Chr. Hansen,Dr.,Kim,Binderup,"Vice President of Innovation, Human Health at Chr. Hansen A/S",kim.binderup@dk.chr-hansen.com  Or kim.binderup@chr-hansen.com,Betalain,Betalain,1782,"""Officially"" email bounced back, but took a couple of days making me suspicious ",2016-08-04 /prepared,,,,
Chr. Hansen,Dr. ,Elke,Brockmann,Principal Research Scientist at Chr. Hansen A/S,elke.brockmann@dk.chr-hansen.com ,Betalain,Betalain,1782,,08/11/2016,,,,
Clariant,Mr.,Amol,Kirtikar,Innovation Manager at Clariant,amol.kritikar@clariant.com,Algal Oil + Cellulosomes ,Algal Oil + Cellulosomes ,1796 +1536,,,,,,
Clariant,Dr,Amir,Mahmoudkhani,Global Innovation Manager - Emerging Technologies at Clariant,amir.mahmoudkhani@clariant.com,Algal Oil + Cellulosomes ,Algal Oil + Cellulosomes ,1796 +1536,,01/10/2017,,,01/17/2017,
Clariant,Dr.,Johannes,Benkhoff,Senior Vice President Group Chemical Research bei Clariant,,Algal Oil + Cellulosomes ,Algal Oil + Cellulosomes ,1796 +1536,,,,,,
Clariant,Dr.,Hans Tobias,Macholdt,Senior Manager Open Innovation at Clariant,hans.macholdt@clariant.com,Algal Oil + Cellulosomes ,Algal Oil + Cellulosomes ,1796 +1536,,email failed,,,,
Clariant (Fp7 consortium on sunliquid),Dr.,Markus,Rarbach,"Head of Start-up Business Biofuels and Derivatives, Clariant",markus.rarbach@clariant.com,Algal Oil + Cellulosomes ,Algal Oil + Cellulosomes ,1796 +1536,,,,,,
Cleanaway,Mr.,Simon,Jenner,Business Development and Innovation Lead at Cleanaway Waste Management Limited,simon.jenner@cleanaway.com.au,,Filter for water,1564,"Auto-reply on 2017-08-08, no reply since then",08/02/2017,,,08/08/2017,
Cleanaway,Mr.,Frank,Lintvelt,Head of Mergers & Acquisitions at Cleanaway Waste Management Ltd,,,,,,,,,,
Cleanaway,Mr.,Mark,Sheridan ,Head of Major Programs at Cleanaway (Formerly Transpacific Industries Group),,,,,,,,,,
Cleanaway,Mr.,Damien,Moss,,Damien.Moss@cleanaway.com.au,,,,,,,,,
Coca Cola Co,Dr. ,Michael,Brown,"Director, Sweetness and Taste Research at The Coca-Cola Company", mbrown9@na.ko.com,Betalain,Betalain,1782,,07/27/2016,,,08/03/2016,
Coca Cola Co,,Nora,Maya,External Technology Assessment Team,nmaya@coca-cola.com,Cellulosomes and Betalains,Cellulosomes and Betalains,1536 + 1782,,,11/30/2016,,01/12/2017,Wants to have a chat and is setting up a time organized by Maya. Chat will happen 2017-01-30
Coca Cola Co,,Betsy,Tse,External Technology Assessment Team,btse@coca-cola.com,Cellulosomes and Betalains,Cellulosomes and Betalains,1536 + 1782,,,11/30/2016,,,
Coca-Cola,Dr.,David,Del Pozo,Global R&D Lead- Sports Category at The Coca-Cola Company,ddelpozo@na.ko.com,Cellulosomes and Betalains,Cellulosomes and Betalains,1536 + 1782,,,,,,
"Coca-Cola (Simply Orange, Minute Maid, Fruitopia)",Mr.,David,Butler,"VP Innovation, Coca-Cola; I led global design at Coca-Cola; now I lead early-stage venturing",dbutler@coca-cola.com,Cellulosomes and Betalains,Cellulosomes and Betalains,1536 + 1782,,09/18/2016,09/26/2016,"Basically forwarded it to Dr. Shell Huang, and then she forwarded it to Gregg Carpenter who is officially responsible. ",09/26/2016,
"Coca-Cola (Simply Orange, Minute Maid, Fruitopia)",Mr.,Gregg,Carpenter,Head of Tech Scouting, grecarpenter@coca-cola.com ,Cellulosomes and Betalains,Cellulosomes and Betalains,1536 + 1782,,09/27/2016,10/26/2016,Looking into the request because he apparently sent it forward already.,10/26/2016,2016-11-29 another review reminder
Codexis,Dr.,Gjalt,Huisman,"VP, Pharma Technology & Innovation at Codexis",gjalt.huisman@codexis.com,Cellulosomes,Cellulosomes,1536,Enzyme engineers,09/18/2016,09/18/2016,"Forwarded to  Dr. Jim Lalonde, SVP R&D ",,
Codexis,Dr.,Jim ,Lalonde,SVP R&D,Jim.Lalonde@codexis.com,Cellulosomes,Cellulosomes,1536,,10/26/2016,10/26/2016,Negative - Codexis no longer works in the area of biomass conversion,,
colorMaker,CEO,Stephen ,Lauro,Colorful Executive Officer,stephenl@colormaker.com,Betalains,Using Betalain Exclusive Exec Summary,1782,Wait with this one,,,,,
colorMaker,Dr. ,Gabriel,L Lauro,R&D Manager,gabriell@colormaker.com,Betalains,Using Betalain Exclusive Exec Summary,1782,Auto-rejected email,07/11/2016,07/11/2016,Failure to deliver,,
Company Name,Title,First Name,Last Name,Position/ Description,E-Mail,Product being sold,Executive Summary,Case Number,Comments,Date Sent,Date of Response,Type of Response,Reminder Email,Review Reminder Email (for maybe answers)
Complete Nutrition,,,,,Kelly Guinane. kguinane@completenutrition.com,,,,,,,,,
Complete Nutrition,Mr.,Christopher ,Gendron,Vice President of Product Development at Complete Nutrition,CGendron@completenutrition.com,,,,,,,,,
Complete Nutrition,Mr.,Jim,Heidenreich,CEO,jHeidenreich@completenutrition.com,,,,,,,,,
COPIA,Mr.,Eyal,Cohen,CEO,eyal@copia-agro.com,Carbon Fixing,Carbon Fixing,1736,,01/10/2017,01/17/2017,Negative,01/17/2017,2017-01-17 Orly forgot and Eval already reviewed the technology. I sent the email redundantly.
Corsair,Mr.,Jack,Truong,Product Development Engineering Manager at Corsair,jackt@corsair.com,Multi-state polymers for memory and logic gates,Web page,1568,,bounced,,,,
Corsair,,Andy,Paul,,andyp@corsair.com,,,,,,,,,
"Coty, Inc.",,lambros,kromidas,TEMPLATE, lambros_kromidas@cotyinc.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,,,,,
"Coty, Inc.",Dr.,Hongjie,Liu,Senior Scientist,Hongjie_Liu@cotyinc.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,,,,,
"Coty, Inc.",Ms.,Jennifer,Chin,Principal Scientist at COTY Inc.,jennifer_chin@cotyinc.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,01/10/2017,,,01/17/2017,
Covestro (spin off of Bayer Material Science),Dr.,Karsten ,Danielmeier,Senior Vice President Global R&D at BU CAS at Covestro,karsten.danielmeier@covestro.com,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,03/21/2018,03/21/2018,Negative,,
Covestro (spin off of Bayer Material Science),Dr.,Xy,Li,"Director of Innovation New Applications NAFTA, CAS",xy.li@covestro.com,,,,,,,,,
Creative BioLabs,,,,,,,,,,,,,,
Crispr Therapeutics,Dr.,Jon,Terrett,Head of Immuno Oncology,j.terrett or jon.terrett,,,,,,,,,
Crispr Therapeutics,Dr. , Demetrios ,Kalaitzidis,Associate Director,d.kalaitzidis@crisprtx.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,,07/18/2018,
Crispr Therapeutics,Dr.,Rebecca,Blanchard,"VP, Experimental Medicine",,,,,,,,,,
CTTSO,Mr.,Gabriel ,Ramos,"Director, Operations Division at CTTSO",ramosg@tswg.gov,,,,,,,,,
CTTSO,Dr.,James,Frank,"R&D Program Director (Biotech, Biodefense, Energy, Advanced Analytics)",frankj@tswg.gov,Catalytic BioScanvangers,ES,1750,,04/24/2018,,,,
CytRx ,,,,,,,,,,,,,,
D.D. Williamson & Co.,Mr.,Jason,Armao,Innovation and Application Team - D.D. Williamson, jason.armao@ddwcolor.com,Betalain,Betalain,1782,,08/22/2016,,,08/29/2016,
D.D. Williamson & Co.,Dr.,Connie,Sandusky,Strategic Projects (Licensing Person),Connie Sandusky [Connie.Sandusky@ddwcolor.com],Betalain,Betalain,1782,"Forwarded by Jason Armao to her, she and the team are examining the technology",,08/31/2016,"2016-10-06 Not interested, but a good contact for future technologies",09/26/2016,
Daiichi Sankyo,Dr.,Jeffrey,Warmke,"Senior Vice President, External Scientific Affairs at Daiichi Sankyo",,,,,,,,,,
Daiichi Sankyo,Mr.,Hiroki ,Hanashima,"Director, Business Development at Daiichi Sankyo Inc.",,,,,,,,,,
DAM technology of Ido Amit and Michal Schwartz,,,,,,,,,,,,,,
Dan Tawfik 1750 Enzymatic breakdown of nerve agents,,,,,,,,,,,,,,
Danzinger Innovations,PhD,Hanne,Volpin,Deputy CEO and Head of R&D,hanne.volpin@danziger-innovations.com,Betalains,Using Betalain Exclusive Exec Summary,1782,,07/11/2016,07/11/2016,Positive - Passed onto the division of new products for determination of whether they want it or not.,,
Danzinger Innovations,CEO,Michael,Danzinger,CEO,Micha@danziger-innovations.com,Betalains,Using Betalain Exclusive Exec Summary,1782,,,,,,
DARPA,Dr.,Justin,Sanchez,"Director, Biological Technologies Office at DARPA",justin.sanchez@darpa.mil,,,,,04/24/2018,,,,
DARPA,Dr.,Renee ,Wegrzyn,Program Manager at DARPA Biological Technologies Office,renee.wegrzyn@darpa.mil,Catalytic BioScanvangers,ES,1750,,,,,,
Dean Foods Co,Mr.,Dean A. ,Lippold,Vice President R&D at Dean Foods,,Betalain,Betalain,,,,,,,
Dean Foods Co,Mr.,Bill,Zollinger,Sr. Director Corporate Development & Strategy at Dean Foods,bzollinger39@yahoo.com,Betalain,Betalain,1782,,07/27/2016,08/03/2016,"Negative -but polite, just not interested",08/03/2016,
"Del Monte Foods, Inc",,Jason,Spires,Template,jspires@freshdelmonte.com,betalain,,,,,,,,
"Del Monte Foods, Inc",Mr.,Mario,DiFalco,Senior Director of Innovation,mdifalco@freshdelmonte.com,Betalain,Betalain,1782,,email failed,,,,
"Del Monte Foods, Inc",Ms.,Loren,Druz,"Fruit, Vegetable, Tomato, and Broth Product Development & Innovation Process Leader at Del Monte
",ldruz@freshdelmonte.com,Betalain,Betalain,1782,,,,,,
"Del Monte Foods, Inc",Ms.,Michelle,Flood,"Senior Food Technologist at Del Monte Foods, Inc.",mflood@freshdelmonte.com,Betalain,Betalain,1782,,,,,prepared,
"Del Monte Foods, Inc",Dr.,Jaime Rudolf,Reeves,"Group Manager Tomato, Broth & Innovation R&D at Del Monte Foods Inc",jreeves@freshdelmonte.com,Betalain,Betalain,1782,,,,,,
Delta,Mr.,Ed,Bastian,Chief Executive Officer at Delta Air Lines,ed.bastian@delta.com,,,,,,,,,
Delta,Mr.,Sandeep,Dube,Vice President - Delta Air Lines (Customer Engagement & Loyalty),sandeep.dube@delta.com or sandeep.X.dube@delta.com,,,,,,,,,
Delta,Ms.,Kelly,Nodzak,"General Manager, Strategy and Business Development at Delta Air Lines",kelly.nodzak@delta.com,,,,,,,,,
Destiny Pharma Ltd.,Mr.,Stephane,Hauduc,Discovery Chemistry and Intellectual Property Manager at Destiny Pharma,"busdev@destinypharma.com, sh@destinypharma.com",MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,No Response,,05/22/2017,
Destiny Pharma Ltd.,Dr.,William ,Love,"Founder, Chief Scientific Officer and Director ",wl@destinypharma.com,,,,,,,,,
Dicerna Pharmaceuticals,Dr.,Henryk (Hank),Dudek,Director at Dicerna Pharmaceuticals,hdudek@dicerna.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
Dicerna Pharmaceuticals,Dr.,Marc,Abrams,"Senior Director, Preclinical Development at Dicerna Pharmaceuticals, Inc.",mabrams@dicerna.com,,,,bounced back,,,,,
Dicerna Pharmaceuticals,Dr.,Henryk (Hank),Dudek,Director at Dicerna Pharmaceuticals,hdudek@dicerna.com,,,,,,,,,
Dicerna Pharmaceuticals,Dr.,Marc,Abrams,"Senior Director, Preclinical Development at Dicerna Pharmaceuticals, Inc.",mabrams@dicerna.com,miR-218,ES,1498,,08/16/2017,08/17/2017,"Not interested in this tech, but would like to hear more from YEDA in the future.",,
Discuva Ltd.,Dr.,Clive,Mason,Director of Biology,info@discuva.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,No Response,,05/22/2017,
DMP Corporation,Mr.,Darly,Mandoza,Director Of Business Development at DMP Corporation,dmandoza@dmpcorp.com,,Filter for water,1564,,08/02/2017,,,08/08/2017,
DMP Corporation,Mr.,Mark,Masters,President at DMP Corporation,,,,,,,,,,
DMP Corporation,,Steve,Wait,,swait@dmpcorp.com,,,,,,,,,
Domtar,,,,,nicholas.estrela@domtar.com,,,,,,,,,
Domtar,Mr.,Brine,Ranson,Director Technology Innovation at Domtar,brine.ranson@domtar.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,,,09/26/2016,
Dow AgroSciences,Dr.,Nigel,Mouncey,Bioengineering and Bioprocessing R&D Director at Dow AgroSciences, NJMouncey@dow.com,Cellulosomes,Cellulosomes,1536,Biofuels,,,,,
Dow Chemical Company,Mr.,Robert D.,Connors,Senior New Business Development Leader - Ventures and Business Development at The Dow Chemical Company,rdconnors@dow.com,,Filter for Nanoparticles and water,1564,,08/02/2017,,,08/08/2017,
Dow Chemical Company,Ms.,Cedella E (Brodie),Beazley,Business Unit Director - Filtration at Dow Water & Process Solutions,cebeazley@dow.com or cebrodie@dow.com,,Filter for water,1564,,08/22/2017,,,08/29/2017,
Dow Chemical Company,Dr.,Chris ,Jones,Global Strategy Director at The Dow Chemical Company,,,,,,,,,,
Dow Chemical Company,Mr.,Mike,Levinson,Director New Business Development at The Dow Chemical Company,,,,,,,,,,
Dr Pepper Snapple Group,,,,,zachary.killian@dpsg.com,,,,,,,,,
Dr Pepper Snapple Group,Dr.,Adrian,Sepcic,Manager Product Development Research and Development at Dr Pepper Snapple Group,adrian.sepcic@dpsg.com,Cellulosomes and Betalains,Cellulosomes and Betalains,1536 + 1782,,09/18/2016,,,09/26/2016,
Dr Pepper Snapple Group,Mr. ,Jeff,Nutt,Sr. Scientist at Dr Pepper Snapple Group,jeffrey.nutt@dpsg.com,Cellulosomes and Betalains,Cellulosomes and Betalains,1536 + 1782,,,,,,
DSM,Mr. ,Ronald,Schimanofsky,Licensing Manager at DSM Innovation Centre,RONALD.SCHIMANOFSKY@DSM.COM,Cellulosomes and Betalains,Cellulosomes and Betalains,1536 + 1782,,09/18/2016,09/19/2016,"Sent it for evaluation, Update 2016-11-02 Negative response",10/26/2016,
DSM,Mr.,Gerald ,Dard,"Business Unit Director, Cultures & Enzymes at DSM",GERALD.DARD@DSM.COM,Cellulosomes and Betalains,Cellulosomes and Betalains,1536 + 1782,,,,,,
DSM,,,,,christian.loechte@dsm.com,,,,,,,,,
DSM,Mr.,Johan,van Doesum,Intellectual Asset Manager at DSM,johan.vandoesum@dsm.com or johan.van.doesum@dsm.com,Cellulosomes,Cellulosomes,1536,Biofuels,,,,,
DSM,Mr. ,Ronald,Schimanofsky,Licensing Manager at DSM Innovation Centre,RONALD.SCHIMANOFSKY@DSM.COM,Astaxanthin producing ecoli,ES,1650,,04/08/2018,04/09/2018,Neutral - Shared it around. 2018-04-10 asked for a patent application (basically more data). 2018-04-17 Not interested,,
DSM Biotechnology Center,Mr. ,Ronald,Schimanofsky,Licensing Manager at DSM Innovation Centre,RONALD.SCHIMANOFSKY@DSM.COM,Algal Oil,Algal Oil,1796,Mention food and fuel,01/10/2017,01/10/2017,Reviewing the Technology,,2017-03-06 Sent email
DSM Biotechnology Center,Mr. ,Ronald,Schimanofsky,Licensing Manager at DSM Innovation Centre,RONALD.SCHIMANOFSKY@DSM.COM,,,,,,,,,
"DSM Nutritional Products (Martek Biosciences Corporation, Ocean Nutrition Canada Limited)",Dr.,Manfred ,Eggersdorfer,Sen. Vice President Nutrition Science bei DSM Nutritional Products,manfred.eggersdorfer@dsm.com,Colitis Treatment,,1831,,06/01/2017,,No Reply,06/08/2017,
"DSM Nutritional Products (Martek Biosciences Corporation, Ocean Nutrition Canada Limited)",Dr.,Tom ,Frost,Director of Innovation & Application at DSM Nutritional Products,,,,,,,,,,
"DSM Nutritional Products (Martek Biosciences Corporation, Ocean Nutrition Canada Limited)",Dr.,Kim,Binderup,"Vice President Innovation, Human Nutrition & Health at DSM",kim.binderup@dsm.com,Colitis Treatment,,1831,"Email works, is away on business travel till 2017-06-27",06/13/2017,06/03/2017,"Positive - Setup a TC on 2017-06-19 with Hans Holm, Kevin Prudence, and Emily Tellers.  2017-07-02 an NDA was in process and is now trailed off/frozen.",,
DSP Group,,victor,halpert,template,victor.halpert@dspg.com,,,,,,,,,
DSP Group,Ms.,Tali,Chen,CVP Corporate Development & Chief Evangelist ,tali.chen@dspg.com,,,,,,,,,
DSP Group,Ms.,Dana,Cohen,Strategic planning consultant at DSP Group,dana.cohen@dspg.com,,,,,,,,,
DuPont,PhD,Julie M. ,Vogel,senior licensing manager,Julie.M.Vogel@pioneer.com,L-DOPA and Betalians,Using Betalian and L-DOPA Exec Summary,1782 + 1587,,07/11/2016,07/12/2016,Negative – Not interested but very polite,,
DuPont,Dr. ,Sandra,Ramer,"Head of Biochemistry, Industrial Biosciences at DuPont",sandra.ramer@dupont.com Or sandra.ramer@usa.dupont.com,Cellulosomes,Cellulosomes,1536,Biofuels,,,,,
DuPont,Dr.,William D.,Provine,Global Innovation Leader,william.d.provine@dupont.com,Cellulosomes,Cellulosomes,1536,Biofuels,,,,,
DuPont,Dr. ,Jan,Koninckx,"Business Director for Biofuels, DuPont",jan.koninckx@dupont.com,Cellulosomes,Cellulosomes,1536,Biofuels (Butamax as well),,,,,
DuPont,Mr.,Ken,Hill,Global Business Leader - Cellulosic Enzymes/Tech Licensing | Emerging Markets Business Development | DuPont BioSciences,ken.hill@dupont.com or kenneth.hill@dupont.com,Cellulosomes,Cellulosomes,1536,Need a different email all bounced back,,,,,
DuPont,PhD,Julie M. ,Vogel,senior licensing manager,Julie.M.Vogel@pioneer.com,Carbon Fixing,Carbon Fixing,1736,,,,,,
DuPont (Pioneer),Dr.,Barbara,Marzur,Vice President Technology Acquisition Strategy,barbara.j.mazur@cgr.dupont.com (NEW EMAIL: barbara.j.mazur@pioneer.com),Carbon Fixing + Glycoalkaloids,Carbon Fixing + Glycoalkaloids,1736 +1587,,01/10/2017,01/12/2017,"No, but was very friendly. Informed me in the future to contact Siqun Wang from now on.",,
DuPont (Pioneer),Dr.,Siqun,Wang,Tech Scouter,siqun.wang@pioneer.com,,,,RELEVANT CONTACT FOR AGRITECH AT DUPONT/PIONEER,,,,,
DuPont & BP (Butamax),Dr. ,Jan,Koninckx,"Business Director for Biofuels, DuPont",jan.koninckx@dupont.com,Cellulosomes,Cellulosomes,1536,Biofuels (Butamax as well),01/10/2017,,,01/17/2017,
DuPont/Danisco,Dr.,Stuart,Thomas,"Vice President - Technology and LIcensing at DuPont Danisco Cellulosic Ethanol, LLC",Stuart-m1.Thomas@dupont.com,Cellulosomes,Cellulosomes,1536,,09/20/2016,,,09/26/2016,
Dynavax ,,,,,,,,,,,,,,
Earthbound LLC,Dr. ,Sharon,Dayan,Business Development,sharon@earthboundllc.com,Betalain and L-DOPA,Betalain and L-DOPA,,,,,,,
Editas Medicine (Focused on CRISPR),Ms.,Katrine,Bosley,"CEO, Editas Medicine",,,,,,,,,,
Editas Medicine (Focused on CRISPR),Dr.,Jonathan,McNeill,Business Development at Editas Medicine,jonathan.mcneill@editasmed.com,Genetic Logic Gates,NOR based Device,1764,2017-07-04 sending another reminder email.,06/15/2017,06/21/2017,Neutral - Under review. 2017-08-24 Rejected the technology but still wants to stay in touch.,06/21/2017,
Editas Medicine (Focused on CRISPR),,Mark,Mullikin,IR Inquiries,mark.mullikin@editasmed.com,,,,,,,,,
EGEN (Expression Genetics) [not active],,,,,,,,,,,,,,
Eisai,Dr.,David,Levin,"Head of Business Development, Neurology Business Group",david_levin@eisai.com,,,,,,,,,
Eisai,Dr.,Chad,Swanson,"Senior Director, Neuroscience Clinical Research",chad_swanson@eisai.com,,,,,,,,,
Eisai pharma,Mr.,Toshiyuki,Tamai,Scientist,Toshiyuki_Tamai@eisai.com,,,,,,,,,
Eisai pharma,,Mendel,Jansen,,mendel_jansen@eisai.net ,,,,,,,,,
Eisai pharma,Ms.,Irene,(Peñalver) Mata,"Manager, Alliance Management, Eisai Inc.",Irene_Mata@eisai.com,,,,,,,,,
Eisai pharma,Ms.,Lena R.,Frank,"Executive Director, Alliance & Program Management at Eisai",Lena_Frank@eisai.com,,,,,,,,,
Eisai pharma,Ms.,Shivaranjani ,Sridharan,"Director, Oncology Alliances at Eisai US",,,,,,,,,,
Eisai pharma,Ms.,June X.,Nguyen,"Executive Director, Business Development - Americas at Eisai",,,,,,,,,,
Eisai pharma,Ms.,Irene,(Peñalver) Mata,"Manager, Alliance Management, Eisai Inc.",Irene_Mata@eisai.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Eli Lilly,,,,,,,,,,,,,,
Eli Lilly,Dr.,Aafia,Chaudhry,Vice President Global and US Medical Affairs Oncology at Eli Lilly and Company,aafiac@hotmail.com,,,,,,,,,
Eli Lilly,Dr.,Mike,Myers,"Sr. Director - Lilly Research Labs, Due Diligence at Eli Lilly",myers_michael_r@lilly.com,,,,,,,,,
Eli Lilly,Mr.,Darren,Carroll,"Senior Vice President, Corporate Business Development at Eli Lilly and Company",,,,,,,,,,
Eli Lilly,Ms.,Ann ,Swiontek,Alliance Medical Affairs Advisor at Eli Lilly and Company,,,,,,,,,,
Eli Lilly,Dr.,Garcia,Quevedo,VP Medical Affairs & Product Dev.,garcia_salvador@lilly.com,Beta Cell isolation method,ES,1643,,04/15/2018,,,04/23/2018,
Eli Lilly,Ms.,Averie,Hason,"Assistant General Patent Counsel, Eli Lilly & Company",averie.hason@lilly.com,,,,,,,,,
emergent biosolutions,Mr.,Steve,Rambo," Vice President, Biodefense Division at Emergent BioSolutions ",Rambos@ebsi.com,Catalytic BioScanvangers,ES,1750,,06/20/2018,,,07/02/2018,
emergent biosolutions,Dr., Barbara ,Solow , Senior Vice President Research & Development ,solowb@ebsi.com,Catalytic BioScanvangers,ES,1750,,07/17/2018,07/17/2018,Neutral - Sent for review,,
emergent biosolutions,Dr.,Sukjoon,Park," Sr. Director, Product Development at Emergent BioSolutions ",parks@ebsi.com,,,,,,,,,
Emfutur Technologies,,,,,,,,,,,,,,
Enaqua - a Grundfos Innovation Company,Mr.,Donavan,Hendricks,Co Owner at Enaqua,dhendricks@enaqua.com,,Filter for water,1564,,bounced,,,,
EnviroChemie GmbH,Dr.,Eva,Gilbert,Team Leader Research & Development,eva.gilbert@enivrochemie.com,,Filter for water,1564,,bounced,,,,
EnviroChemie GmbH,Ms.,Eva,Feit,Project engineer at EnviroChemie GmbH,,,,,,,,,,
EnviroChemie GmbH,Mr.,Tibor,Kretschmann,Projektingenieur bei EnviroChemie GmbH,,,,,,,,,,
EnviroChemie GmbH,Mr.,Werner,Loeser,Process Engineer / Water Consultant,,,,,,,,,,
Enzyme Development Corporation,Mr.,Peter,Moodie,President,cpm@enzymedevelopment.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,,,09/26/2016,
Enzyme Innovation,Mr.,Dipak,Roda,Vice President - Market & Business Development at Enzyme Innovation,dipak@enzymeinnovation.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,09/26/2016,"Sending it for review, also CEO C. Rathi and Dr. Anil Gupta will review the technology - 2016-10-02 I replied directly to Dr. Gupta. - 2016-10-13 Orly Replied to Dr. Gupta, no responses (That I am aware of at the moment)",09/26/2016,
EvenFlo,Mr.,Dave,Sander,"Product Engineering Manager at Good Baby International, Evenflo Brand,",DAVE.SANDER@EVENFLO.COM,,,1431,,,,,,
EvenFlo,Mr.,Dan,Fox,Global Innovation Engineering Leader,dan.fox@evenflo.com ,,,,,,,,,
EvenFlo,Ms.,Diane,Lawley,Business Development Director,Diane.lawley@evenflo.com,Breastfeeding monitoring device,onepager,1431,2017-08-22 Got an autoreply,08/15/2017,,,08/22/2017,
Evogene,Dr.,Assaf,Sagiv,Senior Business Development Manager,,,,,,,,,,
Evogene,Dr.,Maya,Schushan,"Director of Business Development, Crop enhancement at Evogene",,,,,,,,,,
Evolva,Dr.,Jørgen,Hansen,Chief Scientific Officer at Evolva Biotech,jorgenh@evolva.com,Betalain and L-DOPA,Betalain and L-DOPA,,,,,,,
Evolva,"""Dr""",Michael,Naesby ,,michaeln@evolva.com ,Betalain and L-DOPA,Betalain and L-DOPA,1782,"Away till Aug 29th, 2016 – Replied 2016/08/30 – Wants to have a phone meeting somewhere on the week of Sept 12th",08/11/2016,08/30/2016,,,
Evolva,Dr.,Giovanni,Salerno,"Senior Vice President, Global Technology Outreach & Integration at Evolva SA",giovannis@evolva.com,Betalain and L-DOPA,Betalain and L-DOPA,1782,,07/31/2016,,,,
Evolva,Dr.,Michael,Naesby ,,michaeln@evolva.com ,Carbon Fixing,Carbon Fixing,1736,,,,,,
Evonik,Dr.,Christoph ,Weckbecker,Senior Innovation Manager at Evonik Industries AG,christoph.weckbecker@evonik.com,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,03/21/2018,,,,
Evonik,Dr.,Ulrich ,Kuesthardt,Chief Innovation Officer at Evonik Industries AG,ulrich.kuesthardt@evonik-stiftung.de or ulrich.kuesthardt@evonik.com,,,,,,,,,
Evonik,Dr.,Holger ,Warth,Vice President Innovation Management High Performance Polymers at Evonik,,,,,,,,,,
Evonik Nutrition & Care GmbH,Mr.,David,Lydzinski,Director - Innovation and Growth at Evonik Corporation,david.lydzinski@evonik.com,Algal Oil,Algal Oil,1796,,01/10/2017,,Out of office - no explicit return date,01/17/2017,
Evonik Nutrition & Care GmbH,Dr.,Ted,Pettijohn,Senior Vice President at Evonik Corporation,ted.pettijohn@evonik.com,Algal Oil,Algal Oil,1796,,,,,,
Evonik Nutrition & Care GmbH,Dr.,Sanjay,Gupta,Vice President and Regional Head of Corporate Innovation Division,sanjay.gupta@evonik.com,Algal Oil,Algal Oil,1796,,,,,,
Evoqua Water Technologies,Mr.,Michael,Costello,"Director Strategy & Marketing, Evoqua Water Technologies",michael.costello@evoqua.com,,,,,bounced,,,,
Evoqua Water Technologies,Mr.,Rodney,Aulick,"President, Industrial Division at Evoqua Water Technologies LLC",RODNEY.AULICK@EVOQUA.COM,,Filter for water,1564,,08/02/2017,08/10/2017,"Clear no, but then I asked them why. This led to a full phone conversation between Ronen and Evoqua representatives on 2017-08-14",08/08/2017,
Evoqua Water Technologies,Mr.,Marc,Roehl,Vice President & General Manager at Evoqua Water Technologies,,,,,,,,,,
Evoqua Water Technologies,,,,,scott.ceranec@evoqua.com,,,,,,,,,
Evotec,Dr.,Thomas,Hanke,"EVP, Head of Academic Partnerships at Evotec",Thomas.hanke@evotec.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,No Response,,05/22/2017,
EvoTec,,Itta (Bluhn-Chertudi), MacNevin,Senior Director Business Development ,itta.macnevin@evotec.com (?),,,,,,,,,
EvoTec,Dr.,Christoph, Wiessner, SVP Neuroscience ,Christoph.Wiessner@evotec.com,,,,,,,,,
EvoTec,Dr.,Dave,Hallett,Executive Vice President,dave.hallett@evotec.com or david.hallett@evotec.com,,,,,,,,,
Exicure,,,,,licensing@exicuretx.com,,,,,,,,,
Exicure,Dr.,David ,Giljohann,CEO,davidg@exicuretx.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,06/23/2017,Negative - Found the technologies interesting but not in there focus,06/13/2017,
Exicure,Dr.,Bart R. ,Anderson,Research Scientist at Exicure,Barta@exicuretx.com,,,,,,,,,
Exicure,,,,,licensing@exicuretx.com,,,,,,,,,
Exicure,Dr.,David ,Giljohann,CEO,davidg@exicuretx.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Exicure,Dr.,Bart R. ,Anderson,Research Scientist at Exicure,Barta@exicuretx.com,,,,,,,,,
ExxonMobil,Wayne,Barnette,,Template,wayne.barnette@exxonmobil.com another example wayne.n.richard@exxonmobil.com,Algal Oil,Algal Oil,1796,,,,,,
ExxonMobil,Dr.,Jim,Bielenberg,ExxonMobil Research & Engineering,jim.bielenberg@exxonmobil.com,Algal Oil,Algal Oil,1796,,,,,,
ExxonMobil,Dr.,Prasenjeet,Ghosh,Global Product and Business Manager at ExxonMobil Chemical Company,prasenjeet.ghosh@exxonmobil.com,,,,,,,,,
ExxonMobil,Dr.,Nazeer A. ,Bhore,"Manager, Lead Generation and Downstream Breakthrough Research at Exxonmobil Research & Engrg",nazeer.a.bhore@exxonmobil.com,Algal Oil,Algal Oil,1796,,01/10/2017,,,01/17/2017,
ExxonMobil,Dr.,Vijay,Swarup,Vice President-R&D,vijay.swarup@exxonmobil.com,Algal Oil,Algal Oil,1796,,01/23/2017,,,prepared,
ExxonMobil,Mr.,Louis,Burns,"Global Licensing Manager, Fuels Applications at ExxonMobil",louis.burns@exxonmobil.com,Algal Oil,Algal Oil,1796,,,,,,
ExxonMobil,Dr.,Anna,Gorshteyn,Licensing Manager at ExxonMobil Research and Engineering,Anna.gorshteyn@exxonmobil.com,Algal Oil,Algal Oil,1796,,,,,,
Exxonmobil,Dr.,Terry,Helton,Licensing Manager at ExxonMobil Chemical Company,terry.helton@exxonmobil.com,Algal Oil,Algal Oil,1796,,,,,,
F. Hoffmann-La Roche AG.,Dr.,Alexander,Breidenbach,"Director, Global Business Development",Alexander.Breidenbach@roche.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,05/12/2017,Forwarded to Lesley Bester,,
F. Hoffmann-La Roche AG.,Ms.,Lesley,Bester,Director: Global Business Development,lesley.bester@roche.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,"She stated "" strategic focus for antibiotic development and commercialization lies in systemic anti-bacterials for the treatment of severe, difficult-to-treat Gram negative ESKAPE pathogens in hospitalized patients with infections where the unmet need is highest, such as HAP/VAP, cUTI and cIAI. Our scientists and portfolio experts consider Gram positive pathogens to be a “better-served” area of unmet need, adequately addressed by current and emerging therapies. """,,05/12/2017,Negative - But informative,,
F. Hoffmann-La Roche AG.,Dr.,Alexander,Breidenbach,"Director, Global Business Development",Alexander.Breidenbach@roche.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,Forwarded by Dr. Huebner,06/07/2017,,,06/13/2017,
F. Hoffmann-La Roche AG.,Dr.,Michael R,Huebner,Oncology BD&L Team - Roche Partnering,"BDOncology, pharma <pharma.bdoncology@roche.com>",TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,,07/03/2017,Negative - diabetes is currently not within their corporate partnering strategy,,
F. Hoffmann-La Roche AG.,Dr.,Alexander,Breidenbach,"Director, Global Business Development",Alexander.Breidenbach@roche.com,,,,,,,,,
F. Hoffmann-La Roche AG.,Dr.,Alexander,Breidenbach,Global Head Neuroscience/Ophthalmology/Rare Diseases Partnering at Roche,Alexander.Breidenbach@roche.com,,,,,,,,,
F. Hoffmann-La Roche Ltd,Dr.,James ,Cai,"Head of Data Science at Roche
Roche Translational Clinical Research Center (TCRC) ",james.cai@roche.com,Bcl2 inhibitor predictive software,Cover letter,1881,2018-03-21 Received out of office reply,03/21/2018,,,04/09/2018,
F1 Oncology,Dr.,Alissa R. ,Kerner,"Associate Director, New Product Planning",akerner@f1oncology.com,,,,,,,,,
F1 Oncology,Dr.,James ,Onuffer,VP Synthetic Biology and Immunology,,,,,,,,,,
F1 Oncology,Dr., Gregory,Schreiber,"Sr. Director, IP Strategy & Licensing",gschreiber@f1oncology.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,"Email Reply: ""Thank you for thinking of F1 Oncology and reaching out.  I reviewed these opportunities and unfortunately, neither of them would be a good fit for F1’s current platforms of autologous CAR-T therapy.  Please do continue to send technologies that you think might be a good fit for us.  At this time, F1 does not have a “wish list” of technologies we are looking to license.  I would be interested, however, in reviewing technologies you may have for the tunable expression of genes/proteins using small molecules."" Therefore 1847 Arbitrium tech sent to him per request.",07/09/2018,07/13/2018,Negative - because focused on autologous technology,,
Fate Therapeutics,Dr.,Raedun,Clarke,Senior Scientist - Cancer Immunotherapy,Raedun.clarke@fatetherapeutics.com,,,,,,,,,
Fate Therapeutics,Mr. ,Scott,Wolchko ,President & CEO ,scott.wolchko@fatetherapeutics.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,,07/18/2018,
Fedora Pharmaceuticals Inc.,Dr.,Sameeh,Salama,"Vice President, Business Development at Fedora Pharmaceuticals Inc. and Brass Dome Ventures",info@fedorapharma.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,No Response,,05/22/2017,
Fidelity,,Mann,Fung,https://www.forbes.com/sites/luketimmerman/2016/02/10/fidelity-biogen-sanofi-join-45m-bet-on-alzheimers-and-parkinsons-startup/#65cf09492ec1,,,,,,,,,,
FLIR,Mr.,Shane,Harrison,"Senior Vice President - Corporate Development & Strategy, at FLIR Systems",,,,,,,,,,
FLIR,Dr.,Lei,Bennett,Director of Product Strategy and Development at FLIR Systems,lei.bennett@flir.com,Catalytic BioScanvangers,ES,1750,Will be out of office till 2018-04-30,04/24/2018,,,,
Florida's Natural,Ms.,Adrijana,Hunt,"Marketing Manager, New Products @ Florida's Natural Growers",Adrijana.Hunt@Citrusworld.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,,,09/26/2016,
FMC corporation,Mr.,Sebastian,Felsen,Director Strategy and Business Development at FMC Corporation,Sebastian.Felsen@fmc.com,Colitis Treatment,,1831,,06/01/2017,,No Reply,06/08/2017,
FMC corporation,Mr.,Pramod,Thota,"Global Business Director, FMC Global Specialty Solutions at FMC Corporation",pramod.thota@fmc.com,Colitis Treatment,,1831,,06/13/2017,,,,
Food Ingredient Solutions LLC ,Mr.,Jeff,Greaves,"President at Food Ingredient Solutions, LLC.",jgreaves@foodcolor.com ,Betalain,Betalain,1782,,07/27/2016,07/27/2016,Positive – Will have video conference/chat,,
Food Ingredient Solutions LLC ,Mr.,Martin,Trott,,mtrott@foodcolor.com,Betalain,Betalain,,,,,,,
Fortress Biotech,Mr.,Sa’ar,Yaniv,"Director, Business Development",SYaniv@fortressbiotech.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,07/09/2018,Very positive wants to learn more,,
Fortress Biotech,Dr.,Charles,Buchen,"Director, Business Development",Charles Buchen <cbuchen@fortressbiotech.com>,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,"2018-07-09 Passed along from Mustang Bio. 2018-07-16 TC with Sa'ar, Charles, Assaf, Orly, and Myself  to give some initial impressions.",,07/09/2018,Very positive wants to learn more,,
Frutarom Industries,Ms.,Judith,Glezer,Senior Research Scientist at Frutarom,jglezer@il.frutarom.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,,,,,
Frutarom Industries,Ms.,Adi,Melamed,Director of Business Development,amelamed@il.frutarom.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,01/10/2017,,,01/17/2017,
Frutarom Industries,Ms.,Judith,Glezer,Senior Research Scientist at Frutarom,jglezer@il.frutarom.com,,,,,,,,,
Frutarom Industries,Ms.,Adi,Melamed,Director of Business Development,amelamed@il.frutarom.com,Colitis Treatment,,1831,,06/01/2017,06/01/2017,"Positive, wants an initial chat.",06/06/2017,
Frutarom Industries,Ms.,Adi ,Melamed,Director of Business Development,Adi Melamed <amelamed@frutarom.com>,Colitis Treatment,,1831,,,06/26/2017,"Positive - Wanted more information, but we couldn't do anything. We had a TC 2017-06-26 with Adi and Yoni Glickman. 2017-08-04 Signed an NDA. 2017-09-04 I replied and informed we could only do an in person reply, as Ayelet was unwilling to share. And from their it died.",,
Fuji Chemicals (AstaReal),Ms.,Hsinying ,Lin,Scientific Officer at Fuji Chemical Group ,h-lin@fujichemical.co.jp,Astaxanthin producing ecoli,ES,1650,,bounced,,,,
FuturaGene,Dr.,Ilya,Pittel,R&D and Partnership Coordinator,ilya@futuragene.com,Carbon Fixing + Glycoalkaloids,Carbon Fixing + Glycoalkaloids,1736 +1587,,01/10/2017,01/17/2017,Negative - but want to hear from us in the future,01/17/2017,
FutureCarbon,Mr.,Klaus,Zeyn,CEO at FutureCarbon GmbH,Klaus.Zeyn@future-carbon.de,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,03/21/2018,,,,
FutureCarbon,Ms.,Jerri,Durrett,Business Development Manager at FutureCarbon GmbH,jerri.durrett@future-carbon.de,,,,,,,,,
Gat Foods (Prigat),Mr.,Leor,Ben Yakov,VP Business Development at Gat Foods (Prigat),Orly is a LinkedIn contact,Cellulosomes,Cellulosomes,1536,,,,,,
Gelesis,,,,,,,,,,,,,,
Genentech,Dr.,Josh ,Kaminiker,"Director of OMNI Bioinformatics and Senior Scientist, Bioinformatics & Computational Biology",kaminker.josh@gene.com,Pathifier Algorithm,Onepager,1629,Not so much advertising just trying to get directions for companies that would actually be interested in the technology,01/21/2018,,,01/25/2018,
General Mills,Ms.,Emily ,Riley,Sr. Technology Manager | Disruptive Innovation Consumer First,emily.riley@genmills.com,Betalain,Betalain,,,,,,,
General Mills,Dr. ,Kurt,Waananen,"Sr. R&D Director, International Snacks at General Mills",kurt.waananen@genmills.com,Betalain,Betalain,1782,,07/27/2016,07/27/2016,Positive – Forwarded it to relevant parties,08/29/2016,
Genialis,Dr.,Rafael,Rosengarten,"President, Co-founder of Genialis Inc.",rafael@genialis.com,Pathifier Algorithm,Onepager,1629,,,,,,
Genialis,Dr.,Miha ,Štajdohar,Chief Technology Officer,miha@genialis.com,Pathifier Algorithm,Onepager,1629,,01/28/2018,,,,
Gevo,,,,,Mike Willis Email: mwillis@gevo.com,,,,,,,,,
Gevo,Mr.,Alex,Clayton,VP Commercial Development at Gevo,aclayton@gevo.com,Cellulosomes,Cellulosomes,1536,Biofuels,09/18/2016,,,09/26/2016,
Gilead,Ms.,Monica ,Viziano,"Senior Director, Alliance Management, Corporate Development at Gilead Sciences",monica.viziano@gilead.com,Diabetes treatment augmentation,1-pager,1804,,02/11/2018,,,02/15/2018,
Gilead,Dr.,Amy,Tatsutani,"Associate Director, Alliance Management ",amy.tatsutani@gilead.com,,,,,,,,,
Ginkgo Bioworks,Dr.,Jason,Kelly,Founder at Ginkgobioworks,jason@ginkgobioworks.com,Betalain and L-DOPA,Betalain and L-DOPA,1782,,,,,,
Ginkgo Bioworks,Dr. ,Massimo,Merighi,"Project Lead/Project Manager at Ginkgo Bioworks, Inc.",Merighi@ginkgobioworks.com,Betalain and L-DOPA,Betalain and L-DOPA,1782,,10/26/2016,11/01/2016,,11/01/2016,Forwarded it for a deeper look.
Ginkgo Bioworks,Dr. ,Massimo,Merighi,"Project Lead/Project Manager at Ginkgo Bioworks, Inc.",Merighi@ginkgobioworks.com,Carbon Fixing + Betalain,Carbon Fixing + Betalain,1736+1782,This is a reminder for 1782 (betalain) and introduction for 1736 (carbon fixation),11/29/2016,11/29/2016,"He said he would check back, he hasn't...",01/10/2017,"Replied 2017-01-11, says that they have sents documents for NDAs and such. But checking in with Orly, we have not received them. On 2017-01-12 I replied that we have yet to receive said NDAs and would like to send our own. "
Ginkgo Bioworks,Mr.,Zach,Smith,Director of Business Development at Ginkgo Bioworks,Zach@ginkgobioworks.com,,,,,,,,,
Ginkgo Bioworks,Dr.,Will ,Schroeder,Head of Metabolic Engineering at Ginkgo Bioworks,,,,,,,,,,
Ginkgo Bioworks,Mr.,Seth,Goldblum,"Head, Business Development at Ginkgo Bioworks, Inc.",seth@ginkgobioworks.com or sgoldblum@ginkgobioworks.com,,,,,,,,,
Ginkgo Bioworks,Dr.,Reshma,Shetty,Co-founder,reshma@ginkgobioworks.com,,,,,,,,,
Ginkgo Bioworks,Dr.,Jason,Kelly,Founder at Ginkgobioworks,jason@ginkgobioworks.com,,,,,,,,,
Ginkgo Bioworks,Mr.,Zach,Smith,Director of Business Development at Ginkgo Bioworks,Zach@ginkgobioworks.com,PFL metabolic pathway for Formate + Acetate conversion to Pyruvate,ES,1657,,01/30/2018,,,02/06/2018,
"Glanbia Performance Nutrition (BSN, Optimum Nutrition)",Mr.,David,Klavsons,President,,,,,,,,,,
"Glanbia Performance Nutrition (BSN, Optimum Nutrition)",Mr.,Hugh,McGuire,CEO Glanbia Performance Nutrition. Executive Director Glanbia PLC,hMcGuire@glanbia.ie,Colitis Treatment,,1831,,06/13/2017,,,,
"Glanbia Performance Nutrition (BSN, Optimum Nutrition)",Ms.,Noreen,Gallagher,President at Glanbia Performance Nutrition EMEA,ngallagher@glanbiausa.com,,,,,,,,,
"Glanbia Performance Nutrition (BSN, Optimum Nutrition)",Mr.,Adam,Skibley,"Director, Strategy & Corporate Development",askibley@glanbiausa.com,,,,,,,,,
"Glanbia Performance Nutrition (BSN, Optimum Nutrition)",Ms.,Anna,DuHamel,"Director, Strategy and Corporate Development at Glanbia Performance Nutrition (GPN)",aduhamel@glanbia.ie,Colitis Treatment,,1831,Bounced back,06/01/2017,,,,
"Glanbia Performance Nutrition (BSN, Optimum Nutrition)",Ms.,Alma ,Mullins,Director Product Development - International at Glanbia Performance Nutrition - GPN,,,,,,,,,,
"Glanbia Performance Nutrition (BSN, Optimum Nutrition)",Mr.,Brent,Petersen,Associate Director of Research at Glanbia Global Ingredients (US),bpetersen@glanbiausa.com,,,,,,,,,
"Glanbia Performance Nutrition (BSN, Optimum Nutrition)",Mr.,David,Perry,"Senior Director, Research and Development at Glanbia Nutritionals",dperry@glanbiausa.com,,,,,,,,,
"Glanbia Performance Nutrition (BSN, Optimum Nutrition)",Mr.,Andrew,Lynch,VP Research & Development at Glanbia Performance Nutrition,,,,,,,,,,
GlaxoSmithKline,Dr.,Kristen,Slaoui,"Vice President, Head of Business Development, North America - GlaxoSmithKline",kristen.e.belmonte@gsk.com,,,,,,,,,
GlaxoSmithKline,Ms.,Lisa,Martin,Transformational Leader | Change Advocate | Procurement Professional,Lisa.Martin@gsk.com,,,,,,,,,
Galvani Bioelectronics,Ms.,Kristen connors,Rall,"Alliance Director, Business Development at Galvani Bioelectronics",kristen.x.rall@gsk.com,,,,,,,,,
Zafgen,Ms.,Erin ,Brubaker,"VP, R&D Strategy Development and Deployment",erin.e.brubaker@gsk.com,Diabetes treatment augmentation,1-pager,1804,,02/11/2018,,,02/15/2018,
GlaxoSmithKline,Dr. ,Trupti ,Trivedi,"Vice President, Business Strategy, R&D at GSK",trupti.trivedi@gsk.com,,,,,,,,,
GlaxoSmithKline,Dr.,Hal ,Barron,President Research And Development,barron.hal@gene.com,,,,,,,,,
ZAFGEN,Mr.,Brian,McVeigh,Chief Business Officer at Zafgen,brian.p.mcveigh@gsk.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,No Response,,05/22/2017,
Global Bioenergies,Mr.,Bernard,Chaud,Directeur de la Stratégie Industrielle chez Global Bioenergies,bernardchaud@orange.fr,Cellulosomes (Biofuels),Cellulosomes,1536,,,,,,
Global Bioenergies,Mr.,Thomas,Buhl,Head of Business Development at Global Bioenergies,thomas.buhl@global-bioenergies.com,Cellulosomes (Biofuels),Cellulosomes,1536,,01/10/2017,01/10/2017,Reviewing the Technology,,Sent 2017-03-06
Global Bioenergies,Mr.,Bernard,Chaud,Directeur de la Stratégie Industrielle chez Global Bioenergies,bernardchaud@orange.fr,,,,,,,,,
Global Bioenergies,Mr.,Thomas,Buhl,Head of Business Development at Global Bioenergies,thomas.buhl@global-bioenergies.com,,,,,,,,,
Global BioTherapeutics ,Dr.,Blanca,Segura,Chief Scientific Officer, b.segura@global-biotherapeutics.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
Global BioTherapeutics ,Dr.,Blanca,Segura,Chief Scientific Officer, b.segura@global-biotherapeutics.com,miR-218,ES,1498,,bounced,,,,
GlobalFoundries,Dr.,Srinivasa ,Banna,Fellow & Director of Technology Research,srinivasa.banna@globalfoundries.com,,Filter for Nanoparticles,1564,,08/02/2017,,,08/08/2017,
Glonatech,Dr.,Vassilis ,Vamvakas,"Expert in Semiconductor Technology, Vacuum and Thin Film Deposition and Characterization",vVamvakas@glonatech.com,,,,,,,,,
Glonatech,Dr.,Thanasis ,Bouras,Senior Researcher R&D Department at Glonatech,tBouras@glonatech.com,,,,,bounced,,,,
Glonatech,Dr.,Stephanos ,Nitodas,Research and Business Development Manager,snitodas@glonatech.com,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,03/21/2018,,,,
GNC,,,,,"Rathbun,Lynsi -GNC,lynsi-rathbun@gnc-hq.com",,,,,,,,,
GNC,Mrs.,Jenifer,Murphy,"Manager, Reasearch & Development at GNC",Jennifer-Murphy@gnc-hq.com,,,,,,,,,
GNC,Mr.,Shawn,Cupples,"Vice President, International Business Development at GNC",Shawn-Cupples@gnc-hq.com,Colitis Treatment,,1831,,06/01/2017,,No Reply,06/08/2017,
GNC,Dr. ,Guru, Ramanathan,Chief Innovation Officer at General Nutrition Corporation,Guru-Ramanthan@gnc-hq.com,Colitis Treatment,,1831,"bounced back, email dead",06/13/2017,,,,
GNC,Dr. ,Sudipta ,Veeramachaneni,"Sr. Director, R&D at GNC",sudipta-veeramachaneni@gnc-hq.com,Colitis Treatment,,1831,,06/13/2017,,,06/27/2017,
GNT International B.V.,,,,,,,,,,,,,,
Google,Dr.,Frederik G.,Pferdt,"Chief Innovation Evangelist, Google",fgpferdt@google.com,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,07/19/2017,On Vacation,07/19/2017,
Google,Ms.,Laura,Thompson,Investor at Google Ventures (GV),,,,,,,,,,
Google,Dr.,Adi,Aron-Gilat,"Google [X], Head of Business Innovation Strategy",,,,,,,,,,
Google,,,,,,,,,,,,,,
GreenBiologics,Mr.,Tim,Staub,Global VP Business Development at Green Biologics Ltd.,,Cellulosomes (Biofuels),Cellulosomes,1536,,,,,,
GreenBiologics,Dr.,Preben,Krabben,Head of Innovation,Preben.Krabben@greenbiologics.com,Cellulosomes (Biofuels),Cellulosomes,1536,,01/10/2017,01/10/2017,Interested in the technology and wants to review patents. 2017-01-12 I send the relevant patents + publications. Replies 2017-01-12 Says will get back to us in a few months,,
Groove Biopharma (Permanently Closed!),,,,,,,,,,,,,,
Halo-Bio (Just started up),Dr.,Todd,Hauser,Founder & CEO,thauser@halo-bio.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,bounced back,06/07/2017,,,06/13/2017,
Halo-Bio (Just started up),Dr.,Todd,Hauser,Founder & CEO,thauser@halo-bio.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Hanmi,,,,,,,,,,,,,,
Harlan/Envigo ,,Nati,Ezov,,nati.ezov@envigo.com,Mouse monitoring systems,ES,1571 and 1593,Trying to setup a meeting but Nati has been unresponsive. Talk to Neta about him intervening.,07/04/2018,07/04/2018,Interested and would like to learn more,,
Hazera Seeds,,,,,info@hazera.com,,,1587,,,,,,
Hazera Seeds,Ms.,Dganit ,Vered,Head of R&D Division,,,,1587,,,,,,
Hazera Seeds,Ms.,Orna,Livneh,Global Innovation Manager at Hazera seeds,ornal@hazera.com,,Alkaloids,1587,,06/27/2016,06/27/2016,Positive - Meeting was organized,,
Hazera Seeds,Mr. ,Alejandro,Szechtman,Breeding Director at Hazera Seeds,,,,1587,,,,,,
Hazera Seeds,Dr.,Zur ,Granevitze,Director Breeding Technology,Zur.Granevitze@hazera.com,,Alkaloids,1587,,06/27/2016,,,,
Hazera Seeds,Ms.,Susan,Mor,Strategy Development Manager,,,,1587,,,,,,
Hazera Seeds,Ms.,Orna,Livneh,Global Innovation Manager at Hazera seeds,ornal@hazera.com,Carbon Fixing,Carbon Fixing,1736,,01/10/2017,01/14/2017,Reviewing the Technology,,Sent 2017-03-06
Heineken,Dr. ,Jan-Marteen ,Geertman, Lead Scientist Fermentation and Yeast,janmaarten.geertman@heineken.com,Betalain,Betalain,1782,"Away till Aug 22nd, 2016",08/04/2016,08/11/2016,Negative- Just not interested,08/11/2016,
Heliae,Dr.,Laura,Carney,"Manager, AgScience & Molecular Ecology at Heliae",lcarney@heliae.com,Algal Oil,Algal Oil,1796,,,,,,
Heliae,Dr.,Jon,Hansen,"VP, Science and Technology at Heliae",jhansen@heliae.com,Algal Oil,Algal Oil,1796,,01/10/2017,,,01/17/2017,
Heliae,Dr. ,Sandip,Shinde,"Director of Product Development at Heliae, LLC",sshinde@heliae.com,Algal Oil,Algal Oil,1796,,,,,,
"Henkel AG & Company, KGaA",,Sebastian ,Hinz,TEMPLATE,sebastian.hinz@henkel.com,,,,,,,,,
"Henkel AG & Company, KGaA",Mr.,Jamie,Serenson,"Innovation Program Manager, Technology Start Up at Henkel",jamie.serenson@henkel.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,,,,,
"Henkel AG & Company, KGaA",Mr.,Vito,Buffa,"Director, Innovation Management at Henkel",vito.buffa@henkel.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,01/10/2017,,,01/17/2017,
Hershey Co.,Mr.,Jeff A. ,Mundt,Sr. Marketing Manager of Technology & Transformational Innovation at The Hershey Company,jmundt@hersheys.com,Betalain,Betalain,,,,,,,
Hershey Co.,Mr.,Robert,Gavazzi,"Senior Director, Front of Funnel Innovation & Strategy at The Hershey Company",rgavazzi@hersheys.com,Betalain,Betalain,1782,,07/27/2016,,,,
Hershey Co.,Ms. ,Diane,Lorello,VP Innovation at The Hershey Company,diane.lorello@hersheys.com,Betalain,Betalain,,,,,,,
HiQ-Nano ,Dr.,Enrico ,Binetti,Researcher - Product Development - Product Management,info@hiqnano.com,,Filter for Nanoparticles,1564,,08/02/2017,,,08/08/2017,
Homeland Security,Dr. ,John,Fischer,"Director, Chemical-Biological Defense Division at Department of Homeland Security Advanced Research Projects Agency",,,,,,,,,,
Hongene Biotechnology Limited,,,,,,,,,,,,,,
HP,Mr.,Andrew,Bolwell,Vice President and Chief Disrupter – Global Head of Technology Vision & HP Tech Ventures,andrew.bolwell@hp.com,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,,,07/19/2017,
HP,Ms.,Mei,Jeng,Head of Innovation Strategy and New Business Incubation at Hewlett-Packard; Pan-HP IoT Lead,,,,,,,,,,
HP,,Anna ,Dzvonyar,template,anna.dzvonyar@hp.com,,,,,,,,,
Huons Global Co Ltd,Dr.,Hyunae,Eum,"Chief Researcher - Huons Co., Ltd.",heum@huons.com or hyunaeeum@huons.com,Bcl2 inhibitor predictive software,Cover letter,1881,,bounced,,,,
HZPC,,,,,rd@hzpc.nl,,,1587,,,,,,
HZPC,Mr. ,Robert,Graveland,R&D Director,robert.graveland@hzpc.nl,,Alkaloids,1587,,06/22/2016,09/17/2016,Negative cannot use GM but they want to hear more from us in the future,07/24/2016,
HZPC,Mr. ,Gerard ,Backx,CEO HZPC Holland BV,,,,1587,,,,,,
HZPC,Mr.,Jelle,Bos,Business Development Manager,jelle.bos@hzpc.nl,General email ,Alkaloids,1587,,06/22/2016,,,,
HZPC,Mr.,Andrik,Waalkens,Sector manager,andrik.waalkens@hzpc.nl,,Alkaloids,1587,,06/22/2016,,,,
HZPC,Mr.,Gert,Jan Feddes,Business development manager,,,,1587,,,,,,
IBM,Dr.,Zodik,Gabi,Template,  zodik@il.ibm.com,,,,,,,,,
IBM,,Danny,Harnik,Template,DANNYH@il.ibm.com ,,,,,,,,,
IBM,,Haim,Schneider,Template,haims@il.ibm.com,,,,,,,,,
IBM,Mr.,Lior,Weizman,"Head of Startup & Developer Ecosystem, IBM Israel",liorwe@il.ibm.com,Multi-state polymers for memory and logic gates,Web page,1568,,bounced,,,,
IBM,Dr.,Kristof,Kloeckner,"CTO and General Manager, Technology, Innovation and Automation, IBM Global Technology Services at IBM",,,,,,,,,,
IBM,Dr.,Saul J,Berman,VP & Global Chief Strategist at IBM Global Services,,,,,,,,,,
IBM,Mr.,Ronny,Morad,"Manager, System Verification Technologies at IBM Haifa Research Lab",morad@il.ibm.com,Multi-state polymers for memory and logic gates,Web page,,,07/05/2017,,,07/19/2017,
Ichor Medical Systems ,,,,,,,,,,,,,,
ICL Innovation,Ms.,Alisa,Band,Head of Technology Scouting at ICL,alisa.band@icl-group.com,Carbon Fixing + Glycoalkaloids,Carbon Fixing + Glycoalkaloids,1736 +1587,,01/16/2017,01/16/2017,Clear interest in Milo 1736 technology. Not interested in Glycoalkaloid reduction 1587. Sent out a list of technologies they are explicitly looking for at the moment. Good sign overall. 2017-01-24 Decided to decline the 1736 technology.,,
Illumina,Dr.,Felix,Schlesinger,Senior Bioinformatics Scientist,felix.schlesinger@gmail.com,Pathifier Algorithm,Onepager,1629,Not so much advertising just trying to get directions for companies that would actually be interested in the technology,01/21/2018,01/27/2018,"Positive for what I wanted. Directed me to three companies that would be suitable to approach Ingenuity, Genialis or Partek",01/25/2018,
Industrie De Nora S.p.A. | De Nora Water Technologies,Mr.,Stan,Shmia,Product Manager at De Nora Water Technologies,stan.shmia@denora.com,,,,,,,,,
Industrie De Nora S.p.A. | De Nora Water Technologies,Dr.,Stelios,Kyriacou,General Manager - De Nora Water Technologies,stelios.kyriacou@denora.com,,Filter for water,1564,Directed to Filippo Ronzani,08/22/2017,08/25/2017,Neutral - Under review,,
Industrie De Nora S.p.A. | De Nora Water Technologies,Dr.,Filippo,Ronzani,"Research scientist
Scouting, Basic Research & Scanning
",Ronzani Filippo <filippo.ronzani@denora.com>,,Filter for water,1564,,,09/12/2017,Positive - Wants an NDA to continue the discussion.,,
Industrie De Nora S.p.A. | De Nora Water Technologies,,,,,decio.barros@denora.com,,,,,,,,,
Infineon,Mr.,Adrian ,Mikolajczak,Head - Silicon Valley Innovation Center @ Infineon Technologies: Growth and Innovation General Management,Adrian.Mikolajczak@Infineon.com,,,,,,,,,
"Infinity Pharmaceuticals, Inc.",Dr.,Jeff ,Kutok,Chief Scientific Officer at Infinity Pharmaceuticals,jeff.kutok@infi.com,Bcl2 inhibitor predictive software,Cover letter,1881,,03/21/2018,,,04/09/2018,
Inova Diagnostics - A Werner Company,,,,,,,,,,,,,,
Intarcia ,Mr.,Matthew,Aubin,"Vice President Commercial Strategy, Insights & Analytics & Commercial Operations at Intarcia Therapeutics, Inc.",matthew.aubin@intarcia.com,,,,,,,,,
Intarcia ,Mr. ,Kurt,Graves,"Chairman, President and CEO at Intarcia Therapeutics",kurt.graves@intarcia.com,,,,,,,,,
Intarcia ,,,,business development general,busdev@intarcia.com,,,,,,,,,
Intel,Dr.,Todd,Harple,Director of Innovation,todd.s.harple@intel.com,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,,,07/19/2017,
Intel,Mr.,Amit,Shahar,"Sr. Director, Systems Innovation Group, Intel Corporation",amit.shahar@intel.com,,,,,,,,,
Intel,Mr.,Roy,Ramon,Director at Intel Capital,roy.ramon@intel.com,,,,,,,,,
Intel,,Srinivas ,Subramaniam,Template,srinivas.subramaniam@intel.com,,,,,,,,,
Intellia Therapeutics (Focused on CRISPR),Dr.,Walter,Strapps,"Senior Director at Intellia Therapeutics, Inc.",,,,,,,,,,
Intellia Therapeutics (Focused on CRISPR),Dr.,Jennifer,King,"Senior Vice President Business, Development at Intellia Therapeutics Inc.",jennifer.king@intelliatx.com,Genetic Logic Gates,NOR based Device,1764,,06/15/2017,06/15/2017,Directed me to Jeanne Wilson for review of the technology.,,
Intellia Therapeutics (Focused on CRISPR),Dr. ,Jeanne,Wilson,Senior Manager,Jeanne Wilson <jeanne.wilson@intelliatx.com>,Genetic Logic Gates,NOR based Device,1764,,,06/15/2017,Negative to the Shapiro Tech. But positive about hearing more technologies from YEDA. Sent a full list of relevant technologies they are currently looking for. ,,
Intellia Therapeutics (Focused on CRISPR),Dr.,Nessan,Bermingham ,CEO,nessan@intelliatx.com,,,,,,,,,
Intellia Therapeutics (Focused on CRISPR),,Jennifer Mound,Smoter,"Senior Vice President, External Affairs & Communications", jenn.smoter@intelliatx.com,,,,,,,,,
Intellia Therapeutics (Focused on CRISPR),,Graeme,Bell,"Executive Vice President, Chief Financial Officer", graeme.bell@intelliatx.com,,,,,,,,,
Intellia Therapeutics (Focused on CRISPR),Dr.,John,Finn,Scientist,john.finn@intelliatx.com,,,,,,,,,
InteRNA Technologies (Could push due to pancreatic cancer),Dr.,Roel,Schaapveld,Chief Executive Officer at InteRNA Technologies BV,schaapveld@interna-technologies.com,,,,,,,,,
InteRNA Technologies (Could push due to pancreatic cancer),Ms.,Sijme,Zeilemaker,Director Business Development,zeilemaker@interna-technologies.com,TNBC shRNA ,TNBC shRNA ,1619,,06/07/2017,,,06/13/2017,
International Paper Co,Mr.,Richard ,Faber,Innovation Marketing Manager at International Paper Company,RICHARD.FABER@IPAPER.COM,Cellulosomes,Cellulosomes,1536,,,,,,
International Paper Co,Mr.,Clay,Ellis,Vice President Manufacturing - NA Paper and Pulp,clay.ellis@ipaper.com,Cellulosomes,Cellulosomes,1536,,,,,,
International Paper Co,Mr.,Tommy,Joseph,VP Technlogy at International Paper Co,Thomas.joseph@ipaper.com (WRONG EMAIL) it is tommy.joseph@ipaper.com,Cellulosomes,Cellulosomes,1536,I got confused there is a Thomas Joseph and a Tommy Joseph at this company. Thomas Joseph was kind enough to direct me to the correct individual,09/27/2016,,,10/26/2016,
Intrexon,Dr.,Kipp,Erickson,"Vice President, Technology & Commercialization at Intrexon Corporation",kerickson@intrexon.com,Carbon Fixing + Betalain,Carbon Fixing + Betalain,1736+1782,This email definitely not working.,email failed,,,,
Intrexon,Dr.,Anthony,Clark,R&D Executive in Biotechnology,aclark@intrexon.com,Carbon Fixing + Betalain,Carbon Fixing + Betalain,1736+1782,,01/10/2017,01/10/2017,"Reviewing the Technology - Expliciitly the L-DOPA, No on the carbon fixation. 2017-01-23 setup a phone conference.",,
Intrexon,Mr.,Nir,Nimrodi,"Senior Vice President, Corporate Development at Intrexon Corporation",nnimrodi@intrexon.com,Genetic Logic Gates,NOR based Device,1764,2017-04-07 sending another reminder email.,06/15/2017,06/15/2017,Neutral - Sent for review,,
Intrexon,Mr.,Nir,Nimrodi,"Senior Vice President, Corporate Development at Intrexon Corporation",nnimrodi@intrexon.com,PFL metabolic pathway for Formate + Acetate conversion to Pyruvate,ES,1657,,01/30/2018,01/31/2018,Negative,,
Intrinsiq Materials,Mr.,Robert,Nead,President/CEO at Intrinsiq Materials,RNead@intrinsiqmaterials.com,,Filter for Nanoparticles,1564,,08/02/2017,,,08/08/2017,
Iogen Corporation,Mr.,Gordon,McLennan,V.P. Business Development at Iogen Corporation,gordontmclennan@gmail.com,Cellulosomes,Cellulosomes,1536,Biofuels,09/18/2016,,,09/26/2016,
Ionis Pharmaceuticals (formely Isis) ,Dr.,Stanley T,Crooke,Chairman of the Board & Chief Executive Officer and Founder,scrooke@ionisph.com,,,,,,,,,
Ionis Pharmaceuticals (formely Isis) ,Dr. ,Sang Jun,Lee,Senior Scientist at Ionis Pharmaceuticals,,,,,,,,,,
Ionis Pharmaceuticals (formely Isis) ,Dr.,Bret,Coldren,Director - Pharmaceutical Development at Ionis Pharmaceuticals,bcoldren@ionisph.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
Ionis Pharmaceuticals (formely Isis) ,Dr.,Adam,Mullick,"Director at Ionis Pharmaceuticals, Inc.",,,,,,,,,,
Ionis Pharmaceuticals (formely Isis) ,Dr.,Michael,McCaleb,"Vice President, Ionis Pharmaceuticals",,,,,,,,,,
Ionis Pharmaceuticals (formely Isis) ,Dr.,Stanley T,Crooke,Chairman of the Board & Chief Executive Officer and Founder,scrooke@ionisph.com,,,,,,,,,
Ionis Pharmaceuticals (formely Isis) ,Dr. ,Sang Jun,Lee,Senior Scientist at Ionis Pharmaceuticals,,,,,,,,,,
Ionis Pharmaceuticals (formely Isis) ,Dr.,Bret,Coldren,Director - Pharmaceutical Development at Ionis Pharmaceuticals,bcoldren@ionisph.com,,,,,,,,,
Ionis Pharmaceuticals (formely Isis) ,Dr.,Adam,Mullick,"Director at Ionis Pharmaceuticals, Inc.",,,,,,,,,,
Ionis Pharmaceuticals (formely Isis) ,Dr.,Michael,McCaleb,"Vice President, Ionis Pharmaceuticals",mmccaleb@ionisph.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Irun Cohen patent 2013079 - only technology - 1113,,,,,,,,,,,,,,
Isobionics,Dr.,Georg,Lentzen,Director R&D at Isobionics,,Betalain,Betalain,1782,,,01/17/2017,Wants more info. Replied 2017-01-26 have not gotten an answer back since.,,
Isobionics,Mr. ,Toince,Janssen,CEO Isobionics,toine.janssen@isobionics.com,Betalain,Betalain,1782,,01/10/2017,,,01/17/2017,
iTherapeutics Corp,,,,,,,,,,,,,,
J.R. Simplot,Mr.,Frank,Mulcahy,Research & Development Manager at Simplot Australia,frank.mulcahy@simplot.com.au,,Alkaloids,1587,,06/27/2016,,,,
J.R. Simplot,Ms.,Jolyn,Rasmussen,Research Agronomist at J.R. Simplot Company,jolyn.rasmussen@simplot.com,,Alkaloids,1587,,06/27/2016,,,,
J.R. Simplot,Dr.,Jacob,Blauer,Agronomy Scientist Manager,,,,1587,,,,,,
J.R. Simplot,Mr.,Nate,Lunt,Product Manager at J.R. Simplot Company - Plant Sciences,nathan.lunt@simplot.com,,Alkaloids,1587,,06/27/2016,,,,
J.R. Simplot,Dr.,Craig,Richael,Director of R & D at Simplot Plant Sciences,Craig.Richael@simplot.com,,Alkaloids,1587,,06/27/2016,,Negative – But still wants to see more of our tech,07/24/2016,
J.R. Simplot,Dr.,Craig,Richael,Director of R & D at Simplot Plant Sciences,Craig.Richael@simplot.com,Carbon Fixing,,1736,,01/10/2017,01/17/2017,Negative,01/17/2017,
Janssen Biotech,,,,,,,,,,,,,,
Janssen Pharmaceuticals | Johnson & Johnson,Dr.,Yiu-Lian,Fong,"Global Head, R&D, Dx Innovation and Lab Operation at Janssen Diagnostics",yfong@its.jnj.com,,,,,,,,,
"Japan Melinta Therapeutics, Inc. (Work of Thomas Steitz co-sharer of Nobel prize with Ada Yonath)",Dr.,Erin,Duffy,Chief Scientific Officer,eduffy@melinta.com,,,,,,,,,
"Japan Melinta Therapeutics, Inc. (Work of Thomas Steitz co-sharer of Nobel prize with Ada Yonath)",Dr.,Danping,Li,Director of Drug Product Development,dli@melinta.com,,,,,,,,,
Japanese Tobacco Pharmaceutical,,,,,,,,,,,,,,
Jarrow Formulas,Mr.,Rory,Lipsky,Senior Director of Business Strategy at Jarrow Formulas,rory@jarrow.com,Colitis Treatment,,1831,,06/01/2017,,No Reply,06/08/2017,
Jarrow Formulas,Ms.,Jordan,Lemerande,R&D Senior Associate,jordan@jarrow.com (jordan.lemerande@jarrow.com),,,,,,,,,
Johnson & Johnson,,Kellie,McLaughlin,TEMPLATE,kmclaugh@its.jnj.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,hold off,,,,
Johnson & Johnson,,Greg,Panico,Template,gpanico1@its.jnj.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,hold off,,,,
Johnson & Johnson,Dr.,Jeff,Calcagno,"New Ventures, Johnson & Johnson Innovation",jcalcagn@its.jnj.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,hold off,,,,
Johnson & Johnson,"Dr,",Robert G.,Urban,Global Head - Johnson & Johnson Innovation,rurban@mit.edu or rurban@alum.mit.edu,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,hold off,,,,
Johnson & Johnson,Dr.,Judith,Elkaim,"PhD | Innovation, Open Innovation & Partnerships, Natural Products",,,,,,,,,,
Johnson & Johnson,,,,,,,,,,,,,,
Juno Therapeutics,Dr.,Allison,Bianchi,Senior Director ,allisonbianchi@junotherapeutics.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,Bounced,,
Juno Therapeutics,Dr.,Jason B,Litten,Vice President of Clinical Development,jasonlitten@junotherapeutics.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,Bounced,,
Juno Therapeutics,Dr.,Paul,Brunetta,"Senior Vice President, Translational Sciences",paul.brunetta@junotherapeutics.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,Bounced,,
KalSec,MBA,Jill,McKeague,Product Director - Antioxidants,jMcKeague@kalsec.com,Betalains,Using Betalain Exclusive Exec Summary,1782,,08/04/2016,08/11/2016,Forwarded me to Roger Nahas,08/11/2016,
KalSec,Dr.,Roger,Nahas,Tech Person,"rnaha@kalsec.com

",Betalains,Using Betalain Exclusive Exec Summary,1782,,,,2016-09-13 positive setting up a conference call ,09/12/2016,
KalSec,PhD,John C.,Weaver,Director R&D and Applications,jweaver@kalsec.com,Betalains,Using Betalain Exclusive Exec Summary,1782,,07/11/2016,07/11/2016,Out of office till 2016-07-11,07/24/2016,
Kanegrade,,,,,info@kanegrade.com,Betalain,Betalain,,,,,,,
Kao Corporation,,Last name,First name,Template,takahashi.fumikazu@kao.co.jp,,,,,,,,,
Kao Corporation,Ms.,Sirlei,Waterhouse,Product Development Leader at Kao Brands,sirlei.waterhouse@kaobrands.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,,,,,
Kao Corporation,Ms.,Rebecca,Williams,Research & Development at Kao USA Inc.,rebecca.williams@kaobrands.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,,,,,
Kao Corporation,Ms.,Conni,Weaver,VP of R&D at Kao USA,Connie.Weaver@kao.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,,,,,
Kao Corporation,Mr.,Eric,Spahr,"Senior Director, Global Strategy & Innovation at Kao Corp.",eric.spahr@kao.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,01/10/2017,,,01/17/2017,
Kellogg Company,Mr.,Gus,Hoffman,Senior Director - Commercial Technology Innovation at Kellogg Company,Gus.Hoffman@Kellogg.com,Betalain,Betalain,1782,Email address does not exists,07/27/2016,,,,
Kellogg Company,Mr.,John,Goodall,Senior Director -- Research and Technology at Kellogg Company,John.Goodall@Kellogg.com,Betalain,Betalain,,,,,,,
Kingston,Mr.,Odysseas ,Skarpidis,Business Development Manager at Kingston Technology,,,,,,,,,,
Kingston,Mr.,David,Kuan,"Vice President, Corporate Finance and Business Planning at Kingston Technology",david_kuan@kingston.com,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,,,07/19/2017,
Kingston,,David,Leong,template,david_leong@kingston.com,,,,,,,,,
Kingston,,Giulia,Borracci,Template EMEA,gborracci@kingston.eu,,,,,,,,,
Kite Pharma,Dr.,Brad,Glover,VICE PRESIDENT & HEAD STRATEGY & BUSINESS OPERATIONS,bglover@kitepharma.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,,07/18/2018,
Kite Pharma,Mr.,Jonathan ,Tayco," Director, Strategic Planning and Portfolio Management ",jtayco@kitepharma.com,,,,,,,,,
Koch Membrane Systems,Ms.,Henia (Yacubowicz),Pransky,VP of Technology,henia.pransky@kochmembrane.com,,Filter for water,1564,,bounced,,,,
Koch Membrane Systems,Mr.,Manny,Singh,President at Koch Membrane Systems,manny.singh@kochmembrane.com,,,,,,,,,
Kraft Heinz Company,Mr.,Luca,Brioschi,New concepts and ideation Manager at The Kraft Heinz Company,brioschiluca@yahoo.it,Betalain,Betalain,1782,,07/27/2016,,,08/03/2016,
Kroger,Mr.,Quoc,Tra,Senior Scientist at The Kroger Co. (dairy),,,,,,,,,,
Kurita,Mr.,Hideki,Kobayashi,"New Business Development Manager, Sales Department, New Business Division, Kurita Water Industries Ltd.",hideki.kobayashi@kurita.co.jp,,Filter for water,1564,,08/22/2017,08/30/2017,Neutral - Under Review,08/29/2017,
Kurita,Dr.,Takaaki ,Tokutomi,Chief Researcher, takaaki.tokutomi@kurita.co.jp,,,,,,,,,
KWS,,,,,potato@kws.com,,Alkaloids,1587,,06/22/2016,,,,
KWS,Mr. ,Roland,Peerenboom,Managing Director at KWS Potato B.V.,,,,1587,,,,,,
KWS,Ms.,Nadine,Bautz,HR Manager,n.bautz@kws.com,Not the general format,,1587,,,,,,
KWS,Dr.,Emmet,Dalton,Molecular Breeder at KWS POTATO B.V.,,,,1587,,,,,,
KWS,Mr.,Jan,Mijnheer,Seed Potato Production Manager and Special Projects at KWS Potato B.V.,,"mentions in profile ""Specialties: Breeding, marketing, licensing and production of (seed) potatoes.""",,1587,,,,,,
KWS,Mr. ,Jaap,Brondijk,"KAM, Sales, Area Manager",,,,1587,,,,,,
L’Oreal,,ML,Abella,Template,mlabella@rd.loreal.com,,,,,,,,,
L’Oreal,Mr.,Sagiv,Lustig,"Open Innovation Manager - Israel, Research & Innovation at L'Oréal",sagivl@coloright.com or  slustig@rd.loreal.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,01/10/2017,01/13/2017,Reviewing the Technology - Sent to the HQ in Paris for full review. 2017-01-23 Not interested in 1796 because of the concern of using a virus. ,,
Lallemand,Mr.,Christopher,Veit,Director of Business Development at Lallemand Biofuels and Distilled Spirits,cveit@lallemand.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,09/19/2016,"Sending it off for review, 2016-09-26 Sending it to Kevin Wenger at the Mascoma team for further review",01/10/2017,"No, but technically say that want to check in 1-2 times a year in regard to the technology"
Lallemand (Mascoma),Dr.,Kevin,Wenger,Sr. Vice President of Research and Development,kwenger@lallemand.com,Cellulosomes,Cellulosomes,1536,,10/26/2016,10/26/2016,"Positive Response, wants to sign an NDA and have a phone conference in relation to the technology. 2016-10-27 He replied again and is now in communication with Orly. Phone Conference on 2016-11-29 at 15:00 (IL time).",,
Lansinoh,Mr.,John,Swanson,"President, Americas at Lansinoh Laboratories",jswanson@lansinoh.com,Breastfeeding monitoring device,onepager,1431,,08/15/2017,08/15/2017,A clear no interest,,
Lansinoh,,,,,lnavas@lansinoh.com ,,,,,,,,,
Lenntech Water Treatment,Ms.,Rosario,Gomes,Process & Project Engineer,rosario@lenntech.com,,Filter for water,1564,,08/22/2017,,,08/29/2017,
Lenntech Water Treatment,Mr.,Michele,Stefani,Process Engineer,Michele@lenntech.com,,,,,,,,,
Lenntech Water Treatment,Ms.,Athina,Chrysovergi,Process Engineer,Athina@lenntech.com,,,,,,,,,
Lenovo,Ms.,Pauline,Cristofari,"Analyst, Open Innovation",,,,,,,,,,
Lenovo,Mr.,Joe,Plunkett,"Strategic Technology and Innovation Center, Advanced Manufacturing at Lenovo",j.plunkett@lenovo.com,Multi-state polymers for memory and logic gates,Web page,1568,,bounced,,,,
Lenovo,,lora,eckler,template,l.eckler@lenovo.com ,,,,,,,,,
LG,Mr.,Samuel,Cheng,"Corporate VP at LG Electronics, Innovation Business Center",,,,,,,,,,
LG,Mr.,Robert,Cha,Investment Manager at LG Electronics USA,,,,,,,,,,
LG,Mr.,Edwin,Kwon,"Sr. Director, VC & Startup Partnership ",edwink@lgtca.com,,,,,,,,,
LG,Dr.,Iris,Haas,Chem. Tech. Manager,iris@lgtci.co.il,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,07/19/2017,Reviewing Technology,07/19/2017,
LG Technology Center Israel,Dr.,Iris,Haas,Chem. Tech. Manager,iris@lgtci.co.il,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,03/21/2018,,,,
LipoMedics Inc.,,,,,,,,,,,,,,
Living Ink Technologies,Dr.,Scott,Fulbright,CEO and Co-founder at Living Ink,scott.fulbright@livinginktechnologies.com,Algal Oil,Algal Oil,1796,,01/10/2017,01/17/2017,Negative,01/17/2017,
Lonza,Dr.,Thomas,Kiy,Vice President Business Development Consumer Care,thomas.kiy@lonza.com,,,,,,,,,
Lonza,Dr.,Behzad ,Mahdavi,"Vice President, Strategic Innovation & Alliances",Behzad.mahdavi@lonza.com,Colitis Treatment,,1831,,06/01/2017,06/01/2017,Sending it to colleagues for review.,06/27/2017,
Lufthansa,Ms.,Maya,Edelman,Business Development & Account Steering Expert at Lufthansa,maya.edelman@dlh.de ,,,,,,,,,
Lufthansa,Mr.,Michael,Erfert,Director Business Development & Alliances at Lufthansa,michael.erfert@dlh.de,,,,,,,,,
Lufthansa,Mr.,Thomas,Ahlers,Senior Manager Business Development and Strategy Leisure Sales at Lufthansa,thomas.ahlers@dlh.de,,,,,,,,,
LVMH,,Sylvie ,Bénard,TEMPLATE,sbenard@lvmh.fr,,,,,,,,,
LVMH,Dr.,Carine,Nizard,Bio-science innovation manager à LVMH Recherche. Open Innovation. Expert Principal,cnizard@research.lvmh-pc.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,01/10/2017,,,01/17/2017,
LVMH,Ms.,Brigitte,NOE,Directrice Développement et Innovation galénique chez LVMH Recherche,,,,,,,,,,
Lycored,Mr.,Gil ,Kristovsky,Business Development and Sales Manager - Lycored,,,,,,,,,,
Lycored,Mr.,Itay ,Dana,"Director of New Technologies and Market Research, Health",itay.dana@lycored.com,Betalain and L-DOPA,Betalain and L-DOPA,1782,,07/27/2016,07/27/2016,Positive – Will have an in person meeting,,
Lycored,Mr.,Gil ,Kristovsky,Business Development and Sales Manager - Lycored,,,,,,,,,,
Lycored,Mr.,Itay ,Dana,"Director of New Technologies and Market Research, Health",itay.dana@lycored.com,Colitis Treatment,,1831,,06/01/2017,06/01/2017,Negative - Simply not their area.,,
Lygos,Dr. ,Jeffrey,Dietrich,CTO at Lygos,jadietrich@lygos.com,Cellulosomes,Cellulosomes,1536,Sugar conversion to high value products,09/18/2016,09/19/2016,Negative they only order sugar directly,,
Maabarot,,Dalit,Nobelman,Maarbarot,dalitn@altman.co.il,Colitis Treatment,,1831,,,08/04/2017,"Positive - Wanted a presentation, but we couldn't send it.",,
Marina Biotech ,,,,General Email,bd@marinabio.com ,,,,,,,,,
Marina Biotech ,Mr.,J. Michael,French,Not sure if he still there,admin@marinabio.com ,,,,,,,,,
Marina Biotech ,Mr.,Joseph,Ramelli,"CEO at Marina Biotech, Inc.",admin@marinabio.com ,,,,,,,,,
Marina Biotech ,Ms.,June,Ameen,"Senior Vice President at Marina Biotech, Inc.",jameen@marinbio.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
Marina Biotech ,,,,General Email,bd@marinabio.com ,,,,,,,,,
Marina Biotech ,Mr.,J. Michael,French,Not sure if he still there,admin@marinabio.com ,,,,,,,,,
Marina Biotech ,Mr.,Joseph,Ramelli,"CEO at Marina Biotech, Inc.",jramelli@marinbio.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Marina Biotech ,Ms.,June,Ameen,"Senior Vice President at Marina Biotech, Inc.",jameen@marinbio.com,,,,,,,,,
Mars Inc.,Mr.,Howard-Yana,Shapiro,Chief Agricultural Officer ,Howard-Yana.shapiro@effem.com,Betalain,Betalain,,,,,,,
Mars Inc.,Dr. ,Hank,Izzo,Vice President R&D and New Ventures at Mars Inc.,hank.izzo@effem.com,Betalain,Betalain,1782,,07/27/2016,08/01/2016,"Negative – Rakesh Popoli responded and directed me to new leads, ",,
Matrix Genetics,Dr.,Jim,Roberts,CSO,jroberts@matrixgenetics.com or  jroberts@fredhutch.org,Carbon Fixing + Algal Oil,Carbon Fixing + Algal Oil,1736 + 1796,,01/10/2017,01/17/2017,Negative - don't contact in the future,01/17/2017,
MD Biosciences,Dr.,Sigal,Meilin,,sigal@mdbiosciences.com,Mouse monitoring systems,ES,1571 and 1593,,07/04/2018,,,07/17/2018,
Medela,Mr.,Stephen,Flint,"Chief Technology Officer and EVP, Research and Innovation at Medela AG",STEPHEN.FLINT@MEDELA.COM,,,1431,,,,,,
Medela,Ms.,Melissa,Gonzales,"Managing Director, Medela USA at Medela, Inc.",Melissa.Gonzales@medela.com,Breastfeeding monitoring device,onepager,1431,Forwarded email to Brian Silver,08/15/2017,,,,
Medela,Mr.,Brian,Silver,VP Innovation Scouting at Medela,Brian.Silver@medela.com,Breastfeeding monitoring device,onepager,1431,,,08/17/2017,Negative - heard of the device but simply not interested. 2017-08-28 After sending a second email explaining the difference wants to have either a TC or meeting. Igal will advise,,
Medela,Mr.,Mitchell,Odahowski,"Vice President Healthcare USA at Medela, Inc.",,,,,,,,,,
Medisix Therapeutics Pte Ltd,Dr. ,Murray ,Robinson,Chief Scientific Officer,info@medisixtx.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,,07/18/2018,
Medtronic,Mr.,Geoff,DaCosta,"Director, Business Development and Licensing at Medtronic",,,,,,,,,,
Medtronic,Mr.,Michael,Minette,Vice President Global Strategy & Business Development PMR at Medtronic MITG,,,,,,,,,,
Medtronic,Ms.,Hasini ,Muthucumarana,Director Business Development & Licensing (M&A) - Surgical Innovations,,,,,,,,,,
Medtronic,Ms.,Lauryl (Boyum),Fowler,Director of Strategy at Medtronic,Lauryl.fowler@medtronic.com or lauryl.boyum@medtronic.com,Breastfeeding monitoring device,onepager,1431,,08/15/2017,,,08/22/2017,
Meijo Nano Carbon,,,,,,,,,,,,,,
Meliorum Technologies,,,,general,info@meliorum.com ,,,,,,,,,
Mellanox Technologies,Mr.,Vadim,Balahovski,Senior Director Business Development at Mellanox Technologies,vbalahovski@mellanox.com,,,,,bounced,,,,
Mellanox Technologies,,,,Template,jschreiner@mellanox.com,,,,,,,,,
Merck,,,,,,,,,,,,,,
Merck & Co,,erin,dimauro,,erin.dimauro@merck.com,,,,,,,,,
Merck & Co,Dr.,Michel,de Baar,"Executive Director, BD&L - Infectious Diseases & Vaccines, Cardiovascular & Metabolic Diseases at MSD",michel.debaar@merck.com,,,,,,,,,
"Merck & Co., Inc. (Cubist owned by them)",Mr.,Benjamin,Thorner,Senior Vice President and Head of BD&L at Merck,benjamin.thorner@merck.com,,,,,,,,,
"Merck & Co., Inc. (Cubist owned by them)",Ms.,Pamela,Demain,"Exec. Director, Corporate Licensing at Merck",pamela_demain@merck.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,,Doesn't work,,
Merck Serono,Mr.,Yariv,Hefez,Global Business Innovator & Senior Leader Commercial Strategy | Business Development | Commercialization | Marketing,yariv.hefez@merckgroup.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,,Currently away,05/22/2017,
Merck Serono,Mr.,Yariv,Hefez,Global Business Innovator & Senior Leader Commercial Strategy | Business Development | Commercialization | Marketing,yariv.hefez@merckgroup.com,,,,,,,,,
Meridian Medical Technologies,Mr.,Tom,Handel,"General Manager / President at Meridian Medical Technologies, Inc. a Pfizer company",tom.handel@meridianmt.com,Catalytic BioScanvangers,ES,1750,2018-07-17 basically asking if any result from their review.,06/20/2018,06/20/2018,Neutral - Sent for Review,,
Meridian Medical Technologies,,Jim,Pike,"Director, Product and Pharmaceutical Technology at Meridian Medical Technologies",jim.pike@meridianmt.com,,,,,,,,,
Meridian Medical Technologies,Dr.,Drew,Lewis," Medical Lead at Meridian Medical Technologies, a Pfizer Company ",drew.lewis@meridianmt.com,,,,,,,,,
Merrimack Pharmaceuticals,Dr.,Hong,Zhang,"Senior Scientist, Translational Research in Oncology, Merrimack Pharmaceuticals",hzhang@merrimack.com,,,,,bounced,,,,
Merrimack Pharmaceuticals,Dr.,Bambang ,Adiwijaya,"Senior Director of Systems Clinical Pharmacology and Pharmacometrics, Modeling and Simulation",'badiwijaya@merrimack.com',Bcl2 inhibitor predictive software,Cover letter,1881,"If I had to guess, he blocked my email address",03/21/2018,,,bounced,
Mesoblast,Ms.,Sujatha PVK,Nambiar,Director Project/Program Management,sujathapvknambiar@gmail.com,Beta Cell isolation method,ES,1643,,04/15/2018,,,,
Metabolic Explorer,,Manuela,Falempin,responsable business development chez METABOLIC EXPLORER,mfalempin@metabolic-explorer.com,Carbon Fixing + Cellulosomes,Carbon Fixing + Cellulosomes,1736+1536,,,,,,
Metabolic Explorer,Ms.,Sophie,MACEDO-GALVAING,Business Development Manager - METabolic EXplorer,smacedo-galvaing@metabolic-explorer.com or smacedogalvaing@metabolic-explorerer.com,Carbon Fixing + Cellulosomes,Carbon Fixing + Cellulosomes,1736+1536,,,,,,
Metabolic Explorer,Dr.,Philippe,Soucaille,Chief Scientific Officer at METABOLIC EXPLORER,psoucaille@metabolic-explorer.com,Carbon Fixing + Cellulosomes,Carbon Fixing + Cellulosomes,1736+1536,,01/10/2017,Email does not work,,,
Metabolic Pharmaceuticals,,,,,,,,,,,,,,
MetGen,Mr.,Alex,Michine,MetGen - industrial enzymes pulp&paper and biorenewable chemicals industries,alex@metgen.com,Cellulosomes,Cellulosomes,1536,,,,,,
MetGen,Mr.,Matti,Heikkilä,Technology Director at MetGen,matti@metgen.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,,,09/26/2016,
"Microbion Corporation,",Mr.,Donald,Zinn,"Vice President, Business Development at Microbion Corporation",dzinn@microbioncorp.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,No response,,05/22/2017,
MICRODYN-NADIR GmbH,Mr.,Jeffrey,Flowers,Product Design Engineer at TriSep Corporation,j.flowers@microdyn-nadir.com,,Filter for water,1564,,08/22/2017,,,08/29/2017,
MICRODYN-NADIR GmbH,Mr.,Theiler,DePalma,Engineering Manager at Microdyn-Nadir US Corporation,,,,,,,,,,
MICRODYN-NADIR GmbH,, Megan ,Slonski ,,MSLONSKI@TRISEP.COM,,,,,,,,,
MICRODYN-NADIR GmbH,,,,,s.krause@microdyn-nadir.de,,,,,,,,,
Microiv,Mr.,Casey ,McGrath,Environmental Engineer at Microvi Biotech Inc.,,Carbon Fixing + Cellulosomes,Carbon Fixing + Cellulosomes,1736+1536,,,,,,
Micron Technology,Mr.,Kunal,Parekh,"Director, Process Integration, R&D at Micron Technology",,,,,,,,,,
Micron Technology,Mr.,Steve,Dalton,"Consulting, Advanced Storage Systems & Architecture at Micron Technology",,,,,,,,,,
Micron Technology,Mr.,Dean,Klein,VP Advanced Memory Solutions at Micron Technology,dklein@micron.com,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,07/22/2017,"No, no interest in the technology.",07/19/2017,
Micron Technology,,marc,musgrove,template,mmusgrove@micron.com,,,,,,,,,
Microsoft,Mr.,Vivek ,Malhotra,Director Global Alliances and Business Development,vivekma@microsoft.com,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,,,07/19/2017,
Microvi,Dr.,Fatemeh,Shirazi,"Chief Executive Officer, Chief Technology Officer at Microvi Biotech Inc.",fshirazi@microvibiotech.com,Carbon Fixing + Cellulosomes (Biofuels),Carbon Fixing + Cellulosomes,1736+1536,,01/10/2017,Email does not work,,,
Microvi,Mr.,Ali,Dorri,Director of Business Development at Microvi,,Carbon Fixing + Cellulosomes,Carbon Fixing + Cellulosomes,1736+1536,,,,,,
MicuRx Pharmaceuticals Inc.,Dr.,Mike,Gordeev,"CSO, MicuRx Pharmaceuticals, Inc.",info@micurx.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,No response,,05/22/2017,
MiNA Therapeutics Limited,,,,partnering,bd@minatx.com,,,,,,,,,
MiNA Therapeutics Limited,Dr.,David,Blakey,CSO at MiNA Therapeutics,David.blakey@minatx.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,06/07/2017,Negative - Just doesn't fit their research focus.,,
MiNA Therapeutics Limited,Dr. ,Jon,Voutila,Senior Research Scientist at MiNA Therapeutics,,,,,,,,,,
MiNA Therapeutics Limited,,,,partnering,bd@minatx.com,,,,,,,,,
MiNA Therapeutics Limited,Dr.,David,Blakey,CSO at MiNA Therapeutics,David.blakey@minatx.com,,,,,,,,,
MiNA Therapeutics Limited,Dr. ,Jon,Voutila,Senior Research Scientist at MiNA Therapeutics,jon.voutila@minatx.com,miR-218,ES,1498,,bounced,,,,
miRagen Therapeutics ,Mr.,Christopher J.,Morl,Chief Operating Officer,cmorl@miragenrx.com,,,,,,,,,
miRagen Therapeutics ,Ms.,Graciella,Beyers,"Director, Project and Alliance Management at miRagen Therapeutics, Inc.",gbeyers@miragenrx.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
miRagen Therapeutics ,Mr.,Adam,Levy,Chief Business Officer, alevy@miragenrx.com ,,,,,,,,,
miRagen Therapeutics ,Mr.,Miles,Gerson,"Director, Business Development at miRagen Therapeutics, Inc.",mgerson@miragenrx.com,,,,,,,,,
miRagen Therapeutics ,Mr.,Christopher J.,Morl,Chief Operating Officer,cmorl@miragenrx.com,,,,,,,,,
miRagen Therapeutics ,Ms.,Graciella,Beyers,"Director, Project and Alliance Management at miRagen Therapeutics, Inc.",gbeyers@miragenrx.com,,,,,,,,,
miRagen Therapeutics ,Mr.,Adam,Levy,Chief Business Officer, alevy@miragenrx.com ,,,,,,,,,
miRagen Therapeutics ,Mr.,Miles,Gerson,"Director, Business Development at miRagen Therapeutics, Inc.",mgerson@miragenrx.com,miR-218,ES,1498,,08/16/2017,08/23/2017,Neutral - Reviewing the technology. 2017-09-07 Reminder Email sent. 2017-09-12 Wants more non-confidential data.,08/23/2017,
Mirna Therapeutics ,,Jon,Irvin,,jirvin@mirnarx.com ,,,,,,,,,
Mirna Therapeutics ,Dr.,Jay,Stoudemire,"VP of Preclinical Development, Regulatory, QA at Mirna Therapeutics",jstoudemire@mirnarx.com,,,,,,,,,
Mirna Therapeutics (Strong overlap with Hornstein tech),Dr.,Paul,Lammers,"President & CEO at Mirna Therapeutics, Inc.",plammers@mirnarx.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,06/07/2017,"Negative, they are completely leaving the area of miRNA.",,
Mitsubishi Chemical,Dr. ,Wataru,Mizunashi,Scientists but no proper detail,mizunashi_wa@mrc.co.jp,Carbon Fixing + Cellulosomes,Carbon Fixing + Cellulosomes,1736+1536,,01/17/2017,,,01/17/2017,
Mitsubishi Chemical,Dr.,Daisuke,Kido,Scientists but no proper detail,7804581@cc.m-kagaku.co.jp,Carbon Fixing + Cellulosomes,Carbon Fixing + Cellulosomes,1736+1536,,email failed,,,,
Mitsubishi Chemical,Dr.,Henbin,Wang,Senior Principle Scientist at Mitsubishi Chemical USA,,,,,,,,,,
Mitsubishi Tanabe Pharma America Inc,Dr.,Hideo ,Nakamura,"Senior Director at Mitsubishi-Tanabe Pharma Holdings America, Inc.",Hideo_Nakamura@mt-pharma-us.com,,,,,,,,,
Mo Bio Laboratories ,,,,,,,,,,,,,,
Modern Meadow,Dr.,David,Williamson,CTO,,,,,,,,,,
Modern Meadow,Dr.,Gabor,Forgacs,CSO - Co-founder,gforgacs@modernmeadow.com,Genetic Logic Gates,NOR based Device,1764,,06/15/2017,,,06/21/2017,
Modern Meadow,Mr.,Andras,Forgacs,CEO,aforgacs@modernmeadow.com,,,,,,,,,
Moderna Therapeutics ,Dr.,Eric,Huang,"Head, New Venture Labs and Biologics Discovery at Moderna Therapeutics",eric.huang@modernatx.com,,,,,,,,,
Moderna Therapeutics ,,Jennifer,Nelson,,jennifer.nelson@modernatx.com,,,,,,,,,
Mondelez International Inc.,Ms.,Cynthia,Chen,Global Head of eCommerce at Mondel?z International,farriscindy@gmail.com,Betalain,Betalain,,,,,,,
Mondelez International Inc.,Ms.,Samantha,Greenwood,"Snr Director, Venture Team Lead at Mondel?z International",,Betalain,Betalain,,,,,,,
Mondelez International Inc.,Ms.,Erin,Overly,Sr. Director Global Innovation,Erin.Overly@mdlz.com,Betalain,Betalain,1782,,07/27/2016,,,08/03/2016,
Mondi,Mr.,John,Lindahl,Group Technical Director Mondi Group,john.lindahl@mondigroup.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,,,09/26/2016,
Mondi,Mr.,Mark,Ushpol,President Industrial Bags NA at Mondi Group,mark.uspol@mondigroup.com,Cellulosomes,Cellulosomes,1536,,,,,,
Monsanto,PhD,Gal,Yarden,business strategy,gal.yarden@monsanto.com,L-DOPA and Betalians,Using Betalian and L-DOPA Exec Summary,1782 +1587,,07/11/2016,,Selling his accelerator to us - Ag.Bio.Chem. Accelerator,,
Monsanto,PhD,Gal,Yarden,business strategy,gal.yarden@monsanto.com,Carbon Fixing,Carbon Fixing,1736,,01/10/2017,01/17/2017,Reviewing the Technology,01/17/2017,Sent 2017-03-06
Mouse tracking technologies | Tali Kimchi 1571 | Alon Chen 1593,,,,,,,,,,,,,,
MSD,Mr.,Rob,Rode,"Sr Vice President and General Manager, CV at Merck",rob.rode@merck.com or rob_rode@merck.com,,,,,,,,,
MSD,Ms.,Sharon,Alon,Managing Director at MSD Israel,,,,,,,,,,
MSD,Dr.,Claudio,Gonzalez,Director Medical Affairs Diabetes Global Human Health,claudio.gonzalez@merck.com or claudio_gonzalez.com,Diabetes treatment augmentation,1-pager,1804,,02/11/2018,02/15/2018,"Was interested in discussing a bit further, I forgot about it…",02/15/2018,
MSD,Dr.,Christian ,Meyer,"Global Director of Scientific Affairs, Diabetes at Merck",,,,,,,,,,
MSD,Ms.,Karen,MacNaul,Head of Discovery Transactions ,karen_macnaul@merck.com,Mouse monitoring systems,ES,1571 and 1593,,07/17/2018,,,,
MT Pharma America,Dr.,Eiji,Tanaka,"Executive Officer, US Operations, Global Business Development at Mitsubishi Tanabe Pharma Corporation",,,,,,,,,,
MT Pharma America,Mr.,Andy,Fujimoto,"President at MT Pharma America, Inc.",,,,,,,,,,
MT Pharma America,Dr. ,Violetta,Stone,Pharmaceutical and Consumer New Product Research / Innovation / Scientific Affairs/ Alliance Management,violetta_stone@mt-pharma-us.com,miR-218,ES,1498,Forwarded email to Hiroshi Kawai,08/16/2017,08/24/2017,Neutral - Under review.,08/23/2017,
MT Pharma America,Dr.,Hiroshi,Kawai,"Vice President, Business Development",Hiroshi_Kawai@mt-pharma-us.com,miR-218,ES,1498,,,09/11/2017,Positive and wants a TC,,
MT Pharma America,,,,,Doug_Dobak@mt-pharma-us.com,,,,,,,,,
Mustang Bio,Dr.,Sadik ,Kassim,Chief Scientific Officer,skassim@mustangbio.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,07/09/2018,"2018-07-09 Initial interest, passed along to their BD officer Charles Buchen of Fortress Biotech",,
Mustang Bio,Dr.,Manuel,Litchman,President & CEO ,,,,,,,,,,
Mylan,Ms.,Lynn,Cayton,"Executive Director, Business Development and Alliance Management",lynn.cayton@mylan.com,Diabetes treatment augmentation,1-pager,1804,,02/11/2018,,,02/15/2018,
Mylan,Mr.,Anil,Amin,Head of Global Business Development at Mylan,anil.amin@mylan.com,,,,,,,,,
Nabriva Therapeutics AG,Dr.,Elyse,Seltzer,"Chief Medical Officer, Nabriva Therapeutics",Elyse.Seltzer@nabriva.com,,,,,,,,,
Nabriva Therapeutics AG,Dr.,Susanne,paukner,, susanne.paukner@nabriva.com,,,,,,,,,
Nabriva Therapeutics AG,Dr.,Leanne,Gasink,"Senior Medical Director, at Nabriva Therapeutics",leanne.gasink@nabriva.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,No repsonse,,prepared,
Nano Oncology (PeptiMed) ,Dr. ,Bey-Dih,Chang,VP of Research & Development at PeptiMed,,,,,,,,,,
Nano Oncology (PeptiMed) ,Mr.,Scott,Schneider, Chief Executive Officer,Scott@peptimed.com,,,,,,,,,
Nanoco Technologies,Dr.,Nigel,Pickett,Founder/Chief Technology Officer at Nanoco Technologies,npickett@nanocotechnologies.com,,Filter for Nanoparticles,1564,,08/02/2017,,,08/08/2017,
nanocomp technologies,Mr.,Jack,Rust,"Business Development Manager, Aerospace & Defense, Nanocomp Technologies Inc.",jrust@nanocomptech.com,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,03/21/2018,,,,
nanocomp technologies,Mr.,John,Kaminsky,Chief Commercial Officer at Nanocomp Technologies,jkaminsky@nanocomptech.com,,,,,,,,,
nanoComposix,Dr.,Tom,Darlington,Chief Scientist at nanoComposix,tom.darlington@nanocomposix.com,,Filter for Nanoparticles,1564,,08/02/2017,,,08/08/2017,
Nanocyl,Dr.,Valérie ,Lison,Polymer Dispersion Technology Manager chez Nanocyl SA,valerie.lison@nanocyl.com,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,03/21/2018,03/21/2018,Out of office,,
Nanocyl,Dr.,Alicia ,Rul,Technical Service and Development Group Manager,,,,,,,,,,
Nanocyl,Dr.,Laurent ,Kosbach,Managing Director/CEO at Nanocyl SA,,,,,,,,,,
Nanophase,Mr.,H. Glenn,Judd,"Vice President of Operations, Director of Engineering at Nanophase Technologies",gjudd@nanophase.com,,Filter for Nanoparticles,1564,,08/02/2017,,,08/08/2017,
Nanophase,Mr.,Jess,Jankowski,President & CEO of Nanophase Technologies,jjankowski@nanophase.com,,,,,,,,,
NanoPhotonica,Dr.,Krishna,Acharya,Senior Research and Development Engineer,krishna.acharya@nanophotonica.net,,Filter for Nanoparticles,1564,,08/02/2017,,,08/08/2017,
NanoPhotonica,Dr.,Chris ,Morton,"Co-Founder, Board Chairman, and CEO",chris.morton@nanophotonica.net,,,,,,,,,
Nanoprobes,Prof.,James,Hainfeld,"President and Chief Research Scientist at Nanoprobes, Inc.",hainfeld@nanoprobes.com,,Filter for Nanoparticles,1564,,08/02/2017,,,,
Nanoshel,,,,,,,,,,,,,,
Nanosolar,Mr.,Scott,Podawiltz,Director of Operation at Nanosolar,scott@nanosolar.com,,,,,bounced,,,,
Nanosys ,Dr.,Heejae,Kim,"Business Development, Technology Marketing, Strategic Planning",hkim@nanosysinc.com,,Filter for Nanoparticles,1564,,08/02/2017,08/03/2017,Neutral - Reviewing Technology. 2017-08-22 has requested an NDA. 2017-08-24 Positive result of NDA signed + TC being organized by Ronen.,,
Nanosys ,Dr.,Hugh,Daniels,Vice President,hdaniels@nanosysinc.com,,,,,,,,,
Naturex S.A.,,,,, f.biron@naturex.com,,,,,,,,,
Naturex S.A.,Dr.,Antoine,Bily,R&D Director at NATUREX,a.bily@naturex.com,Betalain,Betalain,1782,,08/22/2016,,,08/29/2016,
Nestle,Ms.,Deborah,McRonald,"Assistant Vice President, Head of Licensing and R&D Alliances at Nestlé",,,,,,,,,,
Nestle,Dr. ,Clotilde,Aubertin,Innovation Partnership & Licensing manager at Nestlé,clotilde.aubertin@rdls.nestle.com,Betalain,Betalain,1782,Email address does not exists,07/27/2016,,,,
Nestle,Mr.,David,Krause,"Entrepreneurship and Scouting Manager, Portfolio Manager, Project Manager at Nestle, CFS",david.kraus@rdsd.nestle.com,Betalain+ Algal Oil + Cellulosomes ,Betalain+ Algal Oil + Cellulosomes ,1782 + 1796 +1536,,01/10/2017,01/17/2017,Setup meeting about cellulosomes and betalains,01/17/2017,
Nestle,Ms.,Netta,Granot,CTO head of R&D and Technology,,,,,,,,,,
Nestle,Mr.,David,Kraus,"Entrepreneurship and Scouting Manager, Portfolio Manager, Project Manager at Nestle, CFS",david.kraus@rdsd.nestle.com,,,,,,,,,
Nestle Purina,Mr.,Robert,Miller,"Director, Innovation Partnerships & Licensing, Nestlé Purina PetCare R&D",robert.miller@purina.nestle.com,Astaxanthin producing ecoli,ES,1650,,04/08/2018,,,04/23/2018,
Neurofit,Dr.,Bertrand ,Huyard,In vivo behavioural pharmacology,,,,,,,,,,
Neurofit,Dr.,Wagner ,Stéphanie,Neurobiology Group Leader,,,,,,,,,,
Neurofit,Dr.,Emile ,Stéphanie,"General Manager, Head of Research ",andriambeloson@neurofit.com,Mouse monitoring systems,ES,1571 and 1593,,07/04/2018,,,07/17/2018,
Newell Brands,Mr.,Nate,Young,"Senior Vice President, Design and Innovation, Newell Brands",nate.young@NEWELLCO.COM,Breastfeeding monitoring device,onepager,1431,Forwarded email to John Bachner,08/15/2017,,,08/22/2017,
Newell Brands,Ms.,Wendy,Martin,Executive Assistant to Nate Young,Wendy.Martin@newellco.com,,,,Replying for Nate Young,,08/25/2017,Neutral - Sent for review,,
Newell Brands,Mr.,John,Bachner,"Global Vice President, Research & Development","Bachner, John <John.Bachner@newellco.com>",Breastfeeding monitoring device,onepager,,"Setting up meeting with Igal, Ruti, and Arik at Jugend + Kind in Koln Germany",,08/29/2017,,,
Newell Brands,Mr.,James,Bergman,"Director, R&D at Newell Brands",james.bergman@NEWELLCO.COM,,,,,,,,,
Newell Brands,,,,,DANIEL.BRUNICK@NEWELLCO.COM,,,,,,,,,
Newell Brands,, Takiyah  ,Gross,,TGROSS@NEWELLBRANDS.COM,,,,,,,,,
NextCell Pharma AB,Dr.,Mathias ,Svahn,CEO at NextCell Pharma AB,mathias.svahn@nextcellpharma.com,Beta Cell isolation method,ES,1643,,04/15/2018,,,04/23/2018,
NGM Biopharmaceuticals,,Jian,Luo,, jluo@ngmbio.com,,,,,,,,,
NGM Biopharmaceuticals,Dr.,Sofia,Touami,"Senior Director, Business Development at NGM Biopharmaceuticals, Inc",stouami@ngmbio.com,,,,,,,,,
Norfolk Plant sciences,Prof.,Jonathon,Jones,Professor at the Sainsbury Laboratory -- Research guy,jonathan-jones@sainsbury-laboratory.ac.uk,Betalains,,,,,,,,
Norfolk Plant sciences,,,,,info@norfolkplantsciences.com,Betalains,Using Betalain Exclusive Exec Summary,1782,Only three employees total on LinkedIn and I cannot see anything about them,07/11/2016,,,07/24/2016,
Norske Skog,,,,,Paul.Gibb@norskeskog.com,,,,,,,,,
Norske Skog,Mr.,Paul,Banham,Senior Scientist at Norske Skog,paul.banham@norskeskog.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,09/27/2016,"Forwarded me to Dr. Des Richardson, interested and wants to get more updates in regard to the tech",09/26/2016,
Nova Harvest,,,,,info@novaharvest.com,Algal Oil,Algal Oil,1796,,hold off,,,,
Nova Measuring Instruments,Mr.,Zohar,Gil,Corporate Vice President of Marketing and Business Development at Nova Measuring Instruments,zohar-g@novameasuring.com,,,,,,,,,
Nova Measuring Instruments,Mr.,Idan,Doron,Head of Business Development at Nova Measuring Instruments,idan-d@novameasuring.,,,,,,,,,
Novartis AG,Dr.,Markus,Kalousek,"Global Business Development and Licensing, Head Search & Evaluation I&D",Markus.Kalousek@novartis.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,,Negative,05/22/2017,
Novartis AG,Dr.,H. Martin,Seidel,Vice President and Global Head of Strategic Alliances at Novartis Institutes for BioMedical Research,,,,,,,,,,
Novartis AG,Dr.,H. Martin,Seidel,Vice President and Global Head of Strategic Alliances at Novartis Institutes for BioMedical Research,,,,,,,,,,
Novartis AG,Dr.,Bruce,Francis,Clinical Indication Leader; Global Development at Novartis AG,bruce.francis@novartis.com,,,,,bounced,,,,
Novartis AG,Dr.,Kris,Grzegorzewski,Vice President at Novartis Oncology,Kris.Grzegorzewski@novartis.com,Bcl2 inhibitor predictive software,Cover letter,1881,,03/21/2018,,,04/09/2018,
Novartis AG,Dr.,Markus,Kalousek,"Global Business Development and Licensing, Head Search & Evaluation I&D",Markus.Kalousek@novartis.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,2018-07-05 Reminder sent with 1810 technology.,06/21/2018,06/21/2018,Neutral sent to colleague for review,,
Novartis AG,Dr.,Paul,Thibodeau,"Executive Director, Business Development & Licensing,","Thibodeau, Paul <paul.thibodeau@novartis.com>",Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,,,,07/18/2018,
Novartis AG,Dr.,Markus,Kalousek,"Global Business Development and Licensing, Head Search & Evaluation I&D",Markus.Kalousek@novartis.com,Mouse monitoring systems,ES,1571 and 1593,Away till the 23rd of July,07/17/2018,,,,
Novartis AG,Dr.,Avi,Spier,"Director, NIBR BD&L, Search and Evaluation, Novartis",avi.spier@novartis.com,,,,,,,,,
Novo Nordisk,Mr.,Aaron,Schwartz,Director of R&D Innovation Sourcing at Novo Nordisk,aswr@novonordisk.com,,,,,,,,,
Novo Nordisk,Mr.,Aaron,Schwartz,Director of R&D Innovation Sourcing at Novo Nordisk,aswr@novonordisk.com,Diabetes treatment augmentation,1-pager,1804,,02/11/2018,04/17/2018,"Wants more data, sent him redacted results.",02/15/2018,
Novo Nordisk,Mr.,Tomas ,Landh,"Innovation Sourcing VP, Senior Principal Scientist Innovation Sourcing at Novo Nordisk",tolh@novonordisk.com,,,,,,,,,
Now Foods,,,,,cheryl.fabinski@nowfoods.com | lin.wisniewski@nowfoods.com,,,,,,,,,
Now Foods,Mr.,Jim,Chino,Sr. Business Applications Manager at NOW Foods,jim.chino@nowfoods.com,Colitis Treatment,,1831,,06/01/2017,,No Reply,06/08/2017,
Now Foods,Mr.,Andrew,Frampton,R&D Manager at NOW Foods,andrew.frampton@nowfoods.com,,,,,,,,,
Now Foods,Mr.,Srini,Talasila,Sr. Oracle Applications Developer / Business Analyst at Now Foods,,,,,,,,,,
Now Foods,Mr.,Aaron,Secrist,Director of Quality & R&D at NOW Foods,,,,,,,,,,
NUK - Newell Brands,Mr.,Rick,Rubin,Director Research and Development,,,,1431,,,,,,
NUK - Newell Brands,Mr.,Dustin,Nobbe,Senior Director of Operations,,,,,,,,,,
Nvidia,Mr.,Mark,Berger,"Senior Alliance Manager, Life & Material Sciences",mberger@nvidia.com,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,07/19/2017,"Not the right person, forwarded it to Jeff Herbst VP of BD",07/19/2017,
Nvidia,Mr.,Jeff,Herbst,Vice President of Business Development at Nvidia,jherbst@nvidia.com,,,,,,,,,
Nvidia,Ms.,Genevieve,Breed,GPU Architecture Senior Manager at NVIDIA,,,,,,,,,,
Nvidia,Mr.,Greg,Estes,VP Developer Programs at NVIDIA,,,,,,,,,,
NXP,Dr.,Jeroen,Kemp,Head of Strategy (Technology & Operations) at NXP Semiconductors,jeroen.kemp@nxp.com,,Filter for Nanoparticles,1564,,08/02/2017,,,08/08/2017,
NXP,Mr.,Rick,Beale,"Marketing, Strategy & Business Development Executive",,,,,,,,,,
Oakbio,Dr.,William J.,Coleman,"Vice President of Biology at OakBio, Inc.",wcoleman@oakbio.com,Carbon Fixing,Carbon Fixing,1736,,email failed,,,,
Oakbio,Dr.,Heyward,Robinson,VP of Business Development,hrobinson@oakbio.com,Carbon Fixing,Carbon Fixing,1736,,01/10/2017,01/18/2017,Negative - passed on tech to new company,01/17/2017,
Ocean Spray,Mr.,Peter,Wyman,"President, Ocean Spray International & SVP Global Business Development, Ocean Spray Cranberries, Inc",pwyman@oceanspray.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,09/18/2016,Forwarded to Head of Global Innovation and R&D,10/26/2016,
Ocean Spray,Mr.,Aravind,Cherukuri,"Managing Director, Asia Pacific at Ocean Spray Cranberries", acherukuri@oceanspray.com,Cellulosomes,Cellulosomes,1536,,,,,,
OCSiAl,Mr.,Konstantin ,Notman,CEO at OCSiAl Europe and UJET Group,,,,,,,,,,
OCSiAl,Dr.,Alexander ,Bezrodny,Product Developer R&D,bezrodny.ae@ocsial.com,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,03/21/2018,,,,
Oji Fibre Solutions,,,,, Michael.Pryor@ojifs.com,,,,,,,,,
Oji Fibre Solutions,Dr.,Paul,Watson,Technical Manager at Oji Fibre Solutions,paul.watson@ojifs.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,,,09/26/2016,
Omron,Mr.,Jeffrey,Ray,"Executive Director of Business and Technology at Omron Healthcare, Inc.",jeffrey.ray@omron.com,,,,,bounced,,,,
Omron,Mr.,Ranndy,Kellogg,"President and Chief Executive Officer at Omron Healthcare, Inc.",ranndy.kellogg@omron.com,,,,,,,,,
Omron,Mr.,Andrew,Atwell,Exec. Director New Business Development,andrew.atwell@omron.com,,,,,bounced,,,,
Omron,Dr.,toshikazu,shiga,,toshikazu_shiga@ohq.omron.co.jp,Breastfeeding monitoring device,onepager,1431,,08/15/2017,,,08/22/2017,
Opko,,,,,,,,,,,,,,
Orbotech,Mr.,Hananel,Kvatinsky,Director of Intellectual Property at Orbotech and Patent Attorney/ Intellectual Property Consultant,"hkvatinsky@yahoo.com  , hananel.kvatinsky@orbotech.com",,,,,,,,,
Orbotech,,,,Template,rami.rozen@orbotech.com,,,,,,,,,
Orbotech,Dr.,Zvi,Kotler,"Manager, Additive Manufacturing Group (AMG) at Orbotech, Yavne, IL",zvi.kotler@orbotech.com,,,,,,,,,
Orbotech,Mr.,Tal,Opher,VP Business Support at Orbotech,tal.opher@orbotech.com,,,,,,,,,
Orexigen,,Amy ,Halseth,,ahalseth@orexigen.com,,,,,,,,,
Orexigen,Mr.,Franjo,Hanzl,Director-Global Alliance Management at Orexigen Therapeutics,fhanzl@orexigen.com,,,,,,,,,
Oriflame,Dr.,Alain,Mavon,Senior Director of Science & Innovation chez ORIFLAME COSMETICS,Alain.Mavon@oriflame.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,01/10/2017,01/17/2017,Negative,01/17/2017,
Oriflame,Dr.,Johanna,Gillbro,Senior Scientific Innovation Manager at Oriflame,,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,,,,,
Osiris Therapeutics,Dr.,Sandeep ,Dhall,Senior Scientist at Osiris Therapeutics Inc.,SDhall@osiris.com,Beta Cell isolation method,ES,1643,,04/15/2018,,,04/23/2018,
Osiris Therapeutics,Dr.,Dorothy Kurtz ,Phelan,Associate Director of Medical Affairs at Osiris Therapeutics,Dphelan@osiris.com,,,,,,,,,
OSMO Membrane Systems GmbH,Mr.,Martin,Terberl,Inbetriebnahmeingenieur bei OSMO Membrane Systems ,m.terberl@osmo-membrane.de,,Filter for water,1564,,08/22/2017,,,08/29/2017,
Partek,Dr.,Cherry,Ignacio,Product Manager at Partek Inc.,cignacio@partek.com,Pathifier Algorithm,Onepager,1629,,01/28/2018,,,,
PepsiCo,Mr. ,Jaideep,Bhatia,"Supply Chain Agro Director - India, at PepsiCo India Holdings Pvt. Ltd",,,,1587,,,,,,
PepsiCo,Dr.,Rahul ,Chaturvedi,"V.P. Agro R&D at PepsiCo India, Gurgaon",rahul.chaturvedi@intl.pepsico.com,,,1587,,,,,,
PepsiCo,Dr.,Gabe,Gusmini,"PepsiCo R&D Director, Jr. Executive - Agro Discovery & Sustainability Research",gabe.gusmini@pepsico.com,,Alkaloids,1587,,06/22/2016,,,,
Pepsico,Mr.,Rajiv,Wakhle,Sr Director Operations ( Foods) at PepsiCo,,,,1587,,,,,,
PepsiCo,Mr.,Thomas,Hamill,Potato Buyer,Thomas.Hamill@pepsico.com,,,1587,,,,,,
PepsiCo,Mr.,Rick,Dunham,Sr. Director of R&D at Frito-Lay,,,,1587,,,,,,
PepsiCo,Dr. ,Margaret,Dohnalek,Global Head of Technology Scouting at PepsiCo,Margaret.Dohnalek@pepsico.com ,,Alkaloids,1587,,06/22/2016,07/12/2016,Negative – Very interested but “other initiatives” stop them from licensing from Weizmann. They have stored this in a database for future reference. ,,
PepsiCo,Dr. ,Margaret,Dohnalek,Global Head of Technology Scouting at PepsiCo,Margaret.Dohnalek@pepsico.com ,Carbon Fixing,Carbon Fixing,1736,,01/10/2017,01/17/2017,Negative,01/17/2017,
PepsiCo (Tropicana),Dr. ,Margaret,Dohnalek,Global Head of Technology Scouting at PepsiCo,Margaret.Dohnalek@pepsico.com ,Cellulosomes and Betalains,Cellulosomes and Betalains,1536 + 1783,"Make this email more relaxed, you've contacted before",09/18/2016,09/26/2016,Sent the Betalains for review and wanted to learn more about the cellulosomes 2016-09-29 Not so interested - Basically does Asaph need to email her?,09/26/2016,
PFEnex,Mr.,Keith,Haney, Product Development Leader at Pfenex Inc. ,khaney@pfenex.com,,,,,,,,,
PFEnex,Dr. ,Hubert C,Chen,Chief Scientific and Medical Officer, hchen@pfenex.com ,,,,,,,,,
PFEnex,Dr.,Modestus ,Obochi,Strategy & Business Development Advisor,mobochi@pfenex.com,Catalytic BioScanvangers,ES,1750,,06/20/2018,07/02/2018,Neutral - Sent for review,07/02/2018,
PFEnex,Mr.,Eef,Schimmelpennink,CEO and President,eschimmelpennink@pfenex.com,,,,,,,,,
Pfizer,,Subbu,,,Chakrapani.Subramanyam@pfizer.com,,,,,,,,,
Pfizer Inc.,Dr.,Bruce,Lefker,"Research Fellow at Pfizer Global Research and Development
",bruce.a.lefker@pfizer.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,,05/22/2017,Directed me to Ron Newbold,,
Pfizer Inc.,Ms.,Kelly,Longo,"Senior Director, Worldwide Business Development at Pfizer, Inc.",kelly.longo@pfizer.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,,Doesn't work,,
Pfizer Inc.,Dr. ,Morten,Sogaard,"Vice President and Head, Genome Sciences & Technologies, Worldwide R&D at Pfizer",Morten.Sogaard@pfizer.com,,,,,,,,06/05/2017,
Pfizer Inc.,Dr.,Ron,Newbold,Vice President - External R&D Innovation – Americas and Europe  ,"Newbold, Ron' <ron.newbold@pfizer.com>",TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
Pharmaseed ,Dr.,Ilan ,Winkler,,ilan@pharmaseedltd.com,Mouse monitoring systems,ES,1571 and 1593,,07/04/2018,07/17/2018,Shown initial interest - asked for more data and a TC,,
PhaseRx ,Dr.,Paul,Johnson,former cso,paul@phaserx.com,,,,,,,,,
PhaseRx ,Dr.,Mary,Prieve,Director of Biology at PhaseRx Inc.,mary@phaserx.com,,,,,,,,,
PhaseRx  (Ayelet Erez),Ms.,Teri,Blevins,Research Associate,teri@phaserx.com,,,,,,,,,
Philips ,Ms.,Kristin,Molina,"Senior Director, Strategy & Business Development at Philips Healthcare",kristin.Molina@philips.com,Breastfeeding monitoring device,onepager,1431,,08/15/2017,,,08/22/2017,
Philips ,Ms.,Martine,van Beers,R&D manager at Philips Avent,martine.van.beers@philips.com,,,,,,,,,
Philips ,Mr.,Bryan,Windus-Smith,New Technology Lead at Philips AVENT,bryan.windus-smith@philips.com,,,,,,,,,
Philips ,Mr.,Gil,Adato,"Philips - Vice President, Head of New Business Development & Connected Value Propositions",,,,,,,,,,
Phytolutions,Dr.,Claudia,Thomsen,Managing Director,c.thomsen@phytolutions.com,Algal Oil,Algal Oil,1796,,01/10/2017,,,01/17/2017,
Plexus worldwide,Mr.,Alec,Clark,Chief Marketing Officer ,ALEC.CLARK@PLEXUSWORLDWIDE.COM,,,,,,,,,
Plexus worldwide,Mr.,Charlie,High,R&D Scientist at Plexus Worldwide,,,,,,,,,,
Plexus worldwide,Dr.,Tianan (Alan) ,jiang,"Vice President, R&D at Plexus Worldwide",Alan.jiang@PLEXUSWORLDWIDE.COM,,,,,,,,,
Plexus worldwide,Mr.,Marco,Rebaza,"Senior Scientist, Product Innovation at PLEXUS WORLDWIDE",,,,,,,,,,
Poseida Therapeutics,Dr.,Eric,Ostertag,CEO,eostertag@poseida.com,,,,,,,,,
Poseida Therapeutics,Dr.,Joshua,Rychak,Director ,jrychak@poseida.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,,,
Precision Biosciences,Mr.,Michael,Dombeck,Vice President of Business Development,michael.dombeck@precisionbiosciences.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,,07/18/2018,
Precision Biosciences,Ms.,Julia,Chapman,"Director, Alliance Management ",julia.chapman@precisionbiosciences.com,,,,,,,,,
Procter & Gamble,Dr.,David Andrew,Jakubovic,"Director Open Innovation Europe, Middle East, Africa at Procter & Gamble",jakubovic.da@pg.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,01/10/2017,01/17/2017,Sending me to their online submission system,01/17/2017,
Procter & Gamble,Dr.,Jennifer,Moe,Open Innovation Manager at Procter & Gamble,moe.jl@pg.com ,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,,,,,
Prosensa (acquired by biomarin),,,,,,,,,,,,,,
Protagen Diagnostics,,,,,,,,,,,,,,
Protalix,,,,Business development email ,BD@Protalix.com,L-DOPA and Betalians,Using Betalian and L-DOPA Exec Summary,1782,I cannot find their emails,07/11/2016,,,07/24/2016,
Protalix,Mr.,Bill,Taylor,Vice President at Protalix Biotherapeutics,williamt@protalix.com,L-DOPA and Betalians,Using Betalian and L-DOPA Exec Summary,1782,,08/22/2016,,,08/29/2016,
Protalix,Mr.,Ronen,Rosenberg,VP Commercial and Product Planning at Protalix Biotherapeutics,ronenr@protalix.com,L-DOPA and Betalians,Using Betalian and L-DOPA Exec Summary,1782,,08/11/2016,,,08/16/2016,
Prothena,Dr.,Clara,Tourino,Scientist ,clara.tourino@prothena.com,,,,,07/17/2018,,,,
Prothena,Ms.,Amy,Colin,Clinical Trial Specialist,amy.colin@prothena.com,Mouse monitoring systems,ES,1571 and 1593,,bounced,,,,
Prothena,Mr.,Matt,Panuwat,"Vice President, Business Development",matt.panuwat@prothena.com or matthew.panuwat@prothena.com,,,,,,,,,
Prothena,Dr.,Tara,Nickerson,Chief Business Officer,tara.nickerson@prothena.com,,,,,,,,,
Prothena,,Frederic ,Godderis,VP R&D Leadership / R&D Operations / Portfolio & Program Management ,Frederic.Godderis@prothena.com,,,,,,,,,
Qantas,Mr.,David ,Parfett,Head of Group Innovation & Ventures at Qantas,davidparfett@qantas.com.au or dparfett@qantas.com.au,,,,,,,,,
Qantas,Mr.,Huw,Boyd,"Manager, Group Strategy at Qantas",,,,,,,,,,
Qantas,Mr.,Susnata,Banerjee,"Head of Commercial Strategy & Development, Qantas International",,,,,,,,,,
QD Vision,Dr.,Peter,Kazlas,"Director, Advanced Product Development & Process",pkazlas@qdvision.com,,Filter for Nanoparticles,1564,,08/02/2017,,,08/08/2017,
QD Vision,,Jason,Carlson,President, jcarlson@qdvision.com ,,,,,,,,,
Qiagen - Ingenuity,Dr.,Rainer,Metzger,GLOBAL BUSINESS EXECUTIVE AND OPERATIONS LEADER,,,,,,,,,,
Qiagen - Ingenuity,Dr.,Michael,Hadjisavas,"QIAGEN, VP Prod Mgt, Genomic Tech; AMP, Strategic Opportunities Committee Member; GreyBird Ventures, Exec Adviser.",Michael.Hadjisavas@qiagen.com,Pathifier Algorithm,Onepager,1629,,,,,,
Qiagen - Ingenuity,Dr.,Arne,Materna,"Director, Genome Analysis at QIAGEN",arne.materna@qiagen.com,Pathifier Algorithm,Onepager,1629,,01/28/2018,,,,
QPS NEUROPHARMACOLOGY,Dr.,Birgit,Hutter-Paier,Director of Neuropharmacology,Birgit.Hutter-Paier@qps.com,Mouse monitoring systems,ES,1571 and 1593,,07/04/2018,,,07/17/2018,
QPS NEUROPHARMACOLOGY,Dr.,Vera,Niederkofler,Head of In Vivo Research,,,,,,,,,,
Qualcomm,Mr.,Kiran,Koshy,Director of Business Development at Qualcomm,k.koshy@qualcomm.com,,,,,,,,,
Qualcomm,Mr.,Kabir,Kasargod,"Senior Director, Business Development at Qualcomm",,,,,,,,,,
Qualitas Health,Dr.,Isaac,Berzin,Founder and CTO at Qualitas Health,,,,,,,,,,
Quantum Materials,Mr.,David,Doderer,VP of Research & Development at Quantum Materials Corp,DCD@THETITAN.COM,,Filter for Nanoparticles,1564,,08/02/2017,,,08/08/2017,
Quark Pharmaceuticals ,Ms.,Julie,Friedman,"Vice President, Program & Alliance Management",JFriedman@quarkpharma.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,,
Quark Pharmaceuticals ,Ms.,Anna,Muchnik,"VP, Pre-Clinical, Product Development at Quark Pharmaceuticals Inc",amuchnik@quarkpharma.com,,,,,,,,,
Quark Pharmaceuticals ,Dr.,Elena,Feinstein,CSO at Quark Pharmaceuticals Inc,EFeinstein@quarkpharma.com,,,,,,,,,
Quark Pharmaceuticals ,Ms.,Julie,Friedman,"Vice President, Program & Alliance Management",JFriedman@quarkpharma.com,,,,,,,,,
Quark Pharmaceuticals ,Ms.,Anna,Muchnik,"VP, Pre-Clinical, Product Development at Quark Pharmaceuticals Inc",amuchnik@quarkpharma.com,,,,,,,,,
Quark Pharmaceuticals ,Dr.,Elena,Feinstein,CSO at Quark Pharmaceuticals Inc,EFeinstein@quarkpharma.com,,,,,,,,,
Raizen,,,,,roland.iori@raizen.com,,,,,,,,,
Raízen,Mr.,Raphael,Nascimento,Business Development Manager at Raízen,raphael.nascimento@raizen.com,Cellulosomes,Cellulosomes,1536,Biofuels,09/18/2016,,,09/26/2016,
RaNA Therapeutics ,,Daniela,Vincent,Exec Asst at RaNA Therapeutics,dvincent@ranarx.com,,,,,,,,,
RaNA Therapeutics ,Mr.,Ron,Swearingen,Senior Director-Program Management at RaNA Therapeutics,rswearingen@ranarx.com,,,,,,,,,
RaNA Therapeutics ,Dr.,Nelson,Chau,"Vice President, Drug Discovery at RaNA Therapeutics",NChau@ranarx.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
RaNA Therapeutics ,Dr.,Caroline,Woo,Senior Scientist at RaNA Therapeutics,cwoo@ranarx.com,,,,,,,,,
RaNA Therapeutics ,,Daniela,Vincent,Exec Asst at RaNA Therapeutics,dvincent@ranarx.com,,,,,,,,,
RaNA Therapeutics ,Mr.,Ron,Swearingen,Senior Director-Program Management at RaNA Therapeutics,rswearingen@ranarx.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
RaNA Therapeutics ,Dr.,Nelson,Chau,"Vice President, Drug Discovery at RaNA Therapeutics",NChau@ranarx.com,,,,,,,,,
RaNA Therapeutics ,Dr.,Caroline,Woo,Senior Scientist at RaNA Therapeutics,cwoo@ranarx.com,,,,,,,,,
Raymo (NanoIntegris is a subsidiary),Dr.,Jens,Kroeger,Director of Technology at NanoIntegris, jkroeger@raymor.com,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,03/21/2018,,,,
RealTek,Ms.,Fei,Peng,Business Development Manager at Rockchip,feipeng@realtek.com,Multi-state polymers for memory and logic gates,Web page,1568,,bounced,,,,
RealTek,,Bard,Liao,Template,bardliao@realtek.com,,,,,,,,,
Redex,,,,,,,,,,,,,,
ReGenX Biosciences ,,,,,,,,,,,,,,
Regulus Therapeutics,Mr.,David,Szekeres,"Senior Vice President, Business Development & General Counsel at Heron Therapeutics, Inc.",dszekeres@regulusrx.com,,,,,,,,,
Regulus Therapeutics,Mr.,Victor,Knopov,Vice President Pharmaceutical Development at Regulus Therapeutics,vknopov@regulusrx.com,,,,,,,,,
Regulus Therapeutics,Dr.,Edmund,Lee,Associate Director at Regulus Therapeutics,elee@regulusrx.com,,,,,,,,,
Regulus Therapeutics,Dr.,Timothy,Wright,Chief R&D Officer at Regulus Therapeutics,twright@regulusrx.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,April Simora replied,06/07/2017,06/13/2017,Forwarding it to the Business development people. ,06/13/2017,
Regulus Therapeutics,Ms.,April ,Simora,"Associate Director, Business Development at Regulus Therapeutics",April Simora ?[asimora@regulusrx.com]? ,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,,06/13/2017,"Negative - not interested. In terms of islet, needs further development and then they want to hear more.",,
Regulus Therapeutics,Mr.,David,Szekeres,"Senior Vice President, Business Development & General Counsel at Heron Therapeutics, Inc.",dszekeres@regulusrx.com,,,,,,,,,
Regulus Therapeutics,Mr.,Victor,Knopov,Vice President Pharmaceutical Development at Regulus Therapeutics,vknopov@regulusrx.com,,,,,,,,,
Regulus Therapeutics,Dr.,Edmund,Lee,Associate Director at Regulus Therapeutics,elee@regulusrx.com,,,,,,,,,
Regulus Therapeutics,Dr.,Timothy,Wright,Chief R&D Officer at Regulus Therapeutics,twright@regulusrx.com,,,,,,,,,
Regulus Therapeutics,Ms.,April ,Simora,"Associate Director, Business Development at Regulus Therapeutics",April Simora ?[asimora@regulusrx.com]? ,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Renesas,Mr.,Steve,Gaines,Director of Engineering at Renesas Electronics,Steve.Gaines@renesas.com,,,,,,,,,
Renesas,Mr.,Peter,Carbone,Vice President Synergy Platform Business Divison at Renesas Electronics Corporation,Peter.Carbone@renesas.com,,Filter for Nanoparticles,1564,,08/02/2017,,,08/08/2017,
Renewable Energy Group,Mr.,Brad,Albin,VP Manufacturing at Renewable Energy Group,brad.albin@regi.com ,Cellulosomes,Cellulosomes,1536,,09/18/2016,,,09/26/2016,
Rennovia (joint venture with Stora Enso),Dr.,Gary,Diamond,"Vice President, Product Development",gdiamond@rennovia.com,Cellulosomes ,Cellulosomes,1536,,01/10/2017,,,01/17/2017,
Rennovia (joint venture with Stora Enso),Dr.,Eric,Dias,"Director, R&D at Rennovia, Inc.",edias@rennovia.com,Cellulosomes ,Cellulosomes,1536,,,,,,
Rennovia (joint venture with Stora Enso),Dr.,Beatrix ,Ellis,Director Business Development at Rennovia Inc.,,Cellulosomes ,Cellulosomes,1536,,,,,,
Renova Therapeutics ,,SENKA,HADZIMURATOVIC, EXECUTIVE DIRECTOR OF COMMUNICATIONS & OPERATIONS,SENKA@RENOVATHERAPEUTICS.COM,,,,,,,,,
Renova Therapeutics ,Dr.,Peter,Gengo,"Renova Therapeutics, Vice President",peter@renovatherapeutics.com,,,,,,,,,
Renova Therapeutics ,Dr.,Jack,Reich,CEO,jack@RENOVATHERAPEUTICS.COM,,,,,,,,,
Renova Therapeutics ,Mr.,Roy,Cosan,President,Roy@RENOVATHERAPEUTICS.COM,,,,,,,,,
Renova Therapeutics ,,SENKA,HADZIMURATOVIC, EXECUTIVE DIRECTOR OF COMMUNICATIONS & OPERATIONS,SENKA@RENOVATHERAPEUTICS.COM,,,,,,,,,
Resolute Forest Products,,,,,guy.beaulieu@resolutefp.com,,,,,,,,,
Resolute Forest Products,Mr.,Martin,Savoie,VP Strategy and Corporate Development chez Resolute Forest Products,martin.savoie@resolutefp.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,,,09/26/2016,
Resolute Forest Products,Ms.,Stepahnie,Shumsky,Corporate Sustainability Specialist at Resolute Forest Products,Stephanie.shumsky@resolutefp.com,Cellulosomes,Cellulosomes,1536,,,,,,
Roche,,,,,,,,,,,,,,
Roche,,,,,,,,,,,,,,
Roche,Dr.,Max,Nestor,"PharmD | Global Business Development | Immunology, Inflammation, Infectious Disease and Specialty Care",,,,,,,,,,
Roche,Mr.,Brian,Held,"Sr. VP, Global Head of Research & Development Diabetes Care at Roche Diagnostics",,,,,,,,,,
Roche,Mr.,Todd,Tomba,Vice President R&D - Roche Diabetes Care,todd.tomba@roche.com,Diabetes treatment augmentation,1-pager,1804,,02/11/2018,,Bounced,,
Roche,Dr.,Alonso,Montoya ,"Director, Medical Strategy (Neuroscience) ",alonso.montoya@roche.com,Mouse monitoring systems,ES,1571 and 1593,,07/17/2018,,,,
Roche Innovation Center Copenhagen (formerly Santaris Pharma - Roche Acquired),Dr.,morten,lindow,"Innovation, data science and RNA drug discovery",morten.lindow@santaris.com should be morten.lindow@roche.com,,,,,,,,,
Roche Innovation Center Copenhagen (formerly Santaris Pharma - Roche Acquired),Dr.,Fiona,Mack,Director External Innovation at Roche Innovation Center,Fiona.Mack@roche.com,,,,,,,,,
Roche Innovation Center Copenhagen (formerly Santaris Pharma - Roche Acquired),Dr.,Susanna,Obad,Global Business Development Manager at Roche,Susanna.Obad@roche.com,,,,,,,,,
Roche Innovation Center Copenhagen (formerly Santaris Pharma - Roche Acquired),Dr.,Henry,Ørum,"Head of RTR, Roche pRED & Gen. Man. of RICC",hoe@santaris.com | Henrik.orum@roche.com,,,,,,,,,
RODI Systems Corp.,Ms.,Patty,Vance,Business Mgr/VP at RODI Systems Corp.,PATTYV@RODISYSTEMS.COM,,Filter for water,1564,,08/22/2017,08/22/2017,Neutral - Sending it for review,,
Roha Dyechem Pvt,,,,,ramakant.tibrewala@rohagroup.com,,,,,,,,,
Roha Dyechem Pvt,Dr.,Prabhu Dutt,Mishra,Head R & D ROHA DYECHEM PVT LTD,"prabhu.dutt.mishr
a@rohagroup.com or prabhu.mishra@rohagroup.com",Betalain,Betalain,1782,,08/22/2016,,,08/29/2016,
Ron Milo Technology Related to Astaxanthin,,,,,,,,,,,,,,
Roquette Klötze GmbH & Co. KG,Dr.,Jorg,Ullmann,Managing Director; Scientific Project Manager at Roquette Klötze GmbH & Co. KG (Algae Farm Klötze),info@algomed.de,Algal Oil,Algal Oil,1796,,hold off,,,,
Rubinstein + Walker 1643 Cell Surface receptor technology,,,,,,,,,,,,,,
RXi Pharmaceuticals,Dr.,Karen,Bulock,"Vice President, Research at RXi Pharmaceuticals Corp",kbulock@rxipharma.com,,,,,,,,,
RXi Pharmaceuticals,Dr.,James,Cardia,Director of Business Development and Intellectual Property at RXi Pharmaceuticals Corporation,jcardia@rxipharma.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
RXi Pharmaceuticals,Dr.,Karen,Bulock,"Vice President, Research at RXi Pharmaceuticals Corp",kbulock@rxipharma.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
RXi Pharmaceuticals,Dr.,James,Cardia,Director of Business Development and Intellectual Property at RXi Pharmaceuticals Corporation,jcardia@rxipharma.com,,,,,,,,,
Samsung,Mr.,Aviv,Marom,"Open Innovation, Technology Collaboration Group, Senior Manager at Samsung Electronics","

 
 

aviv.marom@samsung.com",,Filter for Nanoparticles,1564,,08/02/2017,08/08/2017,Interested in the use of water filtration. So I sent him the water filter ES.,08/08/2017,
Samsung,Ms.,Rutie,Adar,"Director Business Development, Investments and Incubation at Samsung Electronics",,,,,,,,,,
Samsung,Mr.,Aviv,Marom,"Open Innovation, Technology Collaboration Group, Senior Manager at Samsung Electronics","

 
 

aviv.marom@samsung.com",Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,03/21/2018,,,,
Sanofi,,,,,,,,,,,,,,
Sanofi,Ms.,Myriam,Cohen,Clinical Sciences Operations - Alliance & Partners Leader chez Sanofi,myriam.cohen@sanofi.com,miR-218,ES,1498,,08/16/2017,08/23/2017,Neutral - Sent to the external innovation team for review. 2017-09-07 Sent a review reminder. 2017-09-12 Replied with the external innovation team emails.,08/23/2017,
Sanofi,Dr.,Brian,Bronk,"Head of External Innovation, Rare Diseases",Brian.Bronk@sanofi.com,miR-218,ES,1498,Directed to this guy by Myriam's List,09/07/2017,09/11/2017,Negative - needs more evidence by the PI for it to be considered worth something.,,
Sanofi,Dr.,Varavani,Dwarki,"Vice President, Alliance Management Business Partner",,,,,,,,,,
Sanofi,,,,,wenfei.zhang@sanofi.com,,,,,,,,,
Sanofi,Dr.,Ulrich,Wendt,Head Diabetes Business Development & Licensing at Sanofi,ulrich.wendt@sanofi.com,Diabetes treatment augmentation,1-pager,1804,"His Reply: unfortunately would not be an interesting opportunity for us. The main reasons are that the doses used in the animal experiments are very high (900mg/kg) and that the time when you do the IGTT is only after 50 days. In addition you reported only an effect to blood glucose.

In our assessment it would be necessary to have a much more potent drug acting at a lower dose and with a faster on-set of action. In addition an effect in an IGTT is good but it would be more important to demonstrate good HbA1c lowering in a Diabetes animal model. Also it would be important for us to see additional benefits like a good weight reduction potential, or beneficial effects on cardiovascular parameters to be interesting for us.
",02/11/2018,04/11/2018,Negative ,02/15/2018,
Sanofi,Dr.,Peter,Hamley,"Global Head, External Innovation, Drug Discovery Platforms ",peter.hamley@sanofi.com,Mouse monitoring systems,ES,1571 and 1593,,07/17/2018,,,,
Sanofi,Dr.,Isaac ,Veinbergs,"Head of Business Development and Licensing, Neurosciences at Sanofi Genzyme",Isaac.veinbergs@sanofi.com,,,,,,,,,
Sanofi Ventures,,Bernard ,Davitian,SVP and Managing Director,Bernard.Davitian@sanofi.com,,,,,,,,,
Sapphire energy,Dr. ,Craig,Behnke,"Vice President, Research and Development and Technical Fellow, Chemistry at Sapphire Energy Inc.",craig.behnke@sapphireenergy.com,Carbon Fixing + Algal Oil,Carbon Fixing + Algal Oil,1736 + 1796,,01/10/2017,,,01/17/2017,
Sapphire energy,Dr.,Jim,Astwood,SVP Product Management at Sapphire Energy Inc.,jim.astwood@sapphireenergy.com,Carbon Fixing + Algal Oil,Carbon Fixing + Algal Oil,1736 + 1796,,01/23/2017,,,Prepared,
Sappi,Ms,Beth,Cormier,VP - Research & Development at Sappi Fine Paper,Beth.Cormier@sappi.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,10/28/2016,"She is out till the 27th of Sept, so only email later. 2016-10-28 has now sent off the materials for review. REMEMBER TO CONTACT IN ANOTHER ~3 weeks",10/26/2016,"Replied 2016-10-30 but not has replied since, need to ask what is happening. 2016-11-29 Sent another reminder email to ask about review"
Sappi,Mr,Bob,Forsberg,VP Sales & Business Development at Sappi Fine Paper,,Cellulosomes,Cellulosomes,1536,,,,,,
Sappi,Dr,Laura,Thompson,Director of Sustainability at Sappi Fine Paper North America,Laura.Thompson@sappi.com,Cellulosomes,Cellulosomes,1536,,,,,,
Saputo Inc,Ms.,Pamela,Nalewajek,"Vice President, Strategic Business Development - Deli, Fine Cheese & Imports at Saputo Inc.",pamela.nalewajek@saputo.com,Betalain,Betalain,1782,,07/27/2016,07/27/2016,"Negative – Not the right person, directed me to technical services",,
Saputo Inc,Ms.,Meagan,Jones,"Cheese Product Development Manager, R&D and Technical Services at Saputo",meagan.jones@saputo.com,Betalain,Betalain,1782,Out of office till 2016-07-29,07/27/2016,,,08/03/2016,
Saputo Inc,Mr.,Brett,Tanttu,VP Research and Development at Saputo,brett.tanttu@saputo.com,Betalain,Betalain,1782,,08/11/2016,,,08/16/2016,
Saputo Inc,Ms.,Laura Isabella,Dudet,R&D Manager Dairy Ingredients at Saputo Inc,,Betalain,Betalain,,,,,,,
Saputo Inc,Ms.,Pam,Lockwood,Senior Research Scientist at Saputo Dairy Foods,,Betalain,Betalain,,,,,,,
Saputo Inc,,Frank ,Jaskulka,Principal Scientist- Research & Development at Saputo Dairy Foods USA,,Betalain,Betalain,,,,,,,
Saputo Inc,Ms.,Elizabeth,Teigland,R&D Scientist at Saputo Dairy Foods,,Betalain,Betalain,,,,,,,
Science in Action ,,Raanan,Margalit,,raanan.margalit@gmail.com,Mouse monitoring systems,ES,1571 and 1593,,07/04/2018,,,07/17/2018,
SeaGate,Mr.,Vinay,Hiremath,"Product/Portfolio/Program Development, Management and Marketing",,,,,,,,,,
SeaGate,Mr.,Sanjeev,Tanotra,Sr Program Manager,,,,,,,,,,
SeaGate,Mr.,Jan-Ulrich,Thiele,"Technologist, Senior Director Media R&D at Seagate Technology",jan-ulrich.thiele@seagate.com,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,07/19/2017,"Not the right person, Tech Scouter is Kevin Gomez",07/19/2017,
SeaGate,Mr.,Kevin,Gomez,Tech Scouter,kevin.gomez@seagate.com,Multi-state polymers for memory and logic gates,Web page,1568,,,07/20/2017,"Asked for more materials, I sent him the relevant publications.",,
Semma Therapeutics,Mr.,Jeff,Imbaro,"Vice President, Operations and Alliances at Semma Therapeutics ",j.imbaro@semma-tx.com,Beta Cell isolation method,ES,1643,,04/15/2018,04/16/2018,Neutral - Wants more information. I have passed his question along to Michael Walker for a response.,,
Sensient Technologies Corporation,Dr. ,Judy,Schnurr,"R&D Director, Global BioNutrients at Sensient Technologies Corporation",Judith.Schnurr@sensient.com Or Judy.Schnurr@sensient.com,Betalain,Betalain,1782,,08/22/2016,,,08/29/2016,
Sernova,Dr.,Philip,Toleikis,President & CEO at Sernova Corp.,philip.toleikis@sernova.com,Beta Cell isolation method,ES,1643,,04/15/2018,,,04/23/2018,
Servier,Dr.,Thierry,Wurch ,"Director, External Research & Innovation in Oncology",thierry.wurch@servier.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,07/10/2018,2018-07-09 Strong initial interest and under review. Sent a reply thanking him and waiting to setup the TC.,,
Servier,Dr., Ibtissam ,Marchiq,Project leader- CAR T cell therapy,ibtissam.marchiq@servier.com,,,,,,,,,
SGI-DNA (Synthetic Genomics) ,,Rozi,Morris,," 
r.morris@silence-therapeutics.com",,,,,,,,,
Shandong Xinhua Pharmaceutical,Dr. ,Dittmar,Nerger,International Chief Scientific Officer,dittmar@dittmarnerger.com,L-DOPA,Using L-DOPA Exclusive Exec Summary,1782,,07/11/2016,,Very interested,07/24/2016,2016-08-29
Shionogi,,,,,hiroshi.kamimori@shionogi.co.jp,,,,,,,,,
Shionogi,Dr.,James,Hackworth,"Senior Vice President, Corporate Development and Commercialization Strategy, Shionogi",james.hackworth@shionogi.com,,,,,,,,,
Shionogi,Mr.,Ian,Lauf,"Head, Clinical Business Operations",,,,,,,,,,
Shire,Ms.,Caitlin,Applebaum,Senior Product Manager,caitlin.applebaum or capplebaum@shire.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,,07/18/2018,
Shire,Dr.,Robert,Hollowell,Head of Corporate Strategy and Commercial Assessment,,,,,,,,,,
Shire,Mr.,Mark,Coflin,Head of Alliance Management ,,,,,,,,,,
Shire,Mr.,Jeff,Hurley,"Director, Alliance Management Lead ",,,,,,,,,,
Shiseido,,Jadzia Zielinski ,Tirsch,Template,jtirsch@sca.shiseido.com,,,,,,,,,
Shiseido,Ms.,Michelle,Lou,"Executive Director of Makeup Development, Americas Innovation Center at SHISEIDO Americas",mlou@sca.shiseido.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,01/10/2017,,,01/17/2017,
Showa Denko,Mr.,Chen Chin,Toh,Senior Research and Development Engineer at SHOWA Denko HD singapore,chen.chin.toh@showadenko.com,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,bounced,,,,
Showa Denko,Dr.,EIICHI ,KITAKUNI,"President & CEO of Showa Denko America, inc.",,,,,,,,,,
Siemens ,Dr.,Rene,Pompl,Head of TTB Tel Aviv,rene.pompl@siemens.com or rene.pompl@next47.com  ,Breastfeeding monitoring device,onepager,1431,,08/15/2017,08/15/2017,Not interested in this tech. But generally interested in YEDA tech. Therefore has led to a meeting between Igal and Rene.,,
Siemens Healthineers,,,,,,,,,,,,,,
Sigma,Msc,Liel,Aillenberg,"R&D scientist, Technology scouting at Sigma-Aldrich",liel.aillenberg@sial.com,L-DOPA,Using L-DOPA Exclusive Exec Summary,1782,Same Email,07/11/2016,07/11/2016,"Postive - Will review it – 2016-08-31 Replies back, and wants to know more about the applications of the technologies. Orly trying to setup a meeting. 2016-09-13 Not interested",,2016-08-29
Sigma,PhD,Michal ,Daniely,Tech Scouting,michal.daniely@sial.com,L-DOPA,Using L-DOPA Exclusive Exec Summary,1782,,07/11/2016,,,,2016-08-29
Sigma,Msc,Liel,Aillenberg,"R&D scientist, Technology scouting at Sigma-Aldrich",liel.aillenberg@sial.com,,Filter for Nanoparticles,1564,,08/02/2017,08/02/2017,Neutral - Reviewing Technology,,
Sigma,Dr.,Michal ,Daniely,Tech Scouting,michal.daniely@sial.com,,Filter for Nanoparticles,1564,,08/02/2017,,,,
SILAB,Mr.,Brigitte,CLOSS,Template,b.closs@silab.fr,Algal Oil,Algal Oil,1796,,,,,,
SILAB,Dr.,Aurélie,Bruno,Chef de projet management de l'innovation chez Silab,a.bruno@silab.fr,Algal Oil,Algal Oil,1796,,01/10/2017,,,01/17/2017,
Silence Therapeutics,Dr.,Laura,Roca-alonso,Corporate Development & Strategy Manager at Silence Therapeutics plc,l.roca-alonso@silence-therapeutics.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,06/13/2017,Negative - Just simply not of interest to them.,06/13/2017,
Silence Therapeutics,Dr.,Dmitry,Samarsky,"Chief Scientific Officer, Silence Therapeutics",,,,,,,,,,
Silence Therapeutics,Ms.,Alison,Gallafent,Head of Intellectual Property at Silence Therapeutics plc,,,,,,,,,,
Silence Therapeutics,Dr.,Laura,Roca-alonso,Corporate Development & Strategy Manager at Silence Therapeutics plc,l.roca-alonso@silence-therapeutics.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Silence Therapeutics,Dr.,Dmitry,Samarsky,"Chief Scientific Officer, Silence Therapeutics",,,,,,,,,,
Silence Therapeutics,Ms.,Alison,Gallafent,Head of Intellectual Property at Silence Therapeutics plc,,,,,,,,,,
Singapore Airlines,Ms.,Alicia,Chen,Senior Manager Passenger Development at Changi Airport Group (Singapore) Pte Ltd,alicia_chen@singaporeair.com.sg,,,,,,,,,
Singapore Airlines,Mr.,Vinod,Kannan,Vice President at Singapore Airlines,vinod_kannan@singaporeair.com.sg,,,,,,,,,
Singapore Airlines,Mr.,Yung Han,Ng,Vice President Product Innovation at Singapore Airlines,yunghan_ng@singporeair.com.sg,,,,,,,,,
SK Hynix,Mr.,Harish,Arora,Director of Venture Investments,,,,,,,,,,
SK Hynix,Mr.,Richard,Chin,CEO - Americas at SK Hynix semiconductor,,,,,,,,,,
SK Hynix,Mr.,Yongtak,Song,Director of Venture Investment,yongtak.song@US.SKHYNIX.COM,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,,,07/19/2017,
SK Hynix,Mr.,Byung ,Kim,Vice President Mark,BYUNGKYOON.KIM@US.SKHYNIX.COM,,,,,,,,,
SK Hynix,Mr.,Changhyuk,Lee ,Template," 
changhyuk.lee@skhynix.com",,,,,,,,,
Smith & Loveless,Dr.,Weiming (Wayne),Hu,Wastewater Process Engineer at Smith & Loveless Inc.,whu@smithandloveless.com,,Filter for water,1564,,08/02/2017,08/08/2017,Clear no interest,08/08/2017,
Smith & Loveless,,scott,stephens,,sstephens@smithandloveless.com,,,,,,,,,
Smurfit Kappa Group,Mr.,Brian,Fitzpatrick,General Manager at Smurfit Kappa Gosport,brian.fitzpatrick@smurfitkappa.co.uk,Cellulosomes,Cellulosomes,1536,,,,,,
Smurfit Kappa Group,Mr.,Philip,Husband,Innovation Development Director at Smurfit Kappa,,Cellulosomes,Cellulosomes,1536,,,,,,
Smurfit Kappa Group,Mr.,Marcin,Sowik,Innovation & Development Manager at Smurfit Kappa,,Cellulosomes,Cellulosomes,1536,,,,,,
Smurfit Kappa Group,Mr.,Daniel,Mansfeld,Head of R&D,daniel.mansfeld@smurfitkappa.de,Cellulosomes,Cellulosomes,1536,,09/18/2016,,,09/26/2016,
Smurfit Kappa Group,Mr.,Acro,Berkenbosch,Vice President Innovation and Development at Smurfit Kappa,Arco.Berkenbosch@smurfitkapp.nl,Cellulosomes,Cellulosomes,1536,,,,,,
SnowPure Water Technologies,Dr.,Michael,Snow,"Owner, SnowPure Water Technologies",MICHAEL.SNOW@SNOWPURE.COM,,Filter for water,1564,,08/22/2017,,,08/29/2017,
Soligenix,Dr.,Richard,Straube,Chief Medical Officer,,,,,,,,,,
Soligenix,Dr.,Christopher J. ,Schaber,President and CEO,,,,,,,,,,
Soligenix,Ms.,Karen, Krumeich, Chief Financial Officer,kkrumeich@soligenix.com,Catalytic BioScanvangers,ES,1750,2018-07-17 basically asking if any result from their review.,06/20/2018,06/20/2018,Neutral - Sent for Review,,
Solvay,,,,,,,,,Physical Meeting at AUTM,,,,,
Somagenics ,,,,,"bd@somagenics.com
",,,,,,,,,
Somagenics ,Dr.,Brian,Johnston,"CEO at Somagenics, Inc.",bjohnston@somagenics.com,,,,,,,,,
Somagenics ,Dr.,Anne,Dallas,"Principal Scientist at Somagenics, Inc.",adallas@somagenics.com,,,,,,,,,
Somagenics ,Dr.,Sergei,Kazakov,"Vice President for Discovery Research at Somagenics, Inc.",skazakov@somagenics.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
Somagenics ,,,,,"bd@somagenics.com
",,,,,,,,,
Somagenics ,Dr.,Brian,Johnston,"CEO at Somagenics, Inc.",bjohnston@somagenics.com,,,,,,,,,
Somagenics ,Dr.,Anne,Dallas,"Principal Scientist at Somagenics, Inc.",adallas@somagenics.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Somagenics ,Dr.,Sergei,Kazakov,"Vice President for Discovery Research at Somagenics, Inc.",skazakov@somagenics.com,,,,,,,,,
Sony,Mr.,Joseph ,Tou,Vice President / US Investment Manager,joseph.tou@us.sony.com,,,,,,,,,
Sony,Mr.,Tony,Seeff,Sony Strategic Partnerships & Venture Investments,tony.seeff@sony.com,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,07/24/2017,"No, but interested in other techs of WIS.",07/19/2017,
Sorrento Therapeutics,Dr. ,Wenzhong ,Guo,VP in Cell Therapy ,wguo@sorrentotherapeutics.com,,,,,,,,,
Sorrento Therapeutics,Dr.,Robert,Allen,Head of Oncolytic Immunotherapy,rallen@sorrentotherapeutics.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,,07/09/2018,,,07/18/2018,
Southwest,Ms.,Heather,Figallo,Senior Director of Innovation and Labs at Southwest Airlines,heather.figallo@wnco.com,,,,,,,,,
Southwest,Mr.,Reid,Grandle,"Southwest Airlines Vice President, Corporate Strategy & Innovation",reid.grandle@wnco.com,,,,,,,,,
Southwest,Mr.,Carter,Ganss,Senior Director at Southwest Airlines,carter.ganss@wnco.com,,,,,,,,,
SouthWest NanoTechnologies chasmtek - Chasm Advanced Materials,Dr.,Ricardo Prada ,Silvy,Chief Technology Officer (CTO) at Chasm Advanced Materials, rprada@swentnano.com ,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,Bounced,,,,
Spectra Baby,Ms.,Heidi,Humphries,President/CEO Spectra Baby USA/RN/BSN/IBCLC,hprn@aol.com,Breastfeeding monitoring device,onepager,1431,,08/15/2017,,,08/22/2017,
SPHERIUM BIOMED,Dr.,Jorge,Alemany,Director Madrid Office of Sephrium Investment firm, jAlemany@spheriumbiomed.com,1770,,,Orly has already contacted and started a dialogue. Please note he was introduced to the technology during the 2017 BioMed conference.,,,,,
"SpinTek Filtration, Inc.",Mr.,William,Greene,Owner/CEO,WILLIAM.HODGES@BOUTWELLOWENS.COM,,Filter for water,1564,,08/22/2017,,,08/29/2017,
Spring Bank Pharmaceuticals (expand into diabetes?),Mr.,Martin ,Driscoll,CEO, mdriscoll@springbankpharm.com,,,,,,,,,
Spring Bank Pharmaceuticals (expand into diabetes?),Mr.,Donald,Mitchell,"VP, Operations & Corporate Development at Spring Bank Pharmaceuticals",dmitchell@springbankpharm.com,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
Spring Bank Pharmaceuticals (expand into diabetes?),Dr.,Diane,Schmidt,Senior Scientist/Project Manager at SpringBank Pharmaceuticals,,,,,,,,,,
Spring Bank Pharmaceuticals (expand into diabetes?),Mr.,Martin ,Driscoll,CEO, mdriscoll@springbankpharm.com,,,,,,,,,
Spring Bank Pharmaceuticals (expand into diabetes?),Mr.,Donald,Mitchell,"VP, Operations & Corporate Development at Spring Bank Pharmaceuticals",dmitchell@springbankpharm.com,,,,,,,,,
Spring Bank Pharmaceuticals (expand into diabetes?),Dr.,Diane,Schmidt,Senior Scientist/Project Manager at SpringBank Pharmaceuticals,dschmidt@springbankpharm.com,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Stora Enso,,,,,Michael.Walsh@storaenso.com,,,,,,,,,
Stora Enso,Mr.,Axel,Wizemann,Director Strategic Innovation bei Stora Enso Biomaterials / Innovation & Strategic Marketing,Axel.Wizemann@storaenso.com,Cellulosomes,Cellulosomes,1536,Forwarded to Dr. Bassem Hallac,09/18/2016,09/26/2016,They are reviewing the technology - prepared another reminder emial,9/26/2016 and 2016-10-26,
Stora Enso,Dr. ,Bassem,Hallac,"Development Chemist
Innovation & Strategic Marketing ",Bassem.Hallac@storaenso.com,Cellulosomes,Cellulosomes,1536,"Was forwarded by Axel Wizemann to us. He will be meeting on 2016-11-21 with Ed,Orly, Sarah at 11:00 about the technology. NO NDA was signed so only the basics about the technology.",,11/06/2016,,,
Stora Enso,Mr.,Heiner,Grussenmeyer,Direktor Group R&D at Stora Enso,Heiner.Grussenmeyer@storaenso.com,Cellulosomes,Cellulosomes,1536,,,,,,
Strauss Group,Prof.,Eyal,Shimoni,VP Technology of Strauss grou,Eyal.Shimoni@strauss-group.com ,Betalains,Using Betalain Exclusive Exec Summary,1782,,07/11/2016,07/24/2016,Aware of it via the kitchen,07/24/2016,
Strauss Group,CTO,David,Nini,"the ""Kitchen"", Strauss food tech accelerator",david@TheKitchenHub.com,L-DOPA and Betalians,Using Betalian and L-DOPA Exec Summary,1782 + 1587,,07/11/2016,07/11/2016,"Positive - But misunderstood the email, but wants to push forward the technology",,
Subitec,Dr.,Peter,Bergmann,Head of Research & Development,p.bergmann@subitec.com,Algal Oil,Algal Oil,1796,,01/10/2017,,,01/17/2017,
Suez Environnement S.A,Ms.,Victoria ,Savchenko,Business development manager chez SUEZ,victoria.savchenko@suez.com,,Filter for water,1564,,08/02/2017,08/02/2017,Neutral - Reviewing the technology,,
Suez Environnement S.A,Ms.,Doria ,Bendagha,Business developer - Industrial Solutions chez SUEZ International,,,,,,,,,,
Suez Environnement S.A,,,,,julien.desmaretz@suez.com,,,,,,,,,
Suntory Global Innovation,Mr.,Alexander,Nicolau,Strategic Partnerships Officer @ Suntory Global Innovation,Alexandre_Nicolau@suntory.co.jp,Betalains,Using Betalain Exclusive Exec Summary,1782,,07/11/2016,08/10/2016,"Semi-positive: Sending it forward, will be in Israel from the 25th of Sept. 2016. As 2016-08-30 still interested and continuing along, just needs to determine whether the people at Suntory R&D want it.",07/24/2016,2016-08-29
Susavion Biosciences ,,,,,,,,,,,,,,
Svenska Cellulosa Aktiebolaget SCA,,,,, julio.rosas@sca.com,,,,,,,,,
Svenska Cellulosa Aktiebolaget SCA,Ms.,Annia Ballesteros,Mendoza,Strategy & Business Development,annia.mendoza@sca.com,Cellulosomes,Cellulosomes,1536,,,,,,
Svenska Cellulosa Aktiebolaget SCA,Ms.,Stina,Lindlöf,Global Technical Innovation Manager at Sca Hygiene Products,stina.lindlof@sca.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,,,09/26/2016,
Swanson Health Products,Mr.,Shane,Drukee,Chief Innovation Officer at Swanson Health Products,sdrukee@swansonvitamins.com,Colitis Treatment,,1831,Email bounced back,06/01/2017,,,,
Swanson Health Products,Ms.,Amy,Sunderland,Director of Science and Innovation Swanson Health Products,asunerland@swansonvitamins.com,Colitis Treatment,,1831,Email bounced back,06/13/2017,,,,
Swanson Health Products,Mr.,Rick ,Rayl,CEO,RRAYL@SWANSONVITAMINS.COM,,,,,,,,,
Sylentis ,Dr.,Covadonga,Pañeda,R&D Manager,cpaneda@sylentis.com,,,,,,,,,
Sylentis ,Dr.,Ana Isabel,Jiménez,COO and R&D Director,aijimenez@sylentis.com ,TNBC shRNA and Diabetes miRNA,TNBC shRNA and Diabetes miRNA,1619 and 1610,,06/07/2017,,,06/13/2017,
Sylentis ,Dr.,Covadonga,Pañeda,R&D Manager,cpaneda@sylentis.com,,,,,,,,,
Sylentis ,Dr.,Ana Isabel,Jiménez,COO and R&D Director,aijimenez@sylentis.com ,miR-218,ES,1498,,08/16/2017,,,08/23/2017,
Symrise AG,,,,,christina.witter(at)symrise.com.,,,,,,,,,
Symrise AG,Dr. ,Torsten,Kulke,SVP Global Innovation & Regulatory - Fragrances & Oral Care at Symrise,torsten.kulke@symrise.com,Betalain,Betalain,1782,,08/22/2016,,,08/29/2016,
Syncona,Dr.,Alex,Hamilton,Partner,a.hamilton@Synconaltd.com,Universal CAR-T and Synthetic Niche,ES,1884 and 1810,"Alex was very kind to give a very thorough analysis: Thank you very much for sending these materials over. Having reviewed them, they are not suitable for investment by Syncona:

* Prof. Eshhar’s work is interesting but his use of sphingolimod to trap T cells in lymphatics seems challenging from the perspective of product ownership, and there is no development programme; it could be a suitable project for an existing allogeneic CAR-T company to explore.
* Prof. Geiger’s and Prof. Friedman’s expansion method is also good but similarly, in the absence of any development programme, it represents a potential piece of IP for a T cell therapy manufacturer rather than an actual investment thesis for a company.
",07/09/2018,07/11/2018,Negative,,
Syncona,Mr.," Freddie 
",Dear,Partner,,,,,,,,,,
Syncona,Dr.,Alice ,Renard,Partner,,,,,,,,,,
Syngenta,Mr.,Ido ,Margalit,Regional Licensing Manager,ido.margalit@syngenta.com,L-DOPA and Betalians,Using Betalian and L-DOPA Exec Summary,1782 +1587,,07/11/2016,07/11/2016,"Neutral - not interested in GMO technologies, but interested in using CRISPR modified plants…. Which are GMOs…. Still showed some interest in a different Aharoni technology",,
Syngenta,Dr.,Michael ,Lee,"Managing Director, Syngenta Ventures",michael.lee-1@syngenta.com,Carbon Fixing,Carbon Fixing,1736,,01/10/2017,01/13/2017,"No, but redirected us to Ag Tech Accelerator, explicitly John Dombrovksy. 2017-01-27 Final answer is no.",,
Syngenta,Mr.,Ido ,Margalit,Regional Licensing Manager,ido.margalit@syngenta.com,Carbon Fixing,Carbon Fixing,1736,,,,"Reviewing the Technology, looks like he wants to setup a phone call. 2017-01-27 Final answer is no.",,
Synlogic,Dr.,Aoife,Brennan,Chief Medical Officer at Synlogic,aoife@synlogictx.com,,,,,,,,,
Synlogic,Ms.,Samantha,Truex,COO and Head of Corporate Development at Synlogic Therapeutics,samantha@synlogictx.com,,,,,,,,,
Synlogic,Dr.,Dean,Falb,Co-Founder and CTO at Synlogic,dean@synlogictx.com,Genetic Logic Gates,NOR based Device,1764,Forwarded email to Dr. Paul Miller CSO,06/15/2017,,,06/21/2017,
Synlogic,Dr.,Paul,Miller,Chief Scientific Officer,Paul Miller <paul@synlogictx.com>,Genetic Logic Gates,NOR based Device,1764,2017-07-04 sending another reminder email.,,06/23/2017,Neutral - Now reviewing the technology. 2017-07-19 A clear no.,,
Synlogic,Dr.,Caroline,Kurtz,"Head of Translational Sciences & Product Development, Synlogic",caroline@synlogictx.com,,,,,,,,,
Synlogic,,Sarah,Guilmain,, sarahg@synlogictx.com,,,,,,,,,
Synthetic Genomics,Dr. ,Shaun,Bailey,"Synthetic Genomics, Photosynthesis Lead",sbailey@syntheticgenomics.com,Carbon Fixing + Algal Oil,Carbon Fixing + Algal Oil,1736 + 1796,,01/10/2017,,,01/17/2017,
Synthetic Genomics,Dr.,Leslie,Hickle,"Vice President, Business and Strategic Development",lhickle@syntheticgenomics.com,Carbon Fixing + Algal Oil,Carbon Fixing + Algal Oil,1736 + 1796,,email failed,,,,
Synthetic Genomics,Dr.,Todd,Peterson,CTO,tpeterson@syntheticgenomics.com,Carbon Fixing + Algal Oil,Carbon Fixing + Algal Oil,1736 + 1796,,01/23/2017,,,prepared,
Synthetic Genomics,Mr.,Justin,Bingham,Director of Business Development at Synthetic Genomics/SGI-DNA,jbingham@syntheticgenomics.com,Carbon Fixing + Algal Oil,Carbon Fixing + Algal Oil,1736 + 1796,,,,,,
Synthetic Genomics,Dr.,Todd,Peterson,CTO,tpeterson@syntheticgenomics.com,Genetic Logic Gates,NOR based Device,1764,,06/15/2017,,,06/21/2017,
Takeda,Dr. ,Tomo ,Fujisawa,Business Development (Leshem),fujisawa_tomoyuki@takeda.co.jp,,,,,,,,,
Takeda,Dr.,Alison,Handely,"Senior Director, Global Portfolio Strategy at Takeda Pharmaceuticals",,,,,,,,,,
Takeda,Dr.,Yvonne,Dragan,,Yvonne.dragan@takeda.com,,,,,,,,,
Takeda,Ms.,Gray Scholhamer ,Hulick,"Senior Director, Global Alliance Management at Takeda Pharmaceuticals",,,,,,,,,,
Takeda,Dr.,Daniel,Curran,Senior Vice President and Head of the Center for External Innovation at Takeda Pharmaceuticals,daniel.curran@takeda.com,Diabetes treatment augmentation,1-pager,1804,,02/11/2018,,,02/15/2015,
Takeda,Dr.,Daniel,Curran,Senior Vice President and Head of the Center for External Innovation at Takeda Pharmaceuticals,daniel.curran@takeda.com,Mouse monitoring systems,ES,1571 and 1593,,07/17/2018,,,,
Takeda Pharmaceutical Co Ltd,Dr.,Masanori ,Okaniwa,Global Project Manager & Director of Immuno-Oncology Research - ?Takeda Oncology,Masanori_Okaniwa@takeda.co.jp or masanori.okaniwa@takeda.com,Bcl2 inhibitor predictive software,Cover letter,1881,,03/21/2018,,,04/09/2018,
Tamir Biotechnology ,,,,,,,,,,,,,,
Teewinot Life Sciences,Dr.,Richard,Peet,Executive Vice President at Teewinot Life Sciences Corporation,richard@tlscorp.com,Genetic Logic Gates,NOR based Device,1764,,06/15/2017,,,06/21/2017,
Terravia formerly Solazyme,,,,, tday@solazyme.com,,,,,,,,,
Terravia formerly Solazyme,Mr.,Mark,Brooks,"Senior Vice President, Food & Ingredients",mbrooks@solazyme.com,Algal Oil,Algal Oil,1796,,,,,,
Terravia formerly Solazyme,Mr.,Richard,Kenny,"Director, Business Development at Solazyme, Inc.",rkenny@solazyme.com,Algal Oil,Algal Oil,1796,,01/10/2017,,,01/17/2017,
Terravia formerly Solazyme,Dr.,Celine,Schiff-Deb,"Senior Director, Home, Personal Care & Cosmetics at Solazyme, Inc.",celineschiff@hotmail.com or cschiff@solazyme.com or cschiff-deb@solazyme.com,Algal Oil,Algal Oil,1796,,01/23/2017,,,prepared,
TEVA,PhD,Guy J.,Rosenthal,Manager Global Academic Affairs & R&D Networks,guy.rosenthal@teva.co.il,L-DOPA,Using L-DOPA Exclusive Exec Summary,1782,,07/11/2016,07/28/2016,Positive will forward it relevant parties,07/24/2016,2016-08-29
TEVA,PhD,Guy J.,Rosenthal,Manager Global Academic Affairs & R&D Networks,guy.rosenthal@teva.co.il,,,,,,,,,
Texas Instruments,Mr.,Tom ,Kelly,"Director, IoT Ecosystem and Partners at Texas Instruments",t-kelly3@ti.com,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,,,07/19/2017,
Texas Instruments,Mr.,Tim,Velez,Corporate Development | Business Development | M&A | Investments | PMP® ,,,,,,,,,,
Texas Instruments,Mr.,Ralf J,Muenster,"Director, CTO Office at Texas Instruments",,,,,,,,,,
Texas Instruments,,Rama ,Venkatasubramanian,Template,ramav@ti.com,,,,,,,,,
Texas Instruments,,Arjun ,Rajagopal,Template,arjun@ti.com,,,,,,,,,
Thai Airways,Mr.,Narongchai ,Wongthanavimok,Chief Financial Officer at Thai Airways International,Narongchai.w@thaiairways.com,,,,,,,,,
Thai Airways,Mr.,Krittaphon C.,Chantalitanon,Vice President: Aviation Services Support + Alliance & Commercial Strategy at Thai Airways International pcl,krittaphon.c@thaiairways.com,,,,,,,,,
The Campbell Soup Company (V8 Juice),,,,,joseph_fratick@campbellsoup.com,,,,,,,,,
The Campbell Soup Company (V8 Juice),Dr. ,Stacy,Kimmel,"Director of Research and Development, Global Science and Technology at Campbell Soup Company",stacy_kimmel@campbellsoup.com,Cellulosomes and Betalains,Cellulosomes and Betalains,1536 + 1782,,09/18/2016,,,09/26/2016,
The Campbell Soup Company (V8 Juice),Dr.,Menexia,Tsoubeli,"VP R&D - Campbell Fresh Division, Garden Fresh at Campbell Soup Company",menexia_tsoubeli@campbellsoup.com,Cellulosomes and Betalains,Cellulosomes and Betalains,1536 + 1782,,,,,,
The Campbell Soup Company (V8 Juice),Mr.,Carlos,Barroso,Global Research and Development Executive | Food and Beverage Product Development,carlos_barroso@campbellsoup.com,Cellulosomes and Betalains,Cellulosomes and Betalains,1536 + 1782,,,,,,
The Estée Lauder Companies Inc,,Henk,van der MARK,TEMPLATE,hvdmark@be.esteelauder.com,,,,,,,,,
The Estée Lauder Companies Inc,,Thomas,Mammone,TEMPLATE,tmammone@estee.com,,,,,,,,,
The Estée Lauder Companies Inc,Ms.,Taleen,Johnman,Director of Innovation and Strategic Partnerships at The Estée Lauder Companies Inc.,tjohnman@esteelauder.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,01/10/2017,,,01/17/2017,
The Estée Lauder Companies Inc,Ms.,Lisa,Napolione,"Senior Vice President, Global R&D at The Estée Lauder Companies",lnapolione@esteelauder.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,,,,,
The Kroger Co,Ms.,Nancy,Bryant,Food and Beverage R&D Executive | Innovation & Commercialization | Passion for Food and Understanding the Science,Nancyannbryant@snet.net,Cellulosomes and Betalains,Cellulosomes and Betalains,1536 + 1782,,09/18/2016,,,09/26/2016,
Thermofisher Scientific,,,,,,,,,,,,,,
Tmunity,Mr.,Michael,Christiano,Chief Business Office,,,,,,,,,,
Tmunity,Ms.,Elizabeth ,Eberhardt,"Vice President, Portfolio and Project Management ",,,,,,,,,,
"Tobira Therapeutics, Inc. (merged with Regado Biosciences) ",,,,,,,,,,,,,,
Toray ,Dr.,Felix,Nguyen,Principal Research Scientist at Toray Composites,fnguyen@toray-intl.com,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,bounced,,,,
Toray Membrane Europe,Dr.,Jean-Jacques,Lagref,Head of Chemical Operations & e-Strategy Brand ROPUR at Toray Membrane Europe AG,lagref.jeanjacques@toraywater.com,,Filter for water,1564,,08/22/2017,08/22/2017,Neutral - Sending it for review but had a positive perspective on WIS,,
Tower Jazz (Tower Semiconductor),Mr.,Erez ,Sarig,Director of Business Development & Marketing PM/MS BU at TowerJazz,Erez@towersemi.com or erezs or erezsa or erez.sarig@towerjazz.com,,,,,,,,,
TransAlgae ,Dr.,Ofra,Chen,VP R&D at TransAlgae Israel ltd.,info@transalgae.com,Algal Oil,Algal Oil,1796,,hold off,,,,
Transcend Information,Mr.,Andy,Hinkle,"General Manager at Transcend Information, Inc.",ahinkle@transcendusa.com,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,,,07/19/2017,
Trinity Biotech,,,,,,,,,,,,,,
TSMC,Dr.,Carlos H.,Diaz,Senior Director at TSMC,chdiaz@tmsc.com,,,,,,,,,
Turkish Airways,Mr.,Arif Ali,GEZMISOGLU,Customer Experience Manager at Turkish Airlines,agezmisoglu@thy.com,,,,,,,,,
Turkish Airways,Mr.,Ismail,Ozturk,General Manager at Turkish Airlines,iozturk@thy.com or ismailozturk@thy.com,,,,,,,,,
UMC,Mr.,Ching-Cheng,Chai,Marketing & Business Development Professional,Ching-Cheng_Chai@umc.com or ching_cheng_chai@UMC.com or chingchen_chai@UMC.com,,,,,,,,,
UMC,Mr.,Walter ,Ng,"VP, Business Management at United Microelectronics Corporation (UMC)",walter_ng@umc.com,,,,,,,,,
Unilever,Dr.,Gail,Martino,Senior Project Manager-Emerging Technologies at Unilever,Gail.martino@unilever.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,01/10/2017,,,01/17/2017,
Unilever,Dr.,Maria Teresa,Belmar,Open Innnovation-Technology Scouting,maria.belmar@unilever.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,email failed,,,,
United Airlines,Mr.,Elliot,Kadar,"Director, Global Operations Strategy",elliot.kadar@united.com,,,,,,,,,
United Airlines,Ms.,Holly,Hermes,Director - Innovation ,holly.hermes@united.com,,,,,,,,,
United Airlines,Ms.,Rachel,Walker,"Director of Tools and Technology for Global Operations, Strategy, Planning & Design at United Airlines",rachel.walker@united.com,,,,,,,,,
UniVerve ,Mr.,Raanan,Herzog,Managing Partner & CTO at UniVerve Ltd.,raanan@univerve-biofuel.com,Algal Oil,Algal Oil,1796,,01/10/2017,,,01/17/2017,
UniVerve ,Mr.,Ohad,Zuckerman,CEO and Co-Founder ,ohad@univerve-biofuel.com,Algal Oil,Algal Oil,1796,,,,,,
UPM,Mr.,Esa,Laurinsilta,"Director, Strategic Partnerships, Technology at UPM",Esa.Laurinsilta@upm.com,Cellulosomes,Cellulosomes,1536,,09/18/2016,09/27/2016,"Not now but in early 2017, contact Ms. Meri Ventola",09/26/2016,
UPM,Ms.,Meri,Ventola,"Manager, CBB Process Development",Meri.Ventola@upm.com,Cellulosomes,Cellulosomes,1536,Include the previous email from Esa ,01/10/2017,01/17/2017,Meeting setup on 2017-02-07. Went a bit weird. Send them information on 2017-02-07,01/17/2017,
Valens (company),Mr.,Ilan ,Shaari,AVP Business Development at Valens,,,,,,,,,,
Valensa International LLC,Dr.,John,Minatelli,"Sr. VP Business Development at US Nutraceuticals, LLc d/b/a Valensa International",j.minatelli@valensa.com,Colitis Treatment,,1831,,06/01/2017,,No Reply,06/08/2017,
ValiRx Plc,Dr.,Suzanne ,Dilly,Chief Scientific Officer,suzanne.dilly@valirx.com,Bcl2 inhibitor predictive software,Cover letter,1881,,03/21/2018,,,04/09/2018,
Veolia,Mr.,Johann,Clere,Strategic Partnerships Director chez Veolia,johann.clere@veolia.com,,Filter for water,1564,,08/02/2017,,,08/08/2017,
Veolia,Mr. ,Herve ,Buisson,Vice President - Process Engineering at Veolia Water - Solutions and Technologie,,,,,,,,,,
Veolia,Mr.,Kim,Andersen,"Technology Manager, VP at Veolia Water Technologies",kim.andersen@veolia.com,,Filter for water,1564,Forwarded to Catherine DAINES-MARTINEZ,08/22/2017,08/29/2017,Neutral - Sent for Review at the R&I HQ,08/29/2017,
Veolia,Ms. ,Catherine,DAINES-MARTINEZ,Research Group manager on membrane processes,"Daines, Catherine <catherine.daines@veolia.com>",,Filter for water,1564,,,08/31/2017,"Positive sent an NDA, and wants a meeting",,
Veolia,Dr.,Christian ,Ausfelder,,christian.ausfelder@veolia.com,,,,,,,,,
viacyte,Dr.,Evert,Kroon,Senior Director at ViaCyte,ekroon@viacyte.com,,,,,,,,,
viacyte,Dr.,Eugene ,Brandon,"Senior Director, Strategic Relations",ebrandon@viacyte.com,Beta Cell isolation method,ES,1643,,04/15/2018,,,04/23/2018,
Vinayak Ingredients (INDIA) Pvt. Ltd,Mr.,Ashutosh,Biyani,Director of Vinayak Ingredients (India) Private Limited,,Betalain and L-DOPA,Betalain and L-DOPA,,,,,,,
Vinayak Ingredients (INDIA) Pvt. Ltd,,Sisir,Ghosh,Market Research at Vinayak Ingredients (India) Private Limited, sisir9788@hotmail.com,Betalain and L-DOPA,Betalain and L-DOPA,,,,,,,
Virgin,Mr.,Christoffer ,Sundstrom,Business Development Manager at Virgin Atlantic Airways,christoffer.sundstrom@fly.virgin.com,,,,,,,,,
Virgin,Mr.,Oliver,Byers,"Senior Vice President, Global Sales & Customer Loyalty at Virgin Atlantic",oliver.byers@fly.virgin.com,,,,,,,,,
Virgin,Ms.,Rachel,Elson,Vice President Inflight Services at Virgin Atlantic Airways,rachel.elson@fly.virgin.com,,,,,,,,,
Virgin,Ms.,Rebecca,Brooks-Daw,Senior Customer Experience Manager at Virgin Atlantic Airways,rebecca.brooks-daw@fly.virgin.com,,,,,,,,,
Vitamin Shoppe,,,,,Elyssa Meier elyssa.meier@vitaminshoppe.com,,,,,,,,,
Vitamin Shoppe,Mr.,Colin,Watts,Chief Health Enthusiast/CEO at The Vitamin Shoppe,colin.watts@vitaminshoppe.com,,,,,,,,,
Vitamin Shoppe,Mr.,Brian,Tanzer,"Manager of Scientific Affairs, The Vitamin Shoppe",brian.tanzer@vitaminshoppe.com,Colitis Treatment,,1831,,06/01/2017,01/06/2017,Negative,06/06/2017,
Vivus,, Timothy E,Morris,,morris@vivus.com,,,,,,,,,
Vivus,Mr.,Mark,Oki,CFO,oki@vivus.com,,,,,,,,,
Vivus,Ms.,Deborah,Larsen,"Vice President, CCO at VIVUS, Inc.",larsen@vivus.com,,,,,,,,,
Vivus,Mr. ,Seth,Fischer,CEO,Fischer@vivus.com,,,,,,,,,
"WesTech Engineering, Inc.",Ms.,Libbie,Linton,"Group Leader, Membrane Filtration | WesTech Engineering",llinton@westech-inc.com,,Filter for water,1564,Auto reply 2017-08-22,08/22/2017,,,08/29/2017,
"WesTech Engineering, Inc.",Mr.,Rex,Plaizier,CEO,RPLAIZIER@WESTECH-INC.COM,,,,,,,,,
Western Digital,Mr.,Colm ,Lysaght,"Vice President, Corporate Strategy & Innovation at Western Digital",,,,,,,,,,
Western Digital,Dr.,Andrey,Ovcharenko ,"Engineering Technologist at WD, a Western Digital company",andrey.ovcharenko@wdc.com,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,07/19/2017,"No, not the right person/tech. Need SDD technology.",07/19/2017,
"WILD Flavors, Inc",Ms.,Suzanne Oberer,McCubbin,International Business Development Manager,suzanne.oberer@gmail.com,Betalain,Betalain,1782,,07/27/2016,,,08/03/2016,
"WILD Flavors, Inc",Mr.,Chris ,Williams,Chief Flavorist at WILD Flavors and Specialty Ingredients,,,,,,,,,,
Winbond,Mr.,Anil,Gupta,Technical Executive at Winbond,agupta@WINBOND.COM,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,07/19/2017,Reviewing,07/19/2017,
Wintec Industries,Mr.,Bhaskar ,Bhatt,Chief Technology Officer (CTO) at Wintec Industries,BHASKARB@WINTECIND.COM,Multi-state polymers for memory and logic gates,Web page,1568,,07/05/2017,,,07/19/2017,
Wintec Industries,Mr.,Sanjay ,Bonde,Chief Executive Officer - Corporate,sanjayb@wintecind.com,,,,,,,,,
Working with Bayer in Agriculture,,Trendlines,,,info@trendlines.com,http://www.globes.co.il/en/article-bayer-trendlines-to-invest-10m-in-israeli-agritech-1001118943,,1587,,,,,,
WRL,Mr.,Udi,Cottam,Managing Director,udi@wrl-ltd.com,Carbon Fixing,Carbon Fixing,1736,,01/16/2017,,,,
WRL,Mr.,Uri,Fishelson,Technology Scouting & Business Development,uri@wrl-ltd.com,Carbon Fixing,Carbon Fixing,1736,,01/16/2017,,,,
WRL (BASF),Mr.,Udi,Cottam,Managing Director,udi@wrl-ltd.com,Colitis Treatment,,1831,,06/01/2017,06/07/2017,Negative - BASF not focused on supplementals with clinical effects,,
WRL (BASF),Mr.,Uri,Fishelson,Technology Scouting & Business Development,uri@wrl-ltd.com,Colitis Treatment,,1831,,06/01/2017,06/07/2017,Negative - BASF not focused on supplementals with clinical effects,,
WRL (BASF),Mr.,Udi,Cottan,Managing Director,udi@wrl-ltd.com,,Filter for Nanoparticles and water,1564,,08/02/2017,08/06/2017,Neutral - Reviewing the technology.,,
WRL (BASF),Mr.,Uri,Fishelson,Technology Scouting & Business Development,uri@wrl-ltd.com,,Filter for Nanoparticles and water,1564,They are explicitly focused on the water usage of the technology.,08/02/2017,08/06/2017,Neutral - Reviewing the technology.,,
Wuxi AppTec,Dr.,Michael,Gassen,Vice President DMPK,michael_gassen@wuxiapptec.com,Mouse monitoring systems,ES,1571 and 1593,,07/04/2018,,,07/17/2018,
Wuxi AppTec,Dr.,Jing,Li,Senior Vice President,,,,,,,,,,
Wuxi AppTec,Dr.,Norman,Zhang,Senior Director,,,,,,,,,,
Xintek,Dr.,Andrew ,Tucker,"Project Manager at Xintek, Inc.",atucker@xintek.com,,,,,,,,,
Xintek,Dr.,Peng,Wang,"Research Scientist at Xintek, Inc.",pwang@xintek.com,,,,,,,,,
Xintek,Dr. ,CHENG ,Qian,Director Of R&D,CQian@xintek.com,Nanocomposite - Carbon Nantubes dispersed in Organic nanocrytals,1-pager,1867,,03/21/2018,,,,
Yield10 Bioscience (formerly Metabolix),Dr. ,Kristi,Snell ,Chief Science Officer and Vice President of Research at Yield10 Bioscience/Metabolix,snell@metabolix.com,Carbon Fixing,Carbon Fixing,1736,,01/10/2017,,,01/17/2017,
Yield10 Bioscience (formerly Metabolix),Dr. ,Kristi,Snell ,Chief Science Officer and Vice President of Research at Yield10 Bioscience/Metabolix,snell@metabolix.com,Genetic Logic Gates,NOR based Device,1764,,06/15/2017,,,06/21/2017,
Yves Rocher,,ORMANCEY,XAVIER,Template,xavier.ormancey@yrnet.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,,,,,
Yves Rocher,Mr.,Christian,Lubrano,Responsable du Pôle Innovation du végétal at Yves Rocher,christian.lubrano@yrnet.com,Betalain+ Algal Oil ,Betalain+ Algal Oil,1782 + 1796 ,,01/10/2017,01/18/2017,Interested but no reply since I wrote back to him.,01/17/2017,
Zafgen,Dr.,James,Vath,Head of Discovery and Development,jvath@zafgen.com,,,,,,,,,
Zafgen,Dr.,Dennis,Kim,"Chief Medical Officer at Zafgen, Incorporated",dkim@zafgen.com,,,,,,,,,
Zafgen,Dr.,Michelle Howard,Sparks,"Head of Product Development at Zafgen, Incorporated",msparks@zafgen.com,,,,,,,,,
Zata Pharmaceuticals ,Dr.,David,Tabatadze,President and CEO,dtabatadze@zatapharmaceuticals.com,,,,,,,,,
Zealand Pharma,,,,,,,,,,,,,,
Zelig Eshhar 1884 Universal CAR-T and 1810 SIN ,,,,,,,,,,,,,,
Zeon Nanon,,,,,,,,,,,,,,
Ziopharm ,Dr.,Ellee ,de Groot,"SVP, Program Management and Business Development",edegroot@ziopharm.com,,,,,,,,,
Ziopharm ,Dr.,Francois ,Lebel,Executive Vice President Research & Development,flebel@ziopharm.com,Universal CAR-T,ES,1884,,06/21/2018,07/09/2018,No interest,07/09/2018,
Zivo Bioscience,Dr.,Amy,Steffek,"Director of Research & Development at Zivo Biosciences, INC",info@zivobioscience.com,Algal Oil,Algal Oil,1796,,01/10/2017,,,01/17/2017,
Zydus Pharmaceuticals,Mr.,Marc,Kikuchi,"CEO - Americas at Zydus Pharmaceuticals USA, Inc.",mkikuchi@zydususa.com,Diabetes treatment augmentation,1-pager,1804,,02/11/2018,,,02/15/2018,
Zymergen,,Ruba,Asmussen,Recruiter,ruba@zymergen.com,,,,,,,,,
Zymergen,Dr.,Adam,Safir,"Vice President, Materials Research and Development ",asafir@zymergen.com,Carbon Fixing + Betalain/L-DOPA,Carbon Fixing + Betalain/L-DOPA,1736+1782,,01/10/2017,01/12/2017,"No for now, but maybe in the future, so really no.",,
Zymergen,Dr. ,Zach,Serber,"CSO, VP of Development, and Co-Founder",zach@zymergen.com or zserber@zymergen.com,Carbon Fixing + Betalain/L-DOPA,Carbon Fixing + Betalain/L-DOPA,1736+1782,,,,,,
Zymergen,Dr.,Adam,Safir,"Vice President, Materials Research and Development ",asafir@zymergen.com,Genetic Logic Gates,NOR based Device,1764,,06/15/2017,,,06/21/2017,
Zymergen,Dr.,Adam,Safir,"Vice President, Materials Research and Development ",asafir@zymergen.com,PFL metabolic pathway for Formate + Acetate conversion to Pyruvate,ES,1657,,01/30/2018,,,02/06/2018,
,,,,,,,,1587,,,,,,
,,,,,,,,1587,,,,,,
,,,,,,,,1587,,,,,,
,,,,,,,,1587,,,,,,
,,,,,,,,1587,,,,,,
,,,,,,,,1587,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,anna.stape@sensient.com,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,susan.brunner@mondigroup.com,,,,,,,,,
,,,,,hugo_damours@cascades.com,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,John Littlewood jlittlewood@lallemand.com,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,Dr.,Greg,Schrieber,,gschreiber@intrexon.com,Carbon Fixing + Betalain,Carbon Fixing + Betalain,1736+1782,,,,,,
,,,,,,,,,,,,,,
,Dr.,Zhigang,Zhang,Research Scientist,zzgmbx@gmail.com,Carbon Fixing,Carbon Fixing,1736,,,,,,
,,,,,,,,,,,,,,
,,Peter,Pucher,Template,peter.pucher@bdi-bioenergy.com,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,Bryan ,Dudash,Template,bdudash@nvidia.com,,,,,,,,,
,,,,,,,,,,,,,,
,,art,lamstein,Director of Marketing,artlamstein@qmcdots.com,,,,,,,,,
,,,,,,,,,,,,,,
,,jutta,Quaiser,,jutta.quaiser@envirochemie.com ,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,jais,lawson,Template, jais.lawson@cardinalhealth.com ,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
Pfizer Inc.,,Arpita,Maiti,Inflammation & Immunology,arpita.maiti@pfizer.com,,,,,,,,,
Pfizer Inc.,,Lauren,Shearman,Internal Medicine,lauren.shearman@pfizer.com,,,,,,,,,
Pfizer Inc.,,Laszlo,Kiss,Neurodegenerative Diseases,laszlo.kiss@pfizer.com,,,,,,,,,
Pfizer Inc.,,Fan,Zhang,Cancer Vaccines,fan.zhang8@pfizer.com,,,,,,,,,
Pfizer Inc.,,Hilde,Stubdal,Immuno-Oncology,hilde.stubdal@pfizer.com,,,,,,,,,
Pfizer Inc.,,Denis,Patrick,Targeted Drug Delivery,denis.patrick@pfizer.com,,,,,,,,,
Pfizer Inc.,,Aileen,Healy,Rare Disease,aileen.healy@pfizer.com,,,,,,,,,
Pfizer Inc.,,Barbara,Sosnowski,Vaccines,barbara.sosnowski@pfizer.com,,,,,,,,,
Pfizer Inc.,,Melissa,Fitzpatrick,Tumor Cell Biology,melissamarie.fitzgerald@pfizer.com,,,,,,,,,
Pfizer Inc.,,Anthony,Barry,Drug Safety,anthony.b.barry@pfizer.com,,,,,,,,,
Pfizer Inc.,,Donna,Armentano,Gene Therapy,donna.armentano@pfizer.com,,,,,,,,,
Pfizer Inc.,,Barbara,Sosnowski,Genome Sciences & Technologies,barbara.sosnowski@pfizer.com,,,,,,,,,
Pfizer Inc.,,Anthony,Barry,Medicinal Sciences,anthony.b.barry@pfizer.com,,,,,,,,,
Pfizer Inc.,,Fan,Zhang,Precision Medicine,fan.zhang8@pfizer.com,,,,,,,,,
Pfizer Inc.,,Uwe,Schoenbeck,"Global Scouting, Regional Activities, Seed",uwe.schoenbeck@pfizer.com,,,,,,,,,
Pfizer Inc.,,Yuan-Hua,Ding,Investments,yuan-hua.ding@pfizer.com,,,,,,,,,
Pfizer Inc.,,David,Shields,Centers for Therapeutic Innovation (CTI),david.shields@pfizer.com,,,,,,,,,
Pfizer Inc.,,Joe,Dal Porto,Centers for Therapeutic Innovation (CTI),joseph.dalporto@pfizer.com,,,,,,,,,
Pfizer Inc.,,Denis,Patrick,R&D Innovate (RDI),denis.patrick@pfizer.com,,,,,,,,,
Pfizer Inc.,,Sree,Kant,Innovative Partnering Models,sree.kant@pfizer.com,,,,,,,,,
Pfizer Inc.,,James,Eshelby,Innovative Medicines Initiatives,james.eshelby@pfizer.com,,,,,,,,,
Pfizer Inc.,,Daniel,Karp,Inflammation & Immunology,daniel.karp@pfizer.com,,,,,,,,,
Pfizer Inc.,,Erik,Kuja,Internal Medicine,kujaEW@pfizer.com,,,,,,,,,
Pfizer Inc.,,Brenda,Lammers,Internal Medicine,brenda.k.lammers@pfizer.com,,,,,,,,,
Pfizer Inc.,,tefanie,Hansen,Oncology,stefanie.hansen@pfizer.com,,,,,,,,,
Pfizer Inc.,,Anne-Marie,Mueller,Oncology,anne-marie.mueller@pfizer.com,,,,,,,,,
Pfizer Inc.,,Leslie,Coney,Rare Disease,leslie.coney@pfizer.com,,,,,,,,,
Pfizer Inc.,,Stefanie,Hansen,Vaccines,stefanie.hansen@pfizer.com,,,,,,,,,
Pfizer Inc.,,Anne-Marie,Mueller,Vaccines,anne-marie.mueller@pfizer.com,,,,,,,,,
Pfizer Inc.,,Rob,Sinclair,Vaccines,rob.sinclair@pfizer.com,,,,,,,,,
Pfizer Inc.,,Evan,Cooper,Therapeutic Modalities and Technology Platforms,evan.cooper@pfizer.com,,,,,,,,,
Pfizer Inc.,,Michael,Flakus,Therapeutic Modalities and Technology Platforms,michael.l.flakus@pfizer.com,,,,,,,,,
Pfizer Inc.,,Tina,Goss,Therapeutic Modalities and Technology Platforms,tina.goss@pfizer.com,,,,,,,,,
Pfizer Inc.,,Anne-Marie,Mueller,Therapeutic Modalities and Technology Platforms,anne-marie.mueller@pfizer.com,,,,,,,,,
Pfizer Inc.,,Teesha,Smith,Precision Medicine/Diagnostics,teesha.l.smith@pfizer.com,,,,,,,,,
Pfizer Inc.,,Olivier,Drap,Partnering Platforms,olivier.drap@pfizer.com,,,,,,,,,
Pfizer Inc.,,Melissa,Whorton,Centers for Therapeutic Innovation (CTI),melissa.whorton@pfizer.com,,,,,,,,,
Pfizer Inc.,,Margi,McLoughlin,R&D Innovate (RDI),margi.mcloughlin@pfizer.com,,,,,,,,,
Pfizer Inc.,,Uwe,Schoenbeck,"Global & Regional Scouting Americas, EU & Israel",uwe.schoenbeck@pfizer.com,,,,,,,,,
Pfizer Inc.,,Yuan-Hua-Ding,,Global & Regional Scouting Asia/Pacific,yuan-hua.ding.@pfizer.com,,,,,,,,,
Pfizer Inc.,,Anand,Gautam,Global & Regional Scouting Australia/New Zealand/Southeast Asia,anand.gautam@pfizer.com,,,,,,,,,
Pfizer Inc.,,Patrice,Roy,Global & Regional Scouting Canada,patrice.roy@pfizer.com,,,,,,,,,
Pfizer Inc.,,Juan,Liu,Global & Regional Scouting China,juan.liu7@pfizer.com,,,,,,,,,
Pfizer Inc.,,Xin,Zhao,Global & Regional Scouting China,xin.zhao@pfizer.com,,,,,,,,,
Pfizer Inc.,,Nathalie,ter Wengel,Global & Regional Scouting Europe,nathalie.terwengel@pfizer.com,,,,,,,,,
Pfizer Inc.,,Olivia,Bussod,Global & Regional Scouting France,olivia.bussod@pfizer.com,,,,,,,,,
Pfizer Inc.,,Marie-Pierre,Chevalier,Global & Regional Scouting France,marie-pierre.chevalier@pfizer.com,,,,,,,,,
Pfizer Inc.,,Sabrina,Lesage,Global & Regional Scouting France,sabrina.lesage@pfizer.com,,,,,,,,,
Pfizer Inc.,,Peter,Loeschmann,Global & Regional Scouting Germany,peter-andreas.loeschmann@pfizer.com,,,,,,,,,
Pfizer Inc.,,Johan,Brun,Global & Regional Scouting Scandinavia,johan.brun@pfizer.com,,,,,,,,,
Pfizer Inc.,,Pal,Falck,Global & Regional Scouting Scandinavia,pal.falck@pfizer.com,,,,,,,,,
Pfizer Inc.,,Nick,Clarke,Global & Regional Scouting UK,nick.clarke@pfizer.com,,,,,,,,,
Pfizer Inc.,,James,Eshelby,Global & Regional Scouting UK,james.eshelby@pfizer.com,,,,,,,,,
Pfizer Inc.,,Olga,Krylova,Global & Regional Scouting UK,olga.krylova@pfizer.com,,,,,,,,,
Pfizer Inc.,,Tamara,Mansfeld,Global & Regional Scouting Israel,tamara.mansfeld@pfizer.com,,,,,,,,,
Pfizer Inc.,,Toru,Seo,Global & Regional Scouting Japan,toru.seo@pfizer.com,,,,,,,,,
Pfizer Inc.,,Luis,Yamamoto,Global & Regional Scouting Japan,luis.yamamoto@pfizer.com,,,,,,,,,
Pfizer Inc.,,Yoon-Duk,Han,Global & Regional Scouting Korea,yoon-duk.han@pfizer.com,,,,,,,,,
Pfizer Inc.,,Soo-Hyeon,Lee,Global & Regional Scouting Korea,soo-hyeon.lee@pfizer.com,,,,,,,,,
Pfizer Inc.,,Young-Min,Chung,Global & Regional Scouting South Asia,young-min.chung@pfizer.com,,,,,,,,,
Pfizer Inc.,,Molly,Chen,Global & Regional Scouting Taiwan,mei-ling.molly.chen@pfizer.com,,,,,,,,,
Pfizer Inc.,,Mary,Faris,Global & Regional Scouting USA,mary.faris@pfizer.com,,,,,,,,,
Pfizer Inc.,,Nader,Halim,Global & Regional Scouting USA,nader.halim@pfizer.com,,,,,,,,,
Pfizer Inc.,,Linda,Lohr,Global & Regional Scouting USA,linda.l.lohr@pfizer.com,,,,,,,,,
Pfizer Inc.,,Felice,Shieh,Global & Regional Scouting USA,felice.shieh@pfizer.com,,,,,,,,,
AbbVie,,James,Purcell,Program Director - Oncology Discovery at AbbVie Stemcentr,james.purcell@abbvie.com,,,,,,,,,
AbbVie,Dr.,George,Haig,Group Project Leader at AbbVie,george.haig@abbvie.com,,,,,,,,,
AbbVie,,Eric,Blomme,Vice President Development Biological Sciences at AbbVie,eric.blomme@abbvie.com,,,,,,,,,
AbbVie,Dr.,Marc,Valentin,Strategic Health Projects Manager bei AbbVie,marc.valentin@abbvie.com,,,,,,,,,
AbbVie,,Carlos,Taveras,Versatile and Experienced Communications Strategist,carlos.taveras@abbvie.com,,,,,,,,,
Novartis AG,Dr.,Avi,Spier,"Director, NIBR BD&L, Search and Evaluation, Novartis",avi.spier@novartis.com,MRSA crystal structure,MRSA crystal scture (shortened),1760,,05/11/2017,,Negative,05/22/2017,
Pfizer Inc.,Dr.,Chakrapani,Subramanyam,Associate Res. Fellow at Pfizer,Chakrapani.Subramanyam@pfizer.com,,,,,,,,,
pherecydes-pharma,Dr.,Jérôme,Gabard,CEO - Pherecydes Pharma ,jerome.gabard@pherecydes-pharma.com,,,,,,,,,
pherecydes-pharma,Dr.,Patrick,Champion-Arnaud,Manufacturing Director at Pherecydes Pharma,patrick.champion-arnaud@pherecydes-pharma.com,,,,,,,,,
Adaptive Phage Therapeutics,Dr.,Greg,Merril,CEO,gmerril@aphage.com ,,,,,,,,,
AmpliPhi Biosciences,Dr.,Sandra,Morales,Global Head of Research at AmpliPhi Biosciences,spm@ampliphibio.com,,,,,,,,,
"C3J Therapeutics, Inc.",Dr.,Brian Varnum,,Chief Development Officer,bvarnum@c3jtherapeutics.com,,,,,,,,,
"C3J Therapeutics, Inc.",Dr.,Pierre Kyme,,Business Development,pkyme@c3jtherapeutics.com,,,,,,,,,
enbiotix,Dr.,Ben Perrone,,"Manager, Business Development",Ben.Perrone@EnBiotix.com,,,,,,,,,
enbiotix,Dr.,Diane Joseph -McCarthy,,"Vice President, Translational Science at EnBiotix, Inc.","Vice President, Translational Science at EnBiotix, Inc.",,,,,,,,,
"Intralytix, Inc",Dr., Alexander Sulakvelidze,,Executive Vice President and Chief Scientific Officer of Intralytix,asulakvelidze@intralytix.com,,,,,,,,,
"Intralytix, Inc",Dr.,Joelle Woolston,,Research Scientist/Laboratory Manager at Intralytix,jwoolston@intralytix.com ,,,,,,,,,
,,,,,,,,,,,,,,
"Phagelux, Inc.",Dr.,Rosemonde Mandeville,, Chief Scientific Officer of Phagelux,mandeville@phagelux.com,,,,,,,,,
"OmniLytics, Inc.",Mr.,Tyler Homer,,Director of Regulatory Affairs & New Product Development ,thomer@omnilytics.com ,,,,,,,,,
Phage Biotech Ltd,Mr.,Asher Wilf,,"CEO, Phage Biotech Ltd.",asher@phage-biotech.com ,,,,,,,,,
phageguard,Mr.,Dirk de Meester ,,Director Business Development at MICREOS,d.demeester@micreos.com ,,,,,,,,,
phageguard,Mr.,Wim Nuboer,,Director Business Development,w.nuboer@micreos.com,,,,,,,,,
,,,,,,,,,,,,,,
Proteon Pharmaceuticals,Dr.,Jaros?aw DASTYCH,,"CEO, Proteon Pharmaceuticals",jdastych@proteonpharma.com <jdastych@proteonpharma.com>;,,,,,,,,,
